note_text,diagnostic_bronchoscopy,bal,bronchial_wash,brushings,endobronchial_biopsy,transbronchial_biopsy,transbronchial_cryobiopsy,tbna_conventional,linear_ebus,radial_ebus,navigational_bronchoscopy,therapeutic_aspiration,foreign_body_removal,airway_dilation,airway_stent,thermal_ablation,cryotherapy,mechanical_debulking,brachytherapy_catheter,blvr,peripheral_ablation,bronchial_thermoplasty,whole_lung_lavage,rigid_bronchoscopy,photodynamic_therapy,thoracentesis,chest_tube,ipc,medical_thoracoscopy,pleural_biopsy,pleurodesis,fibrinolytic_therapy,verified_cpt_codes,source_file
"31629 (TBNA), 31623 (Brush), 31627 (Nav), 31654 (EBUS). Small 8mm target required TiLT+ precision (1.1cm correction). ROSE positive for malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"31629 (TBNA), 31624 (BAL), 31626 (Marker), 31627 (Nav), 31654 (EBUS). Forceps bundled. 0.8cm TiLT correction.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"31629 (TBNA), 31627 (Nav), 31654 (EBUS). 1.9cm divergence corrected by TiLT+.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"31629 (TBNA), 31627 (Nav), 31654 (EBUS). Forceps bundled. 11mm target reached with Galaxy/Fluoroscopy.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Adam Rogers
MRN: 2719112
DOB: 04/07/1959
Date: 02/21/2024
Physician: David Kim, MD
===============================================

[INDICATION]
Primary: Right upper lobe mass with ipsilateral mediastinal nodes
Category: Lung Cancer Staging
Target: 27.1mm Ground-glass lesion, LLL posterior basal (B10)
Bronchus Sign: Positive
PET SUV: 15.4

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 85 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC260F-OL8
- Needle: 19G FNB/ProCore
- Stations sampled: 2L, 4R, 7, 11R
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - squamous cell carcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.9mm
- Target: LLL posterior basal (B10)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 3
- Brushings: 2
- ROSE result: Atypical cells

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: David Kim, MD
Date: 02/21/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Alexander White
MRN: 4719392
DOB: 04/12/1970
Date: 09/13/2024
Physician: Michael Rodriguez, MD
===============================================

[INDICATION]
Primary: Right upper lobe mass with ipsilateral mediastinal nodes
Category: Lung Cancer Staging
Target: 28.6mm Ground-glass lesion, RLL lateral basal (B9)
Bronchus Sign: Negative
PET SUV: 8.9

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 92 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC260F-OL8
- Needle: 21G Standard FNA
- Stations sampled: 10R, 11R, 11L, 2R, 4L
- Number of stations: 5 (≥3)
- ROSE available: Yes
- ROSE result: Atypical cells

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 2.6mm
- Target: RLL lateral basal (B9)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 5
- TBNA passes: 4
- Brushings: 2
- ROSE result: Malignant - adenocarcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Michael Rodriguez, MD
Date: 09/13/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Angela Edwards
MRN: 4546122
DOB: 06/10/1959
Date: 06/25/2024
Physician: Brian O'Connor, MD
===============================================

[INDICATION]
Primary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 15.4mm Ground-glass lesion, RML lateral (B4)
Bronchus Sign: Positive
PET SUV: 4.3

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 105 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 21G Standard FNA
- Stations sampled: 10R, 4L, 4R, 11L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Adequate lymphocytes

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.5mm
- Target: RML lateral (B4)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 4
- Brushings: 2
- ROSE result: Atypical cells

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Brian O'Connor, MD
Date: 06/25/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Benjamin James
MRN: 7083224
DOB: 06/24/1967
Date: 10/20/2024
Physician: David Kim, MD
===============================================

[INDICATION]
Primary: PET-avid lung mass and mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 23.3mm Solid lesion, RLL medial basal (B7)
Bronchus Sign: Negative
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 139 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 22G Standard FNA
- Stations sampled: 2R, 10R, 2L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 1.9mm
- Target: RLL medial basal (B7)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 5
- TBNA passes: 4
- Brushings: 2
- ROSE result: Adequate lymphocytes, no malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: David Kim, MD
Date: 10/20/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Brenda Baker
MRN: 8459814
DOB: 10/01/1968
Date: 06/23/2025
Physician: Robert Patel, MD
===============================================

[INDICATION]
Primary: Peripheral nodule and bilateral hilar adenopathy
Category: Lung Cancer Staging
Target: 21.6mm Ground-glass lesion, RUL anterior (B3)
Bronchus Sign: Negative
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 85 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 22G Standard FNA
- Stations sampled: 10L, 4L, 11L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.8mm
- Target: RUL anterior (B3)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 8
- TBNA passes: 4
- Brushings: 2
- ROSE result: Granuloma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Robert Patel, MD
Date: 06/23/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Carolyn Walker
MRN: 4978533
DOB: 04/10/1940
Date: 04/03/2025
Physician: Rachel Goldman, MD
===============================================

[INDICATION]
Primary: Peripheral nodule and bilateral hilar adenopathy
Category: Lung Cancer Staging
Target: 14.0mm Ground-glass lesion, LUL apicoposterior (B1+2)
Bronchus Sign: Negative
PET SUV: 17.6

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 114 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 22G FNB/ProCore
- Stations sampled: 2L, 4L, 10R, 10L, 11L
- Number of stations: 5 (≥3)
- ROSE available: Yes
- ROSE result: Atypical cells

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.5mm
- Target: LUL apicoposterior (B1+2)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 2
- Brushings: 2
- ROSE result: Adequate lymphocytes, no malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Rachel Goldman, MD
Date: 04/03/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Christina Hall
MRN: 2751013
DOB: 05/07/1959
Date: 01/10/2024
Physician: Brian O'Connor, MD
===============================================

[INDICATION]
Primary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 14.5mm Ground-glass lesion, RUL anterior (B3)
Bronchus Sign: Positive
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 136 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 19G FNB/ProCore
- Stations sampled: 11L, 7, 2L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 3.2mm
- Target: RUL anterior (B3)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 4
- Brushings: 2
- ROSE result: Atypical cells

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Brian O'Connor, MD
Date: 01/10/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Christine Ortiz
MRN: 6327293
DOB: 03/05/1971
Date: 07/05/2024
Physician: Maria Santos, MD
===============================================

[INDICATION]
Primary: Right upper lobe mass with ipsilateral mediastinal nodes
Category: Lung Cancer Staging
Target: 31.9mm Ground-glass lesion, LLL anteromedial basal (B7+8)
Bronchus Sign: Negative
PET SUV: 13.4

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 119 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 22G Acquire
- Stations sampled: 11L, 2L, 7, 11R, 10R
- Number of stations: 5 (≥3)
- ROSE available: Yes
- ROSE result: Suspicious for malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 3.2mm
- Target: LLL anteromedial basal (B7+8)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 3
- Brushings: 2
- ROSE result: Suspicious for malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Maria Santos, MD
Date: 07/05/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Deborah Martinez
MRN: 8176549
DOB: 10/05/1946
Date: 01/10/2024
Physician: Maria Santos, MD
===============================================

[INDICATION]
Primary: Combined staging and peripheral nodule diagnosis
Category: Lung Cancer Staging
Target: 16.3mm Part-solid lesion, RUL anterior (B3)
Bronchus Sign: Positive
PET SUV: 12.4

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 75 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC180F
- Needle: 21G Standard FNA
- Stations sampled: 2L, 10L, 7
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - adenocarcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 3.0mm
- Target: RUL anterior (B3)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - adenocarcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Maria Santos, MD
Date: 01/10/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Douglas Watson
MRN: 3367578
DOB: 08/21/1977
Date: 11/26/2025
Physician: Andrew Nakamura, MD
===============================================

[INDICATION]
Primary: Combined staging and peripheral nodule diagnosis
Category: Lung Cancer Staging
Target: 16.3mm Ground-glass lesion, RLL superior (B6)
Bronchus Sign: Positive
PET SUV: 6.9

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 94 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 22G Standard FNA
- Stations sampled: 11L, 4L, 10L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Granuloma

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 3.4mm
- Target: RLL superior (B6)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 4
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Andrew Nakamura, MD
Date: 11/26/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Gary Cook
MRN: 3691751
DOB: 03/11/1977
Date: 08/02/2024
Physician: Eric Johnson, MD
===============================================

[INDICATION]
Primary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 19.5mm Solid lesion, RLL posterior basal (B10)
Bronchus Sign: Positive
PET SUV: 5.4

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 91 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 19G FNB/ProCore
- Stations sampled: 10R, 7, 2R, 4R
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - adenocarcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 3.2mm
- Target: RLL posterior basal (B10)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 3
- Brushings: 2
- ROSE result: Malignant - NSCLC NOS

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Eric Johnson, MD
Date: 08/02/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Jerry Stewart
MRN: 4555645
DOB: 07/01/1941
Date: 04/01/2024
Physician: Lisa Thompson, MD
===============================================

[INDICATION]
Primary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 31.5mm Part-solid lesion, RML medial (B5)
Bronchus Sign: Positive
PET SUV: 7.9

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 105 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 22G Standard FNA
- Stations sampled: 4R, 4L, 10R, 2L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - squamous cell carcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 3.2mm
- Target: RML medial (B5)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 5
- TBNA passes: 4
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Lisa Thompson, MD
Date: 04/01/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Jonathan Peterson
MRN: 2350043
DOB: 01/13/1969
Date: 11/28/2024
Physician: Brian O'Connor, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 31.2mm Solid lesion, LUL inferior lingula (B5)
Bronchus Sign: Positive
PET SUV: 5.0

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 78 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC180F
- Needle: 22G Acquire
- Stations sampled: 10R, 4R, 2L, 2R, 4L
- Number of stations: 5 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.2mm
- Target: LUL inferior lingula (B5)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Brian O'Connor, MD
Date: 11/28/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Jonathan Ramirez
MRN: 4591666
DOB: 03/20/1973
Date: 04/30/2024
Physician: Amanda Foster, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 27.1mm Solid lesion, RLL superior (B6)
Bronchus Sign: Negative
PET SUV: 6.1

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 108 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 22G FNB/ProCore
- Stations sampled: 4L, 2R, 2L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Suspicious for malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.8mm
- Target: RLL superior (B6)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 5
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Amanda Foster, MD
Date: 04/30/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Joseph Moore
MRN: 4236971
DOB: 03/08/1946
Date: 09/27/2024
Physician: Rachel Goldman, MD
===============================================

[INDICATION]
Primary: Right upper lobe mass with ipsilateral mediastinal nodes
Category: Lung Cancer Staging
Target: 20.2mm Solid lesion, LUL inferior lingula (B5)
Bronchus Sign: Positive
PET SUV: 16.9

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 113 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 21G Standard FNA
- Stations sampled: 4L, 7, 10R
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Adequate lymphocytes, no malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 2.3mm
- Target: LUL inferior lingula (B5)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 4
- Brushings: 2
- ROSE result: Malignant - small cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Rachel Goldman, MD
Date: 09/27/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Julie Butler
MRN: 5441983
DOB: 03/05/1949
Date: 08/20/2024
Physician: Katherine Lee, MD
===============================================

[INDICATION]
Primary: Left lower lobe nodule and subcarinal adenopathy
Category: Lung Cancer Staging
Target: 29.8mm Ground-glass lesion, LUL anterior (B3)
Bronchus Sign: Negative
PET SUV: 13.7

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 103 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 21G Standard FNA
- Stations sampled: 10R, 10L, 2L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.8mm
- Target: LUL anterior (B3)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 8
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - adenocarcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Katherine Lee, MD
Date: 08/20/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Karen Nguyen
MRN: 6371088
DOB: 07/09/1953
Date: 05/03/2025
Physician: Brian O'Connor, MD
===============================================

[INDICATION]
Primary: Right upper lobe mass with ipsilateral mediastinal nodes
Category: Lung Cancer Staging
Target: 29.4mm Part-solid lesion, LLL lateral basal (B9)
Bronchus Sign: Negative
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 81 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 22G Standard FNA
- Stations sampled: 10R, 10L, 11R
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Suspicious for malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.8mm
- Target: LLL lateral basal (B9)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Brian O'Connor, MD
Date: 05/03/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Kelly Nguyen
MRN: 4319679
DOB: 10/07/1951
Date: 06/26/2025
Physician: Jennifer Walsh, MD
===============================================

[INDICATION]
Primary: Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 23.2mm Ground-glass lesion, LLL lateral basal (B9)
Bronchus Sign: Positive
PET SUV: 16.0

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 105 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC180F
- Needle: 19G FNB/ProCore
- Stations sampled: 11R, 2L, 4L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Suspicious for malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 2.8mm
- Target: LLL lateral basal (B9)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 2
- Brushings: 2
- ROSE result: Suspicious for malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Jennifer Walsh, MD
Date: 06/26/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Kenneth Sanders
MRN: 3329198
DOB: 09/16/1976
Date: 02/01/2024
Physician: Sarah Chen, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 30.2mm Ground-glass lesion, LUL inferior lingula (B5)
Bronchus Sign: Positive
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 98 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 22G Acquire
- Stations sampled: 4R, 2R, 2L, 10L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Atypical cells

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.2mm
- Target: LUL inferior lingula (B5)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 8
- TBNA passes: 4
- Brushings: 2
- ROSE result: Malignant - small cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Sarah Chen, MD
Date: 02/01/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Kimberly Barnes
MRN: 8696597
DOB: 01/10/1963
Date: 09/27/2024
Physician: Andrew Nakamura, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 25.0mm Solid lesion, LUL anterior (B3)
Bronchus Sign: Positive
PET SUV: 9.6

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 123 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 21G Standard FNA
- Stations sampled: 7, 11L, 10R, 4L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Granuloma

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 1.6mm
- Target: LUL anterior (B3)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 4
- TBNA passes: 3
- Brushings: 2
- ROSE result: Malignant - squamous cell carcinoma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Andrew Nakamura, MD
Date: 09/27/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Lauren Hall
MRN: 4966053
DOB: 10/02/1952
Date: 11/17/2024
Physician: Brian O'Connor, MD
===============================================

[INDICATION]
Primary: Mediastinal staging for biopsy-proven lung adenocarcinoma
Category: Lung Cancer Staging
Target: 22.6mm Solid lesion, RUL apical (B1)
Bronchus Sign: Negative
PET SUV: 9.7

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 131 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 22G Standard FNA
- Stations sampled: 11R, 2L, 4R, 11L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - adenocarcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 1.8mm
- Target: RUL apical (B1)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 4
- TBNA passes: 4
- Brushings: 2
- ROSE result: Suspicious for malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Brian O'Connor, MD
Date: 11/17/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Nicholas Wilson
MRN: 8587536
DOB: 06/24/1978
Date: 08/15/2024
Physician: Robert Patel, MD
===============================================

[INDICATION]
Primary: Peripheral lung nodule with suspicious mediastinal nodes
Category: Lung Cancer Staging
Target: 24.3mm Solid lesion, LUL superior lingula (B4)
Bronchus Sign: Negative
PET SUV: 12.7

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 108 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 21G Standard FNA
- Stations sampled: 4L, 10L, 11L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 1.5mm
- Target: LUL superior lingula (B4)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 4
- TBNA passes: 2
- Brushings: 2
- ROSE result: Adequate lymphocytes

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Robert Patel, MD
Date: 08/15/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Pamela Fisher
MRN: 1432446
DOB: 06/12/1960
Date: 09/12/2025
Physician: Steven Park, MD
===============================================

[INDICATION]
Primary: Peripheral nodule and bilateral hilar adenopathy
Category: Lung Cancer Staging
Target: 34.7mm Part-solid lesion, LUL superior lingula (B4)
Bronchus Sign: Positive
PET SUV: 12.7

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 122 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 21G Standard FNA
- Stations sampled: 7, 11R, 11L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Atypical cells

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 2.5mm
- Target: LUL superior lingula (B4)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 5
- TBNA passes: 3
- Brushings: 2
- ROSE result: Suspicious for malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Steven Park, MD
Date: 09/12/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Pamela Walker
MRN: 2914317
DOB: 04/20/1945
Date: 02/09/2025
Physician: Lisa Thompson, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 23.3mm Solid lesion, RLL posterior basal (B10)
Bronchus Sign: Negative
PET SUV: 2.8

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 125 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 21G Standard FNA
- Stations sampled: 10R, 4R, 7
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - squamous cell carcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 2.4mm
- Target: RLL posterior basal (B10)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 3
- Brushings: 2
- ROSE result: Adequate lymphocytes, no malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Lisa Thompson, MD
Date: 02/09/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Peter Murphy
MRN: 6270624
DOB: 08/11/1976
Date: 08/25/2025
Physician: Eric Johnson, MD
===============================================

[INDICATION]
Primary: Peripheral lung nodule with suspicious mediastinal nodes
Category: Lung Cancer Staging
Target: 19.4mm Solid lesion, RUL anterior (B3)
Bronchus Sign: Positive
PET SUV: 6.7

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 131 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC180F
- Needle: 19G FNB/ProCore
- Stations sampled: 10R, 2L, 11L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - adenocarcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 1.5mm
- Target: RUL anterior (B3)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 3
- Brushings: 2
- ROSE result: Granuloma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Eric Johnson, MD
Date: 08/25/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Rebecca Kelly
MRN: 6130121
DOB: 09/17/1953
Date: 12/31/2024
Physician: Steven Park, MD
===============================================

[INDICATION]
Primary: Combined staging and peripheral nodule diagnosis
Category: Lung Cancer Staging
Target: 27.5mm Ground-glass lesion, RLL superior (B6)
Bronchus Sign: Negative
PET SUV: 16.3

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 100 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Fujifilm EB-580S
- Needle: 22G Acquire
- Stations sampled: 11R, 4R, 11L
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - small cell carcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Galaxy (Noah Medical)
- Registration: CT-to-body, error 2.8mm
- Target: RLL superior (B6)

Procedure 3: Radial EBUS
- View: Eccentric
- Confirmation: CBCT

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 4
- TBNA passes: 3
- Brushings: 2
- ROSE result: Adequate lymphocytes, no malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Steven Park, MD
Date: 12/31/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Richard Miller
MRN: 6503230
DOB: 08/10/1972
Date: 02/09/2025
Physician: Lisa Thompson, MD
===============================================

[INDICATION]
Primary: Lung nodule evaluation with mediastinal lymphadenopathy workup
Category: Lung Cancer Staging
Target: 30.4mm Solid lesion, RML lateral (B4)
Bronchus Sign: Negative
PET SUV: 13.0

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 2
Airway: 8.0mm ETT
Duration: 79 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC260F-OL8
- Needle: 22G FNB/ProCore
- Stations sampled: 2R, 11R, 4R, 7
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Adequate lymphocytes

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.6mm
- Target: RML lateral (B4)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Radial EBUS

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 4
- TBNA passes: 2
- Brushings: 2
- ROSE result: Suspicious for malignancy

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Lisa Thompson, MD
Date: 02/09/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Ryan Howard
MRN: 2747631
DOB: 06/07/1962
Date: 11/29/2024
Physician: David Kim, MD
===============================================

[INDICATION]
Primary: Combined staging and peripheral nodule diagnosis
Category: Lung Cancer Staging
Target: 16.9mm Solid lesion, RML lateral (B4)
Bronchus Sign: Positive
PET SUV: 16.9

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 100 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 21G Standard FNA
- Stations sampled: 10R, 4L, 4R
- Number of stations: 3 (≥3)
- ROSE available: Yes
- ROSE result: Adequate lymphocytes, no malignancy

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.5mm
- Target: RML lateral (B4)

Procedure 3: Radial EBUS
- View: Concentric
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 8
- TBNA passes: 4
- Brushings: 2
- ROSE result: Adequate lymphocytes

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: David Kim, MD
Date: 11/29/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Shirley Torres
MRN: 7571739
DOB: 08/07/1966
Date: 09/02/2025
Physician: Steven Park, MD
===============================================

[INDICATION]
Primary: PET-avid lung mass and mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 30.9mm Ground-glass lesion, RUL anterior (B3)
Bronchus Sign: Negative
PET SUV: N/A

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 3
Airway: 8.0mm ETT
Duration: 77 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Pentax EB-1990i
- Needle: 22G FNB/ProCore
- Stations sampled: 4L, 10R, 4R, 7
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - NSCLC NOS

Procedure 2: Robotic Bronchoscopy
- Platform: Monarch (Auris Health (J&J))
- Registration: CT-to-body, error 2.0mm
- Target: RUL anterior (B3)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 6
- TBNA passes: 4
- Brushings: 2
- ROSE result: Granuloma

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: Steven Park, MD
Date: 09/02/2025
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"===============================================
BRONCHOSCOPY PROCEDURE REPORT
===============================================
Patient: Thomas Gomez
MRN: 3801075
DOB: 06/13/1970
Date: 03/16/2024
Physician: David Kim, MD
===============================================

[INDICATION]
Primary: PET-avid lung mass and mediastinal lymphadenopathy
Category: Lung Cancer Staging
Target: 20.0mm Solid lesion, RML medial (B5)
Bronchus Sign: Negative
PET SUV: 6.5

[ANESTHESIA]
Type: General endotracheal anesthesia
ASA Class: 4
Airway: 8.0mm ETT
Duration: 87 minutes

[DESCRIPTION]
Procedure 1: Linear EBUS-TBNA
- Scope: Olympus BF-UC190F
- Needle: 22G Acquire
- Stations sampled: 2L, 4R, 11R, 11L
- Number of stations: 4 (≥3)
- ROSE available: Yes
- ROSE result: Malignant - small cell carcinoma

Procedure 2: Robotic Bronchoscopy
- Platform: Ion (Intuitive Surgical)
- Registration: CT-to-body, error 2.5mm
- Target: RML medial (B5)

Procedure 3: Radial EBUS
- View: Adjacent
- Confirmation: Augmented fluoroscopy

Procedure 4: Transbronchial Biopsy
- Forceps biopsies: 7
- TBNA passes: 2
- Brushings: 2
- ROSE result: Malignant - NSCLC NOS

Specimens: Cytology, cell block, surgical pathology, BAL cultures
Complications: None
EBL: <10mL

[PLAN]
1. Post-procedure monitoring x2 hours
2. Chest X-ray - completed, no pneumothorax
3. Discharge to home if stable
4. Follow-up: 1-2 weeks for pathology
5. Tumor board review pending final results
6. Molecular testing if malignancy confirmed

===============================================
Electronically signed: David Kim, MD
Date: 03/16/2024
===============================================",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"A 25mm RUL mass was biopsied using the Galaxy robotic system. Navigation to RB2 was accurate, with TiLT confirming a minor 0.8cm divergence. Multimodal sampling (TBNA, forceps, BAL) was performed. A fiducial was placed. Pathology confirmed adenocarcinoma.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"A 51-year-old male presented with a hypermetabolic LUL mass. Diagnostic bronchoscopy was performed utilizing the Galaxy robotic system. Registration accuracy was 3.7mm. Intraoperative C-arm tomosynthesis (TiLT) identified a 1.0cm target divergence. Following alignment, the lesion was sampled via multidimensional approach: TBNA, brushing, and lavage. A fiducial was deployed for potential SBRT.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"A high-risk 12mm LLL nodule was interrogated. Galaxy navigation was employed. A significant 2.1cm divergence caused by atelectasis was identified via TiLT+ and corrected. Upon establishing a concentric rEBUS view, 21G TBNA and cytology brushing were performed. Preliminary pathology indicates atypia.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"A left diagnostic medical thoracoscopy was performed. Fibrinous adhesions and trapped lung were observed. The parietal, visceral, and diaphragmatic pleura were visualized. All fluid was evacuated, and a chest tube was placed. The lung expanded, and no air leak was noted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"A right diagnostic medical thoracoscopy was performed. The parietal pleura appeared thickened with multiple nodules. The visceral and diaphragmatic pleura were also visualized. Remaining pleural fluid was evacuated. A chest tube was inserted, and the lung expanded well. No air leak was noted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Action: Robotic investigation of RUL mass.
Verification: Fluoroscopy and rEBUS (adjacent).
Sampling: Aspirated (needle), biopsied (forceps), brushed.
Result: Granulomatous inflammation.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Adam Morgan, MRN 6609863, a 64-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at UCLA Medical Center on 07/21/2024. The indication was right upper lobe mass with ipsilateral mediastinal nodes with a 27.1mm ground-glass lesion in the LLL posterior basal (B10), bronchus sign positive, PET SUV max 15.4. The patient was ASA class 2 with smoking history of 40 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC260F-OL8 bronchoscope with 19-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2L (20.2mm, 4 passes, ROSE: Malignant - squamous cell carcinoma); station 4R (17.2mm, 4 passes, ROSE: Malignant - adenocarcinoma); station 7 (11.6mm, 3 passes, ROSE: Adequate lymphocytes); station 11R (17.2mm, 3 passes, ROSE: Granuloma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.9mm. The robotic catheter was advanced to the LLL posterior basal (B10) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed atypical cells.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 85 minutes. Attending physician: David Kim, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"After inducing anesthesia, we inserted the Galaxy scope to biopsy the 14mm nodule in the right middle lobe. Because of significant respiratory motion, the TiLT system showed a 2.1cm difference from the pre-op CT, which we corrected. We confirmed the position with a nice concentric EBUS view and took seven needle passes. The pathologist saw some atypical cells on the slide.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Andrew Jones, MRN 4848028, a 72-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Community Hospital on 12/22/2024. The indication was right upper lobe mass with ipsilateral mediastinal nodes with a 20.2mm solid lesion in the LUL inferior lingula (B5), bronchus sign positive, PET SUV max 16.9. The patient was ASA class 3 with smoking history of 43 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4L (24.4mm, 2 passes, ROSE: Adequate lymphocytes, no malignancy); station 7 (20.3mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy); station 10R (20.4mm, 4 passes, ROSE: Atypical cells). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.3mm. The robotic catheter was advanced to the LUL inferior lingula (B5) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - small cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 113 minutes. Attending physician: Rachel Goldman, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 01/02/2025, Brandon Reed, a 56-year-old male patient, presented to Baptist Medical Center in Miami, FL for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Amanda Foster, MD.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 27.1 millimeter solid pulmonary nodule located in the RLL lobe, specifically within the superior (B6) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 6.1. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a negative smoking history. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4L, a heterogeneous lymph node was identified measuring 9.1 millimeters in short axis and 13.1 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2R, a heterogeneous lymph node was identified measuring 14.9 millimeters in short axis and 15.8 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 2L, a homogeneous lymph node was identified measuring 13.2 millimeters in short axis and 25.8 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL superior (B6). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 5 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:03, for a total procedure time of 108 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Amanda Foster, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 01/23/2024, Joyce Sullivan, a 77-year-old female patient, presented to Baptist Medical Center in Los Angeles, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Jennifer Walsh, MD, with Marcus Williams assisting.

The clinical indication for this procedure was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 23.2 millimeter ground-glass pulmonary nodule located in the LLL lobe, specifically within the lateral basal (B9) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 16.0. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 55 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:45.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC180F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11R, a homogeneous lymph node was identified measuring 13.7 millimeters in short axis and 15.8 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2L, a heterogeneous lymph node was identified measuring 8.4 millimeters in short axis and 22.4 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 4L, a heterogeneous lymph node was identified measuring 19.6 millimeters in short axis and 18.4 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LLL lateral basal (B9). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported suspicious for malignancy. Finally, bronchoalveolar lavage was performed from the LLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:30, for a total procedure time of 105 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Jennifer Walsh, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 02/23/2025, Virginia Richardson, a 79-year-old female patient, presented to Memorial Hospital in San Francisco, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Maria Santos, MD, with Kevin Chang assisting.

The clinical indication for this procedure was combined staging and peripheral nodule diagnosis. Preprocedural imaging had demonstrated a 16.3 millimeter part-solid pulmonary nodule located in the RUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 12.4. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 27 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC180F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2L, a homogeneous lymph node was identified measuring 19.0 millimeters in short axis and 23.5 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 10L, a heterogeneous lymph node was identified measuring 22.7 millimeters in short axis and 13.9 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 7, a heterogeneous lymph node was identified measuring 16.8 millimeters in short axis and 24.0 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.0 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - adenocarcinoma. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 08:45, for a total procedure time of 75 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Maria Santos, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 03/30/2025, Joshua Bennett, a 50-year-old female patient, presented to Regional Medical Center in Miami, FL for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Eric Johnson, MD, with Priya Sharma assisting.

The clinical indication for this procedure was peripheral lung nodule with suspicious mediastinal nodes. Preprocedural imaging had demonstrated a 19.4 millimeter solid pulmonary nodule located in the RUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 6.7. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 54 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC180F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a heterogeneous lymph node was identified measuring 21.2 millimeters in short axis and 29.3 millimeters in long axis. The node appeared oval in shape. Using the 19-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 2L, a homogeneous lymph node was identified measuring 8.8 millimeters in short axis and 22.9 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 11L, a heterogeneous lymph node was identified measuring 13.8 millimeters in short axis and 31.1 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported granuloma. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:41, for a total procedure time of 131 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Eric Johnson, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 05/26/2025, Thomas Henderson, a 45-year-old male patient, presented to Academic Health System in Phoenix, AZ for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Sarah Chen, MD, with Emily Chen assisting.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 30.2 millimeter ground-glass pulmonary nodule located in the LUL lobe, specifically within the inferior lingula (B5) segment. The lesion exhibited a positive bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 34 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4R, a heterogeneous lymph node was identified measuring 22.1 millimeters in short axis and 22.1 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 2R, a heterogeneous lymph node was identified measuring 14.8 millimeters in short axis and 16.0 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2L, a homogeneous lymph node was identified measuring 15.4 millimeters in short axis and 34.5 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma. At station 10L, a homogeneous lymph node was identified measuring 10.7 millimeters in short axis and 16.3 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL inferior lingula (B5). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 8 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - small cell carcinoma. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:08, for a total procedure time of 98 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Sarah Chen, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 06/18/2025, Noah White, a 74-year-old female patient, presented to Community Hospital in Atlanta, GA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Rachel Goldman, MD, with Jason Park assisting.

The clinical indication for this procedure was right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging had demonstrated a 20.2 millimeter solid pulmonary nodule located in the LUL lobe, specifically within the inferior lingula (B5) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 16.9. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 43 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:45.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4L, a homogeneous lymph node was identified measuring 24.4 millimeters in short axis and 26.8 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 7, a homogeneous lymph node was identified measuring 20.3 millimeters in short axis and 30.7 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 10R, a homogeneous lymph node was identified measuring 20.4 millimeters in short axis and 33.1 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.3 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL inferior lingula (B5). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - small cell carcinoma. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:38, for a total procedure time of 113 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Rachel Goldman, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 06/22/2024, Anthony Price, a 50-year-old female patient, presented to St. Luke's Medical Center in San Francisco, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Eric Johnson, MD.

The clinical indication for this procedure was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 19.5 millimeter solid pulmonary nodule located in the RLL lobe, specifically within the posterior basal (B10) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 5.4. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a negative smoking history. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a heterogeneous lymph node was identified measuring 11.4 millimeters in short axis and 28.9 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 7, a homogeneous lymph node was identified measuring 8.1 millimeters in short axis and 19.7 millimeters in long axis. The node appeared oval in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 2R, a heterogeneous lymph node was identified measuring 13.6 millimeters in short axis and 28.0 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 4R, a heterogeneous lymph node was identified measuring 22.2 millimeters in short axis and 33.2 millimeters in long axis. The node appeared irregular in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL posterior basal (B10). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - nsclc nos. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:46, for a total procedure time of 91 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Eric Johnson, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 06/27/2025, Noah Mitchell, a 72-year-old female patient, presented to Baptist Medical Center in Denver, CO for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Steven Park, MD, with Jason Park assisting.

The clinical indication for this procedure was combined staging and peripheral nodule diagnosis. Preprocedural imaging had demonstrated a 27.5 millimeter ground-glass pulmonary nodule located in the RLL lobe, specifically within the superior (B6) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 16.3. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 34 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11R, a homogeneous lymph node was identified measuring 22.0 millimeters in short axis and 13.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 4R, a heterogeneous lymph node was identified measuring 13.7 millimeters in short axis and 29.3 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 11L, a homogeneous lymph node was identified measuring 18.9 millimeters in short axis and 31.0 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL superior (B6). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 4 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes, no malignancy. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:10, for a total procedure time of 100 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Steven Park, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 07/01/2025, Julie Mitchell, a 82-year-old male patient, presented to Academic Health System in Miami, FL for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Rachel Goldman, MD.

The clinical indication for this procedure was peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging had demonstrated a 14.0 millimeter ground-glass pulmonary nodule located in the LUL lobe, specifically within the apicoposterior (B1+2) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 17.6. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 34 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2L, a homogeneous lymph node was identified measuring 14.8 millimeters in short axis and 28.3 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 4L, a homogeneous lymph node was identified measuring 24.3 millimeters in short axis and 25.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma. At station 10R, a heterogeneous lymph node was identified measuring 12.9 millimeters in short axis and 30.7 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10L, a heterogeneous lymph node was identified measuring 18.8 millimeters in short axis and 34.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 11L, a heterogeneous lymph node was identified measuring 18.7 millimeters in short axis and 20.8 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL apicoposterior (B1+2). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes, no malignancy. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:09, for a total procedure time of 114 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Rachel Goldman, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 07/08/2024, Stephen Foster, a 74-year-old female patient, presented to Methodist Hospital in Cleveland, OH for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Katherine Lee, MD.

The clinical indication for this procedure was left lower lobe nodule and subcarinal adenopathy. Preprocedural imaging had demonstrated a 29.8 millimeter ground-glass pulmonary nodule located in the LUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 13.7. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 43 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 10:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a homogeneous lymph node was identified measuring 8.4 millimeters in short axis and 29.3 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10L, a heterogeneous lymph node was identified measuring 13.7 millimeters in short axis and 21.1 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 2L, a homogeneous lymph node was identified measuring 11.1 millimeters in short axis and 30.7 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 8 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - adenocarcinoma. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:58, for a total procedure time of 103 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Katherine Lee, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 07/28/2024, Margaret Ortiz, a 64-year-old female patient, presented to Presbyterian Hospital in Houston, TX for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Robert Patel, MD, with Jason Park assisting.

The clinical indication for this procedure was peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging had demonstrated a 21.6 millimeter ground-glass pulmonary nodule located in the RUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a negative bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 41 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10L, a heterogeneous lymph node was identified measuring 13.0 millimeters in short axis and 14.3 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 4L, a homogeneous lymph node was identified measuring 15.7 millimeters in short axis and 23.7 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 11L, a heterogeneous lymph node was identified measuring 19.4 millimeters in short axis and 27.5 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 8 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported granuloma. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:40, for a total procedure time of 85 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Robert Patel, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 08/10/2024, Ashley Sanders, a 68-year-old male patient, presented to Northwestern Memorial Hospital in Cleveland, OH for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Brian O'Connor, MD, with Kevin Chang assisting.

The clinical indication for this procedure was right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging had demonstrated a 29.4 millimeter part-solid pulmonary nodule located in the LLL lobe, specifically within the lateral basal (B9) segment. The lesion exhibited a negative bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 43 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 10:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a homogeneous lymph node was identified measuring 15.5 millimeters in short axis and 31.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 10L, a heterogeneous lymph node was identified measuring 21.7 millimeters in short axis and 14.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 11R, a homogeneous lymph node was identified measuring 20.5 millimeters in short axis and 29.9 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LLL lateral basal (B9). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the LLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:36, for a total procedure time of 81 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Brian O'Connor, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 08/24/2024, Ronald Henderson, a 67-year-old male patient, presented to UCLA Medical Center in Dallas, TX for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by David Kim, MD, with Kevin Chang assisting.

The clinical indication for this procedure was right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging had demonstrated a 27.1 millimeter ground-glass pulmonary nodule located in the LLL lobe, specifically within the posterior basal (B10) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 15.4. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 40 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 10:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC260F-OL8 bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2L, a heterogeneous lymph node was identified measuring 20.2 millimeters in short axis and 30.4 millimeters in long axis. The node appeared oval in shape. Using the 19-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma. At station 4R, a homogeneous lymph node was identified measuring 17.2 millimeters in short axis and 31.1 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 7, a heterogeneous lymph node was identified measuring 11.6 millimeters in short axis and 19.3 millimeters in long axis. The node appeared oval in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 11R, a heterogeneous lymph node was identified measuring 17.2 millimeters in short axis and 15.1 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.9 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LLL posterior basal (B10). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported atypical cells. Finally, bronchoalveolar lavage was performed from the LLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:55, for a total procedure time of 85 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

David Kim, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/02/2024, Timothy Patel, a 64-year-old female patient, presented to Methodist Hospital in New York, NY for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Brian O'Connor, MD, with Jason Park assisting.

The clinical indication for this procedure was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 14.5 millimeter ground-glass pulmonary nodule located in the RUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a positive bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 50 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11L, a heterogeneous lymph node was identified measuring 13.3 millimeters in short axis and 31.3 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 7, a homogeneous lymph node was identified measuring 10.0 millimeters in short axis and 26.5 millimeters in long axis. The node appeared oval in shape. Using the 19-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 2L, a homogeneous lymph node was identified measuring 24.9 millimeters in short axis and 12.2 millimeters in long axis. The node appeared round in shape. Using the 19-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported atypical cells. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:31, for a total procedure time of 136 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Brian O'Connor, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/11/2025, Samantha Williams, a 41-year-old male patient, presented to Memorial Hospital in Chicago, IL for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Robert Patel, MD, with Priya Sharma assisting.

The clinical indication for this procedure was peripheral lung nodule with suspicious mediastinal nodes. Preprocedural imaging had demonstrated a 24.3 millimeter solid pulmonary nodule located in the LUL lobe, specifically within the superior lingula (B4) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 12.7. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 49 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4L, a homogeneous lymph node was identified measuring 21.5 millimeters in short axis and 32.3 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10L, a homogeneous lymph node was identified measuring 21.1 millimeters in short axis and 12.4 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 11L, a homogeneous lymph node was identified measuring 8.8 millimeters in short axis and 15.4 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL superior lingula (B4). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 4 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:18, for a total procedure time of 108 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Robert Patel, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/13/2024, Jerry Morris, a 52-year-old male patient, presented to Regional Medical Center in Atlanta, GA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by David Kim, MD, with Marcus Williams assisting.

The clinical indication for this procedure was pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 20.0 millimeter solid pulmonary nodule located in the RML lobe, specifically within the medial (B5) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 6.5. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 23 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 10:45.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2L, a homogeneous lymph node was identified measuring 13.8 millimeters in short axis and 21.0 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 4R, a heterogeneous lymph node was identified measuring 23.9 millimeters in short axis and 31.2 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 11R, a heterogeneous lymph node was identified measuring 19.6 millimeters in short axis and 30.0 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 11L, a heterogeneous lymph node was identified measuring 17.4 millimeters in short axis and 22.1 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RML medial (B5). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - nsclc nos. Finally, bronchoalveolar lavage was performed from the RML lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 12:12, for a total procedure time of 87 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

David Kim, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/14/2024, Stephanie King, a 51-year-old male patient, presented to Regional Medical Center in Chicago, IL for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Steven Park, MD, with Jason Park assisting.

The clinical indication for this procedure was pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 30.9 millimeter ground-glass pulmonary nodule located in the RUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a negative bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 20 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4L, a homogeneous lymph node was identified measuring 18.3 millimeters in short axis and 28.3 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10R, a heterogeneous lymph node was identified measuring 14.8 millimeters in short axis and 23.9 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 4R, a homogeneous lymph node was identified measuring 20.9 millimeters in short axis and 20.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 7, a homogeneous lymph node was identified measuring 24.0 millimeters in short axis and 28.4 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.0 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported granuloma. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:32, for a total procedure time of 77 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Steven Park, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/17/2024, Paul Perez, a 53-year-old female patient, presented to Cleveland Clinic in Boston, MA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Brian O'Connor, MD, with Marcus Williams assisting.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 31.2 millimeter solid pulmonary nodule located in the LUL lobe, specifically within the inferior lingula (B5) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 5.0. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a negative smoking history. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC180F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a homogeneous lymph node was identified measuring 16.6 millimeters in short axis and 13.8 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 4R, a heterogeneous lymph node was identified measuring 13.5 millimeters in short axis and 29.3 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 2L, a homogeneous lymph node was identified measuring 11.0 millimeters in short axis and 19.3 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 2R, a heterogeneous lymph node was identified measuring 21.8 millimeters in short axis and 17.2 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 4L, a heterogeneous lymph node was identified measuring 22.9 millimeters in short axis and 29.8 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL inferior lingula (B5). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 08:33, for a total procedure time of 78 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Brian O'Connor, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/17/2025, Nancy Gray, a 72-year-old female patient, presented to Veterans Affairs Medical Center in Minneapolis, MN for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Brian O'Connor, MD, with Jessica Martinez assisting.

The clinical indication for this procedure was mediastinal staging for biopsy-proven lung adenocarcinoma. Preprocedural imaging had demonstrated a 22.6 millimeter solid pulmonary nodule located in the RUL lobe, specifically within the apical (B1) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 9.7. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a negative smoking history. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:45.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11R, a homogeneous lymph node was identified measuring 24.9 millimeters in short axis and 17.4 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 2L, a heterogeneous lymph node was identified measuring 14.7 millimeters in short axis and 16.9 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 4R, a heterogeneous lymph node was identified measuring 13.0 millimeters in short axis and 24.5 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 11L, a heterogeneous lymph node was identified measuring 19.1 millimeters in short axis and 15.5 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.8 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RUL apical (B1). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 4 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported suspicious for malignancy. Finally, bronchoalveolar lavage was performed from the RUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:56, for a total procedure time of 131 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Brian O'Connor, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/18/2025, Emma Jones, a 64-year-old male patient, presented to Regional Medical Center in San Francisco, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Andrew Nakamura, MD, with Kevin Chang assisting.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 25.0 millimeter solid pulmonary nodule located in the LUL lobe, specifically within the anterior (B3) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 9.6. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 40 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 7, a heterogeneous lymph node was identified measuring 19.5 millimeters in short axis and 24.9 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma. At station 11L, a homogeneous lymph node was identified measuring 18.1 millimeters in short axis and 17.4 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma. At station 10R, a heterogeneous lymph node was identified measuring 17.1 millimeters in short axis and 27.3 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma. At station 4L, a homogeneous lymph node was identified measuring 11.5 millimeters in short axis and 24.9 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.6 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL anterior (B3). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a eccentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 4 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:33, for a total procedure time of 123 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Andrew Nakamura, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/25/2024, Gregory Flores, a 63-year-old female patient, presented to University Medical Center in Philadelphia, PA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Steven Park, MD, with Emily Chen assisting.

The clinical indication for this procedure was peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging had demonstrated a 34.7 millimeter part-solid pulmonary nodule located in the LUL lobe, specifically within the superior lingula (B4) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 12.7. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 29 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 07:00.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 7, a homogeneous lymph node was identified measuring 8.3 millimeters in short axis and 24.2 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 11R, a homogeneous lymph node was identified measuring 19.4 millimeters in short axis and 15.1 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 11L, a homogeneous lymph node was identified measuring 14.1 millimeters in short axis and 15.1 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LUL superior lingula (B4). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 5 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported suspicious for malignancy. Finally, bronchoalveolar lavage was performed from the LUL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:02, for a total procedure time of 122 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Steven Park, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 09/25/2024, Larry Anderson, a 82-year-old female patient, presented to Community Hospital in San Francisco, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Lisa Thompson, MD, with Kevin Chang assisting.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 23.3 millimeter solid pulmonary nodule located in the RLL lobe, specifically within the posterior basal (B10) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 2.8. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 25 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:00.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a homogeneous lymph node was identified measuring 11.9 millimeters in short axis and 22.1 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma. At station 4R, a homogeneous lymph node was identified measuring 21.4 millimeters in short axis and 27.6 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 7, a heterogeneous lymph node was identified measuring 16.1 millimeters in short axis and 28.6 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.4 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL posterior basal (B10). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using cbct.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes, no malignancy. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:05, for a total procedure time of 125 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Lisa Thompson, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 10/01/2025, Dorothy Price, a 53-year-old female patient, presented to Community Hospital in Cleveland, OH for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Andrew Nakamura, MD, with Jessica Martinez assisting.

The clinical indication for this procedure was combined staging and peripheral nodule diagnosis. Preprocedural imaging had demonstrated a 16.3 millimeter ground-glass pulmonary nodule located in the RLL lobe, specifically within the superior (B6) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 6.9. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 23 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11L, a heterogeneous lymph node was identified measuring 14.4 millimeters in short axis and 23.4 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma. At station 4L, a homogeneous lymph node was identified measuring 21.7 millimeters in short axis and 20.3 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10L, a homogeneous lymph node was identified measuring 19.2 millimeters in short axis and 34.4 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.4 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL superior (B6). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:49, for a total procedure time of 94 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Andrew Nakamura, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 10/06/2024, Jonathan Wood, a 54-year-old female patient, presented to Memorial Hospital in Dallas, TX for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Michael Rodriguez, MD.

The clinical indication for this procedure was right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging had demonstrated a 28.6 millimeter ground-glass pulmonary nodule located in the RLL lobe, specifically within the lateral basal (B9) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 8.9. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 36 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC260F-OL8 bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a heterogeneous lymph node was identified measuring 17.1 millimeters in short axis and 25.9 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 11R, a homogeneous lymph node was identified measuring 8.4 millimeters in short axis and 34.2 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma. At station 11L, a homogeneous lymph node was identified measuring 22.2 millimeters in short axis and 34.6 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma. At station 2R, a heterogeneous lymph node was identified measuring 21.9 millimeters in short axis and 28.9 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported atypical cells. At station 4L, a homogeneous lymph node was identified measuring 18.5 millimeters in short axis and 22.0 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.6 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL lateral basal (B9). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 5 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - adenocarcinoma. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 11:02, for a total procedure time of 92 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Michael Rodriguez, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 10/10/2025, Susan Rodriguez, a 46-year-old male patient, presented to Baptist Medical Center in Boston, MA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Lisa Thompson, MD, with Jason Park assisting.

The clinical indication for this procedure was lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging had demonstrated a 30.4 millimeter solid pulmonary nodule located in the RML lobe, specifically within the lateral (B4) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 13.0. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 46 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC260F-OL8 bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2R, a heterogeneous lymph node was identified measuring 15.3 millimeters in short axis and 24.4 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 11R, a heterogeneous lymph node was identified measuring 23.0 millimeters in short axis and 31.5 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 4R, a heterogeneous lymph node was identified measuring 15.0 millimeters in short axis and 25.3 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 7, a heterogeneous lymph node was identified measuring 13.7 millimeters in short axis and 16.2 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.6 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RML lateral (B4). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 4 specimens. Transbronchial needle aspiration was performed with 2 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported suspicious for malignancy. Finally, bronchoalveolar lavage was performed from the RML lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:49, for a total procedure time of 79 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Lisa Thompson, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 10/30/2025, Elizabeth Morgan, a 79-year-old male patient, presented to Baptist Medical Center in San Francisco, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Lisa Thompson, MD.

The clinical indication for this procedure was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 31.5 millimeter part-solid pulmonary nodule located in the RML lobe, specifically within the medial (B5) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 7.9. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 57 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 4.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 4R, a homogeneous lymph node was identified measuring 23.5 millimeters in short axis and 32.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - squamous cell carcinoma. At station 4L, a homogeneous lymph node was identified measuring 14.3 millimeters in short axis and 14.4 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 10R, a homogeneous lymph node was identified measuring 11.1 millimeters in short axis and 12.3 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2L, a heterogeneous lymph node was identified measuring 20.1 millimeters in short axis and 33.5 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - adenocarcinoma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RML medial (B5). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 5 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported malignant - squamous cell carcinoma. Finally, bronchoalveolar lavage was performed from the RML lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:15, for a total procedure time of 105 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Lisa Thompson, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 11/26/2025, Jason Gomez, a 60-year-old male patient, presented to Presbyterian Hospital in Los Angeles, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Brian O'Connor, MD.

The clinical indication for this procedure was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 15.4 millimeter ground-glass pulmonary nodule located in the RML lobe, specifically within the lateral (B4) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 4.3. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 47 pack-years as a former smoker. The American Society of Anesthesiologists physical status classification was 2.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 09:00.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a homogeneous lymph node was identified measuring 15.1 millimeters in short axis and 29.1 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 4L, a homogeneous lymph node was identified measuring 21.5 millimeters in short axis and 25.6 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 4R, a heterogeneous lymph node was identified measuring 12.6 millimeters in short axis and 19.0 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 11L, a heterogeneous lymph node was identified measuring 22.8 millimeters in short axis and 27.5 millimeters in long axis. The node appeared irregular in shape. Using the 21-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RML lateral (B4). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 7 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported atypical cells. Finally, bronchoalveolar lavage was performed from the RML lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:45, for a total procedure time of 105 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Brian O'Connor, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 12/14/2024, Jennifer Miller, a 54-year-old female patient, presented to Regional Medical Center in Los Angeles, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by David Kim, MD, with Jessica Martinez assisting.

The clinical indication for this procedure was pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging had demonstrated a 23.3 millimeter solid pulmonary nodule located in the RLL lobe, specifically within the medial basal (B7) segment. The lesion exhibited a negative bronchus sign on computed tomography. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a negative smoking history. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 10:30.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Fujifilm EB-580S bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 2R, a heterogeneous lymph node was identified measuring 12.0 millimeters in short axis and 33.3 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - nsclc nos. At station 10R, a heterogeneous lymph node was identified measuring 12.9 millimeters in short axis and 26.6 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2L, a heterogeneous lymph node was identified measuring 13.9 millimeters in short axis and 22.9 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported granuloma.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Galaxy robotic bronchoscopy system, manufactured by Noah Medical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 1.9 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RLL medial basal (B7). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using radial ebus.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 5 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes, no malignancy. Finally, bronchoalveolar lavage was performed from the RLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 12:49, for a total procedure time of 139 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

David Kim, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 12/15/2024, Gregory Perry, a 54-year-old male patient, presented to Memorial Hospital in Los Angeles, CA for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by Maria Santos, MD, with Kevin Chang assisting.

The clinical indication for this procedure was right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging had demonstrated a 31.9 millimeter ground-glass pulmonary nodule located in the LLL lobe, specifically within the anteromedial basal (B7+8) segment. The lesion exhibited a negative bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 13.4. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 57 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:15.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Pentax EB-1990i bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 11L, a homogeneous lymph node was identified measuring 21.6 millimeters in short axis and 19.9 millimeters in long axis. The node appeared round in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 2L, a homogeneous lymph node was identified measuring 14.5 millimeters in short axis and 12.2 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported suspicious for malignancy. At station 7, a homogeneous lymph node was identified measuring 21.8 millimeters in short axis and 25.3 millimeters in long axis. The node appeared oval in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes. At station 11R, a homogeneous lymph node was identified measuring 15.0 millimeters in short axis and 14.3 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 10R, a heterogeneous lymph node was identified measuring 21.4 millimeters in short axis and 18.1 millimeters in long axis. The node appeared irregular in shape. Using the 22-gauge needle, 4 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Ion robotic bronchoscopy system, manufactured by Intuitive Surgical, was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 3.2 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the LLL anteromedial basal (B7+8). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a adjacent view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 6 specimens. Transbronchial needle aspiration was performed with 3 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported suspicious for malignancy. Finally, bronchoalveolar lavage was performed from the LLL lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 10:14, for a total procedure time of 119 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

Maria Santos, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NARRATIVE

On 12/15/2024, Heather Flores, a 57-year-old female patient, presented to Presbyterian Hospital in Phoenix, AZ for a combined bronchoscopic procedure consisting of endobronchial ultrasound-guided mediastinal staging and robotic bronchoscopy with peripheral lung biopsy. The procedure was performed by David Kim, MD, with Jessica Martinez assisting.

The clinical indication for this procedure was combined staging and peripheral nodule diagnosis. Preprocedural imaging had demonstrated a 16.9 millimeter solid pulmonary nodule located in the RML lobe, specifically within the lateral (B4) segment. The lesion exhibited a positive bronchus sign on computed tomography. Positron emission tomography scanning revealed hypermetabolic activity with a maximum standardized uptake value of 16.9. Given the combination of peripheral nodule requiring tissue diagnosis and mediastinal lymphadenopathy necessitating staging, a combined approach was deemed appropriate.

The patient's medical history included a significant smoking history of 58 pack-years as a current smoker. The American Society of Anesthesiologists physical status classification was 3.

Following the administration of general anesthesia by the anesthesiology team, the patient was intubated with a 8.0 millimeter endotracheal tube. The procedure commenced at 08:00.

The first component of the procedure involved systematic mediastinal lymph node evaluation using linear endobronchial ultrasound. The Olympus BF-UC190F bronchoscope was advanced through the endotracheal tube, and a thorough airway inspection was performed, revealing no endobronchial abnormalities. Mediastinal and hilar lymph node stations were then surveyed systematically.

At station 10R, a heterogeneous lymph node was identified measuring 9.9 millimeters in short axis and 21.4 millimeters in long axis. The node appeared round in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes, no malignancy. At station 4L, a heterogeneous lymph node was identified measuring 13.8 millimeters in short axis and 21.2 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 2 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported malignant - small cell carcinoma. At station 4R, a heterogeneous lymph node was identified measuring 21.4 millimeters in short axis and 31.0 millimeters in long axis. The node appeared oval in shape. Using the 21-gauge needle, 3 aspiration passes were performed. The on-site cytopathologist evaluated the specimen and reported adequate lymphocytes.

Following completion of the mediastinal staging component, the procedure transitioned to robotic bronchoscopy for peripheral lesion sampling. The Monarch robotic bronchoscopy system, manufactured by Auris Health (J&J), was prepared and registered using CT-to-body methodology. The registration achieved an accuracy of 2.5 millimeters, which was within acceptable parameters for proceeding with navigation.

The robotic catheter was advanced through the bronchial tree toward the target lesion in the RML lateral (B4). Navigation was successful, and the catheter reached the planned trajectory endpoint. A twenty-megahertz radial endobronchial ultrasound probe was then deployed through the working channel, revealing a concentric view of the target lesion. This confirmed appropriate positioning relative to the lesion. Additional confirmation of tool-in-lesion was obtained using augmented fluoroscopy.

Tissue sampling was then performed using multiple modalities to maximize diagnostic yield. Transbronchial forceps biopsies were obtained, totaling 8 specimens. Transbronchial needle aspiration was performed with 4 passes through the lesion. Two bronchial brushing specimens were also collected. The on-site cytopathologist evaluated the peripheral specimens and reported adequate lymphocytes. Finally, bronchoalveolar lavage was performed from the RML lobe and sent for microbiological analysis including bacterial, fungal, and acid-fast bacilli cultures.

The procedure was completed at 09:40, for a total procedure time of 100 minutes. No complications were encountered during the procedure. There was no significant bleeding, and hemostasis was achieved spontaneously. The estimated blood loss was less than ten milliliters. A post-procedure chest radiograph was obtained and demonstrated no evidence of pneumothorax or other acute abnormality.

The patient was transferred to the recovery area in stable condition. After an uneventful observation period, the patient was discharged home with standard post-bronchoscopy precautions. Follow-up was arranged for review of final pathology results.

In summary, this was a successful combined procedure achieving both mediastinal staging and peripheral lesion tissue diagnosis. The final pathology results will guide subsequent oncologic management and will be reviewed at multidisciplinary tumor board.

David Kim, MD
Interventional Pulmonology",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Adam Collins
MRN: 6000968
Date: 10/17/2024
Attending: David Kim, MD
Fellow: Jessica Martinez
Location: Presbyterian Hospital

PATIENT IDENTIFICATION:
Age: 59 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Combined staging and peripheral nodule diagnosis
Target lesion: 16.9mm solid nodule, RML lateral (B4)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 21G Standard FNA
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 9.9mm, 3 passes
   - Station 4L: 13.8mm, 2 passes
   - Station 4R: 21.4mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Adequate lymphocytes, no malignancy

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.5mm (acceptable)
3. Robotic catheter advanced to RML lateral (B4)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 8
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes
8. BAL obtained from RML

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 4L, 4R) → Cytology, cell block
2. TBBx RML → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of David Kim, MD

Jessica Martinez, PGY-5
David Kim, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Anna Martinez
MRN: 2165517
Date: 02/05/2025
Attending: Andrew Nakamura, MD
Fellow: Kevin Chang
Location: Regional Medical Center

PATIENT IDENTIFICATION:
Age: 61 years
Sex: Male
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 25.0mm solid nodule, LUL anterior (B3)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 21G Standard FNA
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 7: 19.5mm, 4 passes
   - Station 11L: 18.1mm, 2 passes
   - Station 10R: 17.1mm, 4 passes
   - Station 4L: 11.5mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Granuloma

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 1.6mm (acceptable)
3. Robotic catheter advanced to LUL anterior (B3)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 4
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 7, 11L, 10R, 4L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Andrew Nakamura, MD

Kevin Chang, PGY-6
Andrew Nakamura, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Dennis Peterson
MRN: 5615077
Date: 11/09/2024
Attending: Brian O'Connor, MD
Fellow: Jason Park
Location: Methodist Hospital

PATIENT IDENTIFICATION:
Age: 59 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Target lesion: 14.5mm ground-glass nodule, RUL anterior (B3)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 19G FNB/ProCore
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11L: 13.3mm, 4 passes
   - Station 7: 10.0mm, 2 passes
   - Station 2L: 24.9mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 3.2mm (acceptable)
3. Robotic catheter advanced to RUL anterior (B3)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Atypical cells
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11L, 7, 2L) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Brian O'Connor, MD

Jason Park, PGY-6
Brian O'Connor, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Dorothy Hill
MRN: 7100991
Date: 06/12/2024
Attending: Rachel Goldman, MD
Fellow: N/A
Location: Academic Health System

PATIENT IDENTIFICATION:
Age: 85 years
Sex: Male
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Peripheral nodule and bilateral hilar adenopathy
Target lesion: 14.0mm ground-glass nodule, LUL apicoposterior (B1+2)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 22G FNB/ProCore
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2L: 14.8mm, 3 passes
   - Station 4L: 24.3mm, 2 passes
   - Station 10R: 12.9mm, 2 passes
   - Station 10L: 18.8mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Atypical cells

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.5mm (acceptable)
3. Robotic catheter advanced to LUL apicoposterior (B1+2)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes, no malignancy
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2L, 4L, 10R, 10L, 11L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Rachel Goldman, MD

Fellow, PGY-None
Rachel Goldman, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Eric Foster
MRN: 5183641
Date: 07/17/2024
Attending: Eric Johnson, MD
Fellow: N/A
Location: St. Luke's Medical Center

PATIENT IDENTIFICATION:
Age: 47 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Target lesion: 19.5mm solid nodule, RLL posterior basal (B10)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 19G FNB/ProCore
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 11.4mm, 3 passes
   - Station 7: 8.1mm, 3 passes
   - Station 2R: 13.6mm, 2 passes
   - Station 4R: 22.2mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - adenocarcinoma

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 3.2mm (acceptable)
3. Robotic catheter advanced to RLL posterior basal (B10)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Malignant - NSCLC NOS
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 7, 2R, 4R) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Eric Johnson, MD

Fellow, PGY-None
Eric Johnson, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Gregory Phillips
MRN: 9775180
Date: 11/20/2024
Attending: David Kim, MD
Fellow: Kevin Chang
Location: UCLA Medical Center

PATIENT IDENTIFICATION:
Age: 59 years
Sex: Male
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Right upper lobe mass with ipsilateral mediastinal nodes
Target lesion: 27.1mm ground-glass nodule, LLL posterior basal (B10)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC260F-OL8
- EBUS needle: 19G FNB/ProCore
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2L: 20.2mm, 4 passes
   - Station 4R: 17.2mm, 4 passes
   - Station 7: 11.6mm, 3 passes
   - Station 11R: 17.2mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - squamous cell carcinoma

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.9mm (acceptable)
3. Robotic catheter advanced to LLL posterior basal (B10)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Atypical cells
8. BAL obtained from LLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2L, 4R, 7, 11R) → Cytology, cell block
2. TBBx LLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of David Kim, MD

Kevin Chang, PGY-6
David Kim, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Jacob Cooper
MRN: 2812853
Date: 05/28/2025
Attending: Steven Park, MD
Fellow: Jason Park
Location: Regional Medical Center

PATIENT IDENTIFICATION:
Age: 60 years
Sex: Male
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
PET-avid lung mass and mediastinal lymphadenopathy
Target lesion: 30.9mm ground-glass nodule, RUL anterior (B3)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 22G FNB/ProCore
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4L: 18.3mm, 2 passes
   - Station 10R: 14.8mm, 4 passes
   - Station 4R: 20.9mm, 4 passes
   - Station 7: 24.0mm, 2 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.0mm (acceptable)
3. Robotic catheter advanced to RUL anterior (B3)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Granuloma
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4L, 10R, 4R, 7) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Steven Park, MD

Jason Park, PGY-6
Steven Park, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Jerry Rodriguez
MRN: 1494096
Date: 04/10/2025
Attending: David Kim, MD
Fellow: Marcus Williams
Location: Regional Medical Center

PATIENT IDENTIFICATION:
Age: 49 years
Sex: Male
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
PET-avid lung mass and mediastinal lymphadenopathy
Target lesion: 20.0mm solid nodule, RML medial (B5)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 22G Acquire
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2L: 13.8mm, 4 passes
   - Station 4R: 23.9mm, 3 passes
   - Station 11R: 19.6mm, 3 passes
   - Station 11L: 17.4mm, 2 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - small cell carcinoma

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 2.5mm (acceptable)
3. Robotic catheter advanced to RML medial (B5)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - NSCLC NOS
8. BAL obtained from RML

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2L, 4R, 11R, 11L) → Cytology, cell block
2. TBBx RML → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of David Kim, MD

Marcus Williams, PGY-6
David Kim, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Jerry Thompson
MRN: 4534382
Date: 09/02/2025
Attending: Katherine Lee, MD
Fellow: N/A
Location: Methodist Hospital

PATIENT IDENTIFICATION:
Age: 74 years
Sex: Female
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Left lower lobe nodule and subcarinal adenopathy
Target lesion: 29.8mm ground-glass nodule, LUL anterior (B3)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 21G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 8.4mm, 4 passes
   - Station 10L: 13.7mm, 3 passes
   - Station 2L: 11.1mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.8mm (acceptable)
3. Robotic catheter advanced to LUL anterior (B3)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 8
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - adenocarcinoma
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 10L, 2L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Katherine Lee, MD

Fellow, PGY-None
Katherine Lee, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Jessica Robinson
MRN: 3842227
Date: 05/09/2024
Attending: Michael Rodriguez, MD
Fellow: N/A
Location: Memorial Hospital

PATIENT IDENTIFICATION:
Age: 49 years
Sex: Female
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Right upper lobe mass with ipsilateral mediastinal nodes
Target lesion: 28.6mm ground-glass nodule, RLL lateral basal (B9)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC260F-OL8
- EBUS needle: 21G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 17.1mm, 2 passes
   - Station 11R: 8.4mm, 2 passes
   - Station 11L: 22.2mm, 4 passes
   - Station 2R: 21.9mm, 4 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Atypical cells

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 2.6mm (acceptable)
3. Robotic catheter advanced to RLL lateral basal (B9)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 5
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Malignant - adenocarcinoma
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 11R, 11L, 2R, 4L) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Michael Rodriguez, MD

Fellow, PGY-None
Michael Rodriguez, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Jose Miller
MRN: 8472025
Date: 04/30/2025
Attending: Brian O'Connor, MD
Fellow: Marcus Williams
Location: Cleveland Clinic

PATIENT IDENTIFICATION:
Age: 57 years
Sex: Female
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 31.2mm solid nodule, LUL inferior lingula (B5)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC180F
- EBUS needle: 22G Acquire
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 16.6mm, 4 passes
   - Station 4R: 13.5mm, 2 passes
   - Station 2L: 11.0mm, 4 passes
   - Station 2R: 21.8mm, 4 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.2mm (acceptable)
3. Robotic catheter advanced to LUL inferior lingula (B5)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 4R, 2L, 2R, 4L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Brian O'Connor, MD

Marcus Williams, PGY-6
Brian O'Connor, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Justin Cook
MRN: 6605139
Date: 12/24/2024
Attending: Rachel Goldman, MD
Fellow: Jason Park
Location: Community Hospital

PATIENT IDENTIFICATION:
Age: 72 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Right upper lobe mass with ipsilateral mediastinal nodes
Target lesion: 20.2mm solid nodule, LUL inferior lingula (B5)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 21G Standard FNA
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4L: 24.4mm, 2 passes
   - Station 7: 20.3mm, 3 passes
   - Station 10R: 20.4mm, 4 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Adequate lymphocytes, no malignancy

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 2.3mm (acceptable)
3. Robotic catheter advanced to LUL inferior lingula (B5)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Malignant - small cell carcinoma
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4L, 7, 10R) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Rachel Goldman, MD

Jason Park, PGY-6
Rachel Goldman, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Justin Gonzales
MRN: 5502105
Date: 07/11/2024
Attending: Brian O'Connor, MD
Fellow: Kevin Chang
Location: Northwestern Memorial Hospital

PATIENT IDENTIFICATION:
Age: 68 years
Sex: Male
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Right upper lobe mass with ipsilateral mediastinal nodes
Target lesion: 29.4mm part-solid nodule, LLL lateral basal (B9)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 22G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 15.5mm, 3 passes
   - Station 10L: 21.7mm, 2 passes
   - Station 11R: 20.5mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Suspicious for malignancy

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.8mm (acceptable)
3. Robotic catheter advanced to LLL lateral basal (B9)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from LLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 10L, 11R) → Cytology, cell block
2. TBBx LLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Brian O'Connor, MD

Kevin Chang, PGY-6
Brian O'Connor, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Kelly Davis
MRN: 9283251
Date: 02/08/2025
Attending: Maria Santos, MD
Fellow: Kevin Chang
Location: Memorial Hospital

PATIENT IDENTIFICATION:
Age: 50 years
Sex: Male
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Right upper lobe mass with ipsilateral mediastinal nodes
Target lesion: 31.9mm ground-glass nodule, LLL anteromedial basal (B7+8)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 22G Acquire
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11L: 21.6mm, 4 passes
   - Station 2L: 14.5mm, 4 passes
   - Station 7: 21.8mm, 3 passes
   - Station 11R: 15.0mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Suspicious for malignancy

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 3.2mm (acceptable)
3. Robotic catheter advanced to LLL anteromedial basal (B7+8)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Suspicious for malignancy
8. BAL obtained from LLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11L, 2L, 7, 11R, 10R) → Cytology, cell block
2. TBBx LLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Maria Santos, MD

Kevin Chang, PGY-6
Maria Santos, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Larry Robinson
MRN: 6029434
Date: 07/23/2025
Attending: Brian O'Connor, MD
Fellow: N/A
Location: Presbyterian Hospital

PATIENT IDENTIFICATION:
Age: 62 years
Sex: Male
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Target lesion: 15.4mm ground-glass nodule, RML lateral (B4)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 21G Standard FNA
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 15.1mm, 3 passes
   - Station 4L: 21.5mm, 2 passes
   - Station 4R: 12.6mm, 2 passes
   - Station 11L: 22.8mm, 4 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Adequate lymphocytes

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.5mm (acceptable)
3. Robotic catheter advanced to RML lateral (B4)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Atypical cells
8. BAL obtained from RML

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 4L, 4R, 11L) → Cytology, cell block
2. TBBx RML → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Brian O'Connor, MD

Fellow, PGY-None
Brian O'Connor, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Linda Murphy
MRN: 7228788
Date: 11/08/2025
Attending: Lisa Thompson, MD
Fellow: Jason Park
Location: Baptist Medical Center

PATIENT IDENTIFICATION:
Age: 47 years
Sex: Male
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 30.4mm solid nodule, RML lateral (B4)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC260F-OL8
- EBUS needle: 22G FNB/ProCore
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2R: 15.3mm, 3 passes
   - Station 11R: 23.0mm, 3 passes
   - Station 4R: 15.0mm, 3 passes
   - Station 7: 13.7mm, 2 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Adequate lymphocytes

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.6mm (acceptable)
3. Robotic catheter advanced to RML lateral (B4)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 4
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Suspicious for malignancy
8. BAL obtained from RML

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2R, 11R, 4R, 7) → Cytology, cell block
2. TBBx RML → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Lisa Thompson, MD

Jason Park, PGY-6
Lisa Thompson, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Lisa Lopez
MRN: 7802544
Date: 09/27/2024
Attending: Jennifer Walsh, MD
Fellow: Marcus Williams
Location: Baptist Medical Center

PATIENT IDENTIFICATION:
Age: 76 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Target lesion: 23.2mm ground-glass nodule, LLL lateral basal (B9)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC180F
- EBUS needle: 19G FNB/ProCore
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11R: 13.7mm, 4 passes
   - Station 2L: 8.4mm, 2 passes
   - Station 4L: 19.6mm, 4 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Suspicious for malignancy

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 2.8mm (acceptable)
3. Robotic catheter advanced to LLL lateral basal (B9)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 7
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Suspicious for malignancy
8. BAL obtained from LLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11R, 2L, 4L) → Cytology, cell block
2. TBBx LLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Jennifer Walsh, MD

Marcus Williams, PGY-6
Jennifer Walsh, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Matthew Perez
MRN: 5387495
Date: 10/22/2025
Attending: Robert Patel, MD
Fellow: Priya Sharma
Location: Memorial Hospital

PATIENT IDENTIFICATION:
Age: 47 years
Sex: Male
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Peripheral lung nodule with suspicious mediastinal nodes
Target lesion: 24.3mm solid nodule, LUL superior lingula (B4)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 21G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4L: 21.5mm, 2 passes
   - Station 10L: 21.1mm, 2 passes
   - Station 11L: 8.8mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.5mm (acceptable)
3. Robotic catheter advanced to LUL superior lingula (B4)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 4
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4L, 10L, 11L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Robert Patel, MD

Priya Sharma, PGY-5
Robert Patel, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Matthew Robinson
MRN: 6792666
Date: 03/15/2025
Attending: Amanda Foster, MD
Fellow: N/A
Location: Baptist Medical Center

PATIENT IDENTIFICATION:
Age: 58 years
Sex: Male
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 27.1mm solid nodule, RLL superior (B6)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 22G FNB/ProCore
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4L: 9.1mm, 3 passes
   - Station 2R: 14.9mm, 3 passes
   - Station 2L: 13.2mm, 2 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Suspicious for malignancy

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.8mm (acceptable)
3. Robotic catheter advanced to RLL superior (B6)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 5
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4L, 2R, 2L) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Amanda Foster, MD

Fellow, PGY-None
Amanda Foster, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Michael Scott
MRN: 2409175
Date: 08/30/2024
Attending: Steven Park, MD
Fellow: Jason Park
Location: Baptist Medical Center

PATIENT IDENTIFICATION:
Age: 67 years
Sex: Female
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Combined staging and peripheral nodule diagnosis
Target lesion: 27.5mm ground-glass nodule, RLL superior (B6)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 22G Acquire
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11R: 22.0mm, 2 passes
   - Station 4R: 13.7mm, 4 passes
   - Station 11L: 18.9mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - small cell carcinoma

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 2.8mm (acceptable)
3. Robotic catheter advanced to RLL superior (B6)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 4
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes, no malignancy
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11R, 4R, 11L) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Steven Park, MD

Jason Park, PGY-6
Steven Park, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Raymond Nguyen
MRN: 8349919
Date: 06/15/2025
Attending: Sarah Chen, MD
Fellow: Emily Chen
Location: Academic Health System

PATIENT IDENTIFICATION:
Age: 46 years
Sex: Male
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 30.2mm ground-glass nodule, LUL inferior lingula (B5)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 22G Acquire
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4R: 22.1mm, 4 passes
   - Station 2R: 14.8mm, 4 passes
   - Station 2L: 15.4mm, 2 passes
   - Station 10L: 10.7mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Atypical cells

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 2.2mm (acceptable)
3. Robotic catheter advanced to LUL inferior lingula (B5)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 8
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Malignant - small cell carcinoma
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4R, 2R, 2L, 10L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Sarah Chen, MD

Emily Chen, PGY-5
Sarah Chen, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Raymond Wright
MRN: 5022444
Date: 08/13/2025
Attending: Lisa Thompson, MD
Fellow: N/A
Location: Baptist Medical Center

PATIENT IDENTIFICATION:
Age: 85 years
Sex: Male
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy
Target lesion: 31.5mm part-solid nodule, RML medial (B5)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 22G Standard FNA
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 4R: 23.5mm, 2 passes
   - Station 4L: 14.3mm, 4 passes
   - Station 10R: 11.1mm, 2 passes
   - Station 2L: 20.1mm, 2 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - squamous cell carcinoma

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 3.2mm (acceptable)
3. Robotic catheter advanced to RML medial (B5)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 5
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from RML

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 4R, 4L, 10R, 2L) → Cytology, cell block
2. TBBx RML → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Lisa Thompson, MD

Fellow, PGY-None
Lisa Thompson, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Rebecca Anderson
MRN: 6144324
Date: 01/02/2025
Attending: Maria Santos, MD
Fellow: Kevin Chang
Location: Memorial Hospital

PATIENT IDENTIFICATION:
Age: 76 years
Sex: Female
ASA Class: 4

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Combined staging and peripheral nodule diagnosis
Target lesion: 16.3mm part-solid nodule, RUL anterior (B3)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC180F
- EBUS needle: 21G Standard FNA
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2L: 19.0mm, 2 passes
   - Station 10L: 22.7mm, 4 passes
   - Station 7: 16.8mm, 4 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - adenocarcinoma

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 3.0mm (acceptable)
3. Robotic catheter advanced to RUL anterior (B3)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 2
   - Brushings: 2
7. ROSE performed - Malignant - adenocarcinoma
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2L, 10L, 7) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Maria Santos, MD

Kevin Chang, PGY-6
Maria Santos, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Samantha Jones
MRN: 9142556
Date: 03/13/2024
Attending: Steven Park, MD
Fellow: Emily Chen
Location: University Medical Center

PATIENT IDENTIFICATION:
Age: 57 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Peripheral nodule and bilateral hilar adenopathy
Target lesion: 34.7mm part-solid nodule, LUL superior lingula (B4)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 21G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 7: 8.3mm, 2 passes
   - Station 11R: 19.4mm, 4 passes
   - Station 11L: 14.1mm, 4 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Atypical cells

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 2.5mm (acceptable)
3. Robotic catheter advanced to LUL superior lingula (B4)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 5
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Suspicious for malignancy
8. BAL obtained from LUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 7, 11R, 11L) → Cytology, cell block
2. TBBx LUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Steven Park, MD

Emily Chen, PGY-5
Steven Park, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Stephen Morris
MRN: 9726006
Date: 04/04/2025
Attending: David Kim, MD
Fellow: Jessica Martinez
Location: Regional Medical Center

PATIENT IDENTIFICATION:
Age: 51 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
PET-avid lung mass and mediastinal lymphadenopathy
Target lesion: 23.3mm solid nodule, RLL medial basal (B7)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 22G Standard FNA
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 2R: 12.0mm, 4 passes
   - Station 10R: 12.9mm, 3 passes
   - Station 2L: 13.9mm, 2 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 1.9mm (acceptable)
3. Robotic catheter advanced to RLL medial basal (B7)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 5
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes, no malignancy
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 2R, 10R, 2L) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of David Kim, MD

Jessica Martinez, PGY-5
David Kim, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Stephen Ward
MRN: 4286546
Date: 07/02/2024
Attending: Eric Johnson, MD
Fellow: Priya Sharma
Location: Regional Medical Center

PATIENT IDENTIFICATION:
Age: 49 years
Sex: Female
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Peripheral lung nodule with suspicious mediastinal nodes
Target lesion: 19.4mm solid nodule, RUL anterior (B3)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC180F
- EBUS needle: 19G FNB/ProCore
- Robotic platform: Monarch (Auris Health (J&J))
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 21.2mm, 2 passes
   - Station 2L: 8.8mm, 2 passes
   - Station 11L: 13.8mm, 3 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - adenocarcinoma

PART B - ROBOTIC NAVIGATION:
1. Monarch system prepared and registered
2. Registration error: 1.5mm (acceptable)
3. Robotic catheter advanced to RUL anterior (B3)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with Augmented fluoroscopy
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Granuloma
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 2L, 11L) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Eric Johnson, MD

Priya Sharma, PGY-5
Eric Johnson, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Steven Morgan
MRN: 9996681
Date: 12/07/2024
Attending: Andrew Nakamura, MD
Fellow: Jessica Martinez
Location: Community Hospital

PATIENT IDENTIFICATION:
Age: 52 years
Sex: Female
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Combined staging and peripheral nodule diagnosis
Target lesion: 16.3mm ground-glass nodule, RLL superior (B6)
Bronchus sign: Positive

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 22G Standard FNA
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11L: 14.4mm, 4 passes
   - Station 4L: 21.7mm, 3 passes
   - Station 10L: 19.2mm, 2 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Granuloma

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 3.4mm (acceptable)
3. Robotic catheter advanced to RLL superior (B6)
4. Radial EBUS deployed - Adjacent view obtained
5. Tool-in-lesion confirmed with Radial EBUS
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Malignant - squamous cell carcinoma
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11L, 4L, 10L) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Andrew Nakamura, MD

Jessica Martinez, PGY-5
Andrew Nakamura, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Susan Lopez
MRN: 7384677
Date: 02/27/2025
Attending: Lisa Thompson, MD
Fellow: Kevin Chang
Location: Community Hospital

PATIENT IDENTIFICATION:
Age: 80 years
Sex: Female
ASA Class: 2

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Lung nodule evaluation with mediastinal lymphadenopathy workup
Target lesion: 23.3mm solid nodule, RLL posterior basal (B10)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Pentax EB-1990i
- EBUS needle: 21G Standard FNA
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10R: 11.9mm, 3 passes
   - Station 4R: 21.4mm, 2 passes
   - Station 7: 16.1mm, 4 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - squamous cell carcinoma

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 2.4mm (acceptable)
3. Robotic catheter advanced to RLL posterior basal (B10)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 6
   - TBNA passes: 3
   - Brushings: 2
7. ROSE performed - Adequate lymphocytes, no malignancy
8. BAL obtained from RLL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10R, 4R, 7) → Cytology, cell block
2. TBBx RLL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Lisa Thompson, MD

Kevin Chang, PGY-6
Lisa Thompson, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: Virginia Cox
MRN: 4351438
Date: 12/03/2024
Attending: Brian O'Connor, MD
Fellow: Jessica Martinez
Location: Veterans Affairs Medical Center

PATIENT IDENTIFICATION:
Age: 77 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Mediastinal staging for biopsy-proven lung adenocarcinoma
Target lesion: 22.6mm solid nodule, RUL apical (B1)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Olympus BF-UC190F
- EBUS needle: 22G Standard FNA
- Robotic platform: Galaxy (Noah Medical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 11R: 24.9mm, 3 passes
   - Station 2L: 14.7mm, 2 passes
   - Station 4R: 13.0mm, 3 passes
   - Station 11L: 19.1mm, 3 passes
6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - adenocarcinoma

PART B - ROBOTIC NAVIGATION:
1. Galaxy system prepared and registered
2. Registration error: 1.8mm (acceptable)
3. Robotic catheter advanced to RUL apical (B1)
4. Radial EBUS deployed - Concentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 4
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Suspicious for malignancy
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 11R, 2L, 4R, 11L) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Brian O'Connor, MD

Jessica Martinez, PGY-5
Brian O'Connor, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"BRONCHOSCOPY PROCEDURE NOTE

Patient Name: William Scott
MRN: 4404152
Date: 07/29/2025
Attending: Robert Patel, MD
Fellow: Jason Park
Location: Presbyterian Hospital

PATIENT IDENTIFICATION:
Age: 63 years
Sex: Female
ASA Class: 3

PRE-PROCEDURE:
1. Patient identity confirmed with two identifiers
2. Informed consent verified on chart
3. NPO status confirmed (>8 hours)
4. Anticoagulation status reviewed - not on anticoagulation
5. Allergies reviewed - NKDA
6. Time-out performed with all team members

INDICATION:
Peripheral nodule and bilateral hilar adenopathy
Target lesion: 21.6mm ground-glass nodule, RUL anterior (B3)
Bronchus sign: Negative

ANESTHESIA:
Type: General anesthesia
Airway: 8.0mm ETT, oral
Induction: Standard IV induction by anesthesia team

EQUIPMENT USED:
- Linear EBUS scope: Fujifilm EB-580S
- EBUS needle: 22G Standard FNA
- Robotic platform: Ion (Intuitive Surgical)
- Radial EBUS: 20 MHz miniprobe
- Biopsy forceps: Standard
- Cytology brushes: Standard

PROCEDURE STEPS:

PART A - LINEAR EBUS FOR STAGING:
1. Bronchoscope inserted through ETT
2. Standard airway inspection performed - airways patent, no endobronchial lesions
3. Linear EBUS scope exchanged
4. Systematic lymph node survey performed
5. Following stations identified and sampled:
   - Station 10L: 13.0mm, 3 passes
   - Station 4L: 15.7mm, 2 passes
   - Station 11L: 19.4mm, 2 passes

6. ROSE performed - cytopathologist present
7. ROSE results: Malignant - NSCLC NOS

PART B - ROBOTIC NAVIGATION:
1. Ion system prepared and registered
2. Registration error: 1.8mm (acceptable)
3. Robotic catheter advanced to RUL anterior (B3)
4. Radial EBUS deployed - Eccentric view obtained
5. Tool-in-lesion confirmed with CBCT
6. Sampling performed:
   - Forceps biopsies: 8
   - TBNA passes: 4
   - Brushings: 2
7. ROSE performed - Granuloma
8. BAL obtained from RUL

POST-PROCEDURE:
1. Airways inspected - no active bleeding
2. Bronchoscope removed
3. Patient extubated without difficulty
4. Post-procedure CXR ordered - no pneumothorax
5. Patient to recovery area

SPECIMENS SENT:
1. EBUS-TBNA (stations 10L, 4L, 11L) → Cytology, cell block
2. TBBx RUL → Surgical pathology
3. Brushings → Cytology
4. BAL → Cultures (bacterial, fungal, AFB)

COMPLICATIONS: None
ESTIMATED BLOOD LOSS: <10 mL

IMPRESSION:
1. Completed EBUS-TBNA mediastinal staging
2. Completed robotic bronchoscopy with peripheral lung biopsy
3. No immediate complications

PLAN:
1. Monitor in recovery x 2 hours
2. Discharge home if stable
3. Follow-up in clinic for pathology results
4. Results to be discussed at tumor board

Procedure performed under direct supervision of Robert Patel, MD

Jason Park, PGY-6
Robert Patel, MD (Attending - present for entire procedure)",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Billable Services:
- 31627 (Navigational Bronchoscopy): Required for 14mm RML nodule.
- 31629 (Transbronchial Needle Aspiration): Primary sampling modality.
- 31654 (Peripheral EBUS): Used for localization.
Note: High complexity due to 2.1cm divergence requiring TiLT+ correction.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Billing Codes:
- 31641: Destruction of tumor (Microwave Ablation).
- 31627: Navigation (SuperDimension).
- 31654: Radial EBUS.
Note: No biopsy performed today (diagnostic confirmed prior). 31641 is the primary service.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Billing Summary:
- 31653: EBUS-TBNA 3+ stations (4R, 7, 11R sampled).
Note: Do NOT bill 31652 separately; 31653 covers the entire procedure when 3 or more stations are sampled. No other interventions performed.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Billing Summary:
- Primary: 31629 (TBNA of LLL nodule).
- Secondary: 31623 (Brush), 31627 (Navigation), 31654 (rEBUS).
- Complexity: High. Required TiLT+ tomosynthesis to correct 1.3cm divergence caused by atelectasis.
- Outcome: Successful localization and sampling.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Billing: 31628 (Transbronchial lung biopsy - Forceps/Cryo distinct from aspiration), 31654 (Radial EBUS guidance).
Note: 31645 (Therapeutic aspiration) is NOT reported as removal of blood/secretions is incidental. 31628 covers the biopsy work. Radial EBUS (31654) documents the search for peripheral lesions/safe sites.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"Billing: 31629 (TBNA), 31623 (Brush), 31627 (Galaxy Nav), 31654 (rEBUS).
Note: TiLT+ utilized for intra-operative target correction (1.5cm divergence).",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Billing: 31629 (TBNA), 31623 (Brush), 31627 (Nav), 31654 (rEBUS).
Target: RUL (RB2).
Method: Robotic navigation with fluoroscopic confirmation.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Billing: 31630 (Bronchoscopy with dilation of trachea).
Technique: Balloon dilation of a single stricture in the trachea. Serial inflations performed. No stent placed. No biopsy performed.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Billing: 31653 (EBUS-TBNA 3+ stations).
Stations: 2R, 4R, 7, 10R.
Rationale: Sampling of 4 distinct mediastinal/hilar stations falls under the single comprehensive code 31653.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Billing: 32601 (Diagnostic Thoracoscopy).
Rationale: Left pleural space accessed. Adhesions/trapped lung documented. Fluid drained. No biopsies (32609) or lysis (32651) documented in source. Chest tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Billing: 32601 (Diagnostic Thoracoscopy).
Rationale: Right pleural space inspected. Thickened pleura/nodules noted. Fluid drained. No biopsies performed or coded (included in diag if minor, but here focusing on diagnostic code). No pleurodesis. Chest tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Billing: 32609 (Biopsy) & 32650 (Talc).
Site: Left.
Details: Visceral implants seen. 11 parietal biopsies taken. Diaphragmatic biopsies taken. Talc poudrage performed. Chest tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Billing: 32609 (Thoracoscopy with pleura biopsy).
Technique: Right 6th ICS entry. Visual inspection showed inflammation. Biopsy forceps utilized to obtain 12 specimens from parietal pleura and additional from diaphragm to rule out malignancy. No therapeutic pleurodesis (32650) performed. Chest tube inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Billing: 32650 (Pleurodesis).
Rationale: Right pleural space accessed. Inflammatory changes seen. Talc poudrage performed for pleurodesis. Chest tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Brandon Morris, MRN 3673622, a 47-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at St. Luke's Medical Center on 01/13/2024. The indication was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy with a 19.5mm solid lesion in the RLL posterior basal (B10), bronchus sign positive, PET SUV max 5.4. The patient was ASA class 3 with smoking history of None pack-years (never). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 19-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (11.4mm, 3 passes, ROSE: Malignant - adenocarcinoma); station 7 (8.1mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy); station 2R (13.6mm, 2 passes, ROSE: Adequate lymphocytes); station 4R (22.2mm, 3 passes, ROSE: Malignant - small cell carcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.2mm. The robotic catheter was advanced to the RLL posterior basal (B10) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - nsclc nos.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 91 minutes. Attending physician: Eric Johnson, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Brian Cruz, MRN 2961138, a 80-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Memorial Hospital on 05/08/2024. The indication was combined staging and peripheral nodule diagnosis with a 16.3mm part-solid lesion in the RUL anterior (B3), bronchus sign positive, PET SUV max 12.4. The patient was ASA class 4 with smoking history of 27 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC180F bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2L (19.0mm, 2 passes, ROSE: Malignant - adenocarcinoma); station 10L (22.7mm, 4 passes, ROSE: Malignant - adenocarcinoma); station 7 (16.8mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.0mm. The robotic catheter was advanced to the RUL anterior (B3) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - adenocarcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 75 minutes. Attending physician: Maria Santos, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Brian has severe copd so we did cryoablation on his cancer. used the monarch robot found the spot in the RUL. put the cryo probe in and froze it twice for 6 minutes each time. saw the ice ball on the ct spin. he bled a little but it stopped. sending him to the floor.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
Bronchial thermoplasty performed for severe asthma. This was the second of three planned sessions targeting the lower lobes. Radiofrequency energy was delivered to the visible airways of the RLL and LLL. 92 activations total. Procedure complicated by mild bronchospasm which responded to medical therapy.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
Bronchoscopic cryobiopsy for fibrotic ILD. Patient is a 56-year-old female with progressive fibrotic interstitial lung disease. General anesthesia with 8.5 ETT was used. Bronchoscope advanced to left lower lobe basal segments. Radial EBUS used to identify parenchymal sites distant from large vessels. Three cryobiopsies obtained using 1.9 mm cryoprobe and one standard forceps biopsy. Bronchial blocker placed prophylactically. Mild bleeding controlled with blocker inflation and iced saline.,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
Bronchoscopic electromagnetic navigation with microwave ablation of right upper lobe peripheral nodule. 67-year-old gentleman. General anesthesia. Navigation to RUL posterior segment. Radial EBUS and cone-beam CT confirmation. Microwave ablation probe advanced. Ablation 65 watts for 5 minutes. Hyperechoic changes on EBUS. No complications.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
Bronchoscopic microwave ablation. Right upper lobe nodule. General anesthesia. Electromagnetic navigation to RUL anterior segment. Target confirmed in contact position with radial EBUS. Microwave probe inserted. Ablation performed at 60W for 6 minutes. Lesion coverage confirmed. Airway patent. Extubated.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
Bronchoscopy with balloon dilation performed for idiopathic tracheal stenosis. The stenotic segment was identified and traversed. A CRE balloon was utilized for serial dilations up to 12mm. Post-procedure lumen was significantly improved. Patient extubated and stable.,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Bronchoscopy with electromagnetic navigation and biopsy. Indication: LUL peripheral ground-glass nodule. Moderate sedation. Navigation to LUL apical-posterior segment. Radial EBUS confirmation. Sampling via TBNA, forceps, and brush. No complications.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"CPT 31629 (TBNA), 31623 (Brush), 31627 (Nav), 31654 (EBUS). Forceps biopsy performed but bundled. TiLT used to correct 1.4cm divergence to ensure diagnostic yield. ROSE confirmed malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"CPT Code: 31638 (Revision of tracheobronchial stent).
Detail: Existing stent was manipulated and repositioned (not removed/replaced). Balloon dilation (bundled) used to seat the stent. Fluoroscopy confirmed position. Meets criteria for revision.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"CPT Coding Justification:
31627: Navigation (Galaxy system utilized to reach RUL target).
31654: Radial EBUS (Peripheral probe used to localize 22mm lesion).
31629: TBNA (22G needle aspiration of RUL nodule).
31626: Fiducial Markers (Placement of gold marker for SBRT).
31624: BAL (Separate lavage of target segment).
Technique: TiLT+ tomosynthesis used to verify tool-in-lesion.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"CPT Coding Summary:
1. 31624: Bronchoscopy with bronchoalveolar lavage (BAL) performed in the Right Middle Lobe.
2. 31628: Bronchoscopy with transbronchial lung biopsy (TBBx), performed in a separate lobe (Right Lower Lobe). Fluoroscopic guidance utilized for safety. Six specimens obtained.
Medical Necessity: Evaluation of pulmonary nodules and adenopathy (Sarcoidosis).",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"CPT Coding:
- 31626: Placement of fiducial markers (SBRT planning).
- 31629: TBNA.
- 31623: Brush.
- 31627: Navigation (Galaxy).
- 31654: rEBUS.
Note: TiLT+ used to verify tool-in-lesion.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"CPT Justification:
31641: Bronchoscopy with destruction of tumor. 
- Technique: Cryoablation (Erbecryo system).
- Target: LLL peripheral nodule (Malignant).
- Effort: 3 freeze-thaw cycles performed to destroy tumor tissue.
- Guidance: EMN and Radial EBUS used for localization (integral to successful placement of ablation probe).",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Carolyn Ruiz, MRN 6859421, a 75-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Methodist Hospital on 02/21/2024. The indication was left lower lobe nodule and subcarinal adenopathy with a 29.8mm ground-glass lesion in the LUL anterior (B3), bronchus sign negative, PET SUV max 13.7. The patient was ASA class 2 with smoking history of 43 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (8.4mm, 4 passes, ROSE: Malignant - NSCLC NOS); station 10L (13.7mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy); station 2L (11.1mm, 3 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.8mm. The robotic catheter was advanced to the LUL anterior (B3) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (8 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - adenocarcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 103 minutes. Attending physician: Katherine Lee, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Carolyn Thomas, MRN 4775224, a 64-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Presbyterian Hospital on 07/01/2025. The indication was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy with a 15.4mm ground-glass lesion in the RML lateral (B4), bronchus sign positive, PET SUV max 4.3. The patient was ASA class 2 with smoking history of 47 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (15.1mm, 3 passes, ROSE: Adequate lymphocytes); station 4L (21.5mm, 2 passes, ROSE: Adequate lymphocytes, no malignancy); station 4R (12.6mm, 2 passes, ROSE: Suspicious for malignancy); station 11L (22.8mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.5mm. The robotic catheter was advanced to the RML lateral (B4) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed atypical cells.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 105 minutes. Attending physician: Brian O'Connor, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Catherine Gray, MRN 4088877, a 59-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Baptist Medical Center on 10/13/2024. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 27.1mm solid lesion in the RLL superior (B6), bronchus sign negative, PET SUV max 6.1. The patient was ASA class 3 with smoking history of None pack-years (never). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 22-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4L (9.1mm, 3 passes, ROSE: Suspicious for malignancy); station 2R (14.9mm, 3 passes, ROSE: Malignant - NSCLC NOS); station 2L (13.2mm, 2 passes, ROSE: Adequate lymphocytes, no malignancy). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.8mm. The robotic catheter was advanced to the RLL superior (B6) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (5 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 108 minutes. Attending physician: Amanda Foster, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Charles Diaz, MRN 3240651, a 49-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Academic Health System on 09/30/2024. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 30.2mm ground-glass lesion in the LUL inferior lingula (B5), bronchus sign positive. The patient was ASA class 4 with smoking history of 34 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 22-gauge Acquire needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4R (22.1mm, 4 passes, ROSE: Atypical cells); station 2R (14.8mm, 4 passes, ROSE: Suspicious for malignancy); station 2L (15.4mm, 2 passes, ROSE: Granuloma); station 10L (10.7mm, 3 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.2mm. The robotic catheter was advanced to the LUL inferior lingula (B5) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (8 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - small cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 98 minutes. Attending physician: Sarah Chen, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Christine Garcia, MRN 6402233, a 62-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Presbyterian Hospital on 03/04/2024. The indication was combined staging and peripheral nodule diagnosis with a 16.9mm solid lesion in the RML lateral (B4), bronchus sign positive, PET SUV max 16.9. The patient was ASA class 3 with smoking history of 58 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (9.9mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy); station 4L (13.8mm, 2 passes, ROSE: Malignant - small cell carcinoma); station 4R (21.4mm, 3 passes, ROSE: Adequate lymphocytes). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.5mm. The robotic catheter was advanced to the RML lateral (B4) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (8 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 100 minutes. Attending physician: David Kim, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Code Justification:
- 32609 (Thoracoscopy with biopsy): Right pleural space accessed. Diffuse nodules visualized. Biopsy forceps used to obtain 7 specimens from parietal pleura.
- 32650 (Thoracoscopy with pleurodesis): Talc poudrage insufflated under direct visualization for pleurodesis.
Device: Semi-rigid pleuroscope. Outcome: Fluid drained, tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Code Selection:
31626 (Marker), 31629 (TBNA), 31623 (Brush). Add-ons: 31627 (Nav), 31654 (rEBUS).
Medical Necessity: 4X nodule requiring diagnosis and marking.
Tech: Galaxy robot with TiLT+ used to correct 1.5cm divergence.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Code Selection: 31624 (Bronchoscopy with bronchoalveolar lavage).
Rationale: Procedure performed in ICU setting for therapeutic purpose (removal of mucus plugs causing lobar collapse). Saline lavage was integral to clearing the inspissated secretions in the Right Lower Lobe. No biopsies taken.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"Code Selection: 31645 (Therapeutic aspiration of tracheobronchial tree).
Justification: Procedure performed for initial therapeutic purposes to resolve mucus plugging causing respiratory failure. Extensive suctioning and lavage required to clear right mainstem, RML, and RLL bronchi. No biopsy or diagnostic washing performed.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"Code: 31635 (Bronchoscopy with removal of foreign body).
Detail: Removal of aspirated organic material from Right Mainstem/RLL using basket and forceps. Complexity: Piecemeal removal required.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"Code: 31652 (EBUS-TBNA 1-2 stations).
Justification: Only station 7 was sampled per specific clinical request. Systematic staging was not performed.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Code: 31652 (EBUS-TBNA, 1-2 stations).
Specifics: Sampled Station 7 and Station 11R (Total 2 stations). This qualifies for the base EBUS code 31652, not the multiple station code 31653.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"Code: 31653 (EBUS-TBNA 3 or more stations).
Stations sampled: 4L, 7, 11L.
Note: All sampling performed during single session. Validates 31653. No add-on codes applicable.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Code: 31653 (EBUS-TBNA 3+ stations).
Justification: 5 distinct nodal stations were sampled (2R, 4R, 4L, 7, 11R). This meets the criteria for the highest level EBUS code.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"Code: 31661 (Bronchial Thermoplasty, 2 or more lobes).
Details: Treated RLL and LLL (2 lobes). Total activations: 92. Session 2 of standard protocol.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"Code: 32551 (Tube thoracostomy).
Specifics: Open/blunt dissection technique used (not percutaneous/Seldinger). 28Fr tube placed. Connected to suction.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"Code: 32555 (Thoracentesis with imaging guidance).
Specifics: Ultrasound used for localization and real-time guidance (documented). 1.3L removed. No chest tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Code: 32604 (Thoracoscopy with pleural biopsy).
Details: Diagnostic inspection + Biopsy of parietal pleura. No talc (32650) or lung biopsy (32609) performed. Catheter was removed at end of case, so no chest tube code.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Code: 32609 (Biopsy).
Site: Left.
Tech: 12 parietal biopsies obtained. Diaphragm sampled. No talc used. Chest tube inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Codes:
- 31627 (Navigation)
- 31629 (TBNA)
- 31628 (Biopsy)
- 31654 (Radial EBUS)
Note: Multiple modalities used to maximize yield on small GGO.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Codes:
- 31641 (Destruction of tumor - RFA).
- 31627 (Navigation).
- 31654 (Radial EBUS).
Justification: Definitive treatment of malignant nodule via bronchoscopic radiofrequency energy application.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Codes:
- 31652: EBUS (2 stations: 4R, 7).
- 31625: Endobronchial biopsy (RUL lesion).
Justification: Staging via EBUS and separate diagnostic biopsy of visible airway lesion.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Codes: 31626 (Marker), 31629 (TBNA), 31623 (Brush), 31627 (Nav), 31654 (rEBUS).
Note: High complexity. TiLT+ required to correct 1.8cm positioning divergence.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Codes: 31626 (Marker), 31629 (TBNA), 31624 (BAL), 31627 (Nav), 31654 (rEBUS).
Note: 2.3cm divergence corrected via TiLT+.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"Codes: 31627 (Nav), 31629 (TBNA), 31628 (Bx), 31654 (REBUS).
Justification: Multimodal sampling of peripheral nodule utilizing navigation and ultrasound confirmation.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Codes: 31627 (Navigational Bronch), 31654 (REBUS), 31628 (TBBx 1st lobe), 31632 (TBBx addl lobe).
Details: Navigation used. REBUS used. Biopsies taken from RUL and RLL (2 separate lobes).",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Codes: 31629 (TBNA), 31623 (Brush), 31627 (Nav), 31654 (EBUS). Note: Significant 2.1cm divergence required TiLT+ correction to ensure tool-in-lesion.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Codes: 31629 (TBNA), 31624 (BAL), 31623 (Brush), 31627 (Nav), 31654 (EBUS), 31626 (Marker).
Note: Forceps biopsy (31628) performed but bundled with 31629 at same site per NCCI. High complexity procedure using TiLT augmented fluoroscopy.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Codes: 31629 (TBNA), 31624 (BAL), 31623 (Brush), 31627 (Nav), 31654 (rEBUS).
Target: RLL (RB10).
Note: BAL performed for culture/cytology.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Codes: 31629 (TBNA), 31628 (TBBx), +31627 (Navigational bronchoscopy), +31654 (REBUS).
Rationale: TBNA performed (31629 is primary). TBBx performed in same lobe (31628). Navigation and REBUS used for localization. 31626 not used as 31629 takes precedence or specific biopsy codes used.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"Codes: 31629, 31623, 31627, 31654.
Technique: Electromagnetic navigation (Galaxy) with fluoroscopic and rEBUS confirmation. No TiLT divergence noted.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Codes: 31641 (Bronchial tumor destruction), 31627 (Navigational bronchoscopy), 31654 (REBUS), 32557 (Pleural drainage with image guidance).
Justification: MWA constitutes tumor destruction. Navigation and REBUS were utilized. The pneumothorax required a separate procedure (chest tube) involving imaging guidance.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"Codes: 31641 (Bronchoscopy with destruction/relief of stenosis).
Justification: RFA probe used primarily to destroy tumor tissue and secondarily to coagulate bleeding vessels in the tumor bed.
Note: This was a salvage procedure combining hemostasis (normally 31634/31643) and ablation (31641). 31641 is the primary definitive therapy performed.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Codes: 31641 (Tumor destruction), 31627 (Navigational bronchoscopy), 31654 (REBUS).
Note: Cryoablation is coded as destruction of tumor (31641). Robotic navigation (Monarch) supports 31627. REBUS supports 31654. No pleural intervention required.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Codes: 32609 (Biopsy) + 32650 (Pleurodesis).
Site: Right.
Tech: 10 specimens taken from parietal pleura. Diaphragm sampled. Talc insufflated. Chest tube inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Codes: 32609 (Biopsy) + 32650 (Pleurodesis).
Site: Right.
Tech: 11 specimens taken from parietal pleura via forceps. Diaphragm sampled. Talc insufflated for chemical pleurodesis. Chest tube inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Coding Summary:
31627 (Nav) + 31654 (EBUS) + 31629 (TBNA) + 31623 (Brush) + 31624 (BAL) + 31626 (Marker).
Documentation supports use of Galaxy navigation and TiLT+ verification for LUL target. Multiple distinct sampling tools utilized.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Coding: 31641 (Destruction of tumor, bronchoscopic), +31627 (Navigational bronchoscopy), +31654 (Radial EBUS).
Rationale: Primary therapeutic intent was destruction (RFA). Navigation and REBUS used for localization. CBCT (76000/77002) is distinct but noted here for procedural completeness.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Coding: 32609 (Biopsy) & 32650 (Talc Pleurodesis).
Site: Right Hemithorax.
Details: Mass visualized. 12 parietal biopsies obtained. Diaphragmatic biopsies obtained. Talc insufflated for pleurodesis due to malignant appearance. Chest tube placed for drainage.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Context: Lung-RADS 4B mass.
Technique: The Galaxy scope was piloted to the Lingula. A TiLT+ scan exposed a 1.8cm deviation, which was rectified. The lesion was localized via rEBUS. We aspirated the site with a 22G needle, harvested tissue with forceps, and brushed the area.
Result: ROSE indicated squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
Diagnostic and therapeutic thoracentesis performed on the left hemithorax. Ultrasound guidance utilized. 1300 mL of clear straw-colored fluid evacuated. Catheter removed. Patient tolerated well with improvement in dyspnea.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Diagnostic bronchoscopy for a peripheral 8mm Lingular nodule. The Galaxy system was used. TiLT+ tomosynthesis corrected a 1.1cm target divergence. Despite the small size, an eccentric rEBUS signal was obtained. Sampling via TBNA and brush yielded squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Diagnostic bronchoscopy for an 11mm RUL nodule in a patient with prior malignancy history. Galaxy navigation was utilized to reach RB2. Fluoroscopic confirmation was obtained. Sampling via TBNA and forceps revealed granulomatous inflammation, arguing against recurrence.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
Diagnostic bronchoscopy with EBUS. Stations 4R and 7 sampled; both positive. Systematic evaluation completed. Right upper lobe endobronchial lesion biopsied and brushed. No complications.,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Donald Gray, MRN 6980050, a 77-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Baptist Medical Center on 11/13/2025. The indication was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy with a 23.2mm ground-glass lesion in the LLL lateral basal (B9), bronchus sign positive, PET SUV max 16.0. The patient was ASA class 3 with smoking history of 55 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC180F bronchoscope with 19-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11R (13.7mm, 4 passes, ROSE: Suspicious for malignancy); station 2L (8.4mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 4L (19.6mm, 4 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.8mm. The robotic catheter was advanced to the LLL lateral basal (B9) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed suspicious for malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 105 minutes. Attending physician: Jennifer Walsh, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Dr. Cole performed an EBUS procedure on Ms. Reyes to investigate her swollen lymph nodes. We used a special ultrasound scope to guide a needle into nodes in the center of her chest and the right side. The preliminary results show granulomas, which points towards sarcoidosis. We sampled two areas total.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"Dr. Holloway performed a bedside bronchoscopy on Ms. Lopez to address her dropping oxygen levels. We passed the scope through her breathing tube and immediately found heavy mucus blocking the right lung. We spent significant time suctioning and washing the area with saline until the breathing tubes were clear. The left side looked much better. Afterward, her ventilator pressures went down, which is a good sign.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
Dr. Rahman performed a thoracoscopy on Ms. Sanders. We made a small cut in her side and put a camera into the chest cavity. We drained the fluid and saw many small lumps on the lining of the chest wall. We took samples of these lumps to test for cancer. We didn't need to leave a tube in.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Dr. Simmons performed a procedure to drain fluid from around Mr. Patel's left lung. Using ultrasound to guide the needle, we removed 1.3 liters of fluid. This helped his breathing immediately. We sent the fluid to the lab to make sure there is no infection.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Dx: 14mm nodule RML (Lung-RADS 4B).
Method: Galaxy Nav + TiLT + rEBUS.
Findings: 2.1cm divergence corrected via TiLT. rEBUS concentric.
Actions: TBNA 21G x 7 passes.
ROSE: Necrotic debris, rare atypical cells.
Complication: None. Pneumothorax negative on post-op scan.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Dx: Lung-RADS 4X, 22mm LUL.
Method: Galaxy Robot + TiLT+.
Findings: 1.5cm divergence on TiLT. Corrected.
rEBUS: Eccentric.
 intervention: TBNA x5, Forceps x7, Brush, Fiducial.
ROSE: Lymphocytes/benign.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
Dx: Malignant pleural effusion (R). US guidance. 1.5L straw fluid removed. No complications. Samples sent.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,unknown_-5565743540411920300
"EBUS Note
Patient: James Carter
Indication: RUL mass staging
Stations sampled: 4R, 7, 11R
Needle: 21G
Results: 4R positive for cancer. Others neg.
Plan: Oncology referral.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"EBUS Note
Patient: Linda Reyes
1. ETT 8.0.
2. EBUS scope in.
3. Station 7: 4 passes -> Granulomas.
4. Station 11R: 3 passes -> Granulomas.
5. No other nodes sampled.
6. Pt stable.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"EBUS Note
Patient: Robert Lee
Query: Recurrent SCLC
Stations: 2R, 4R, 7, 10R
ROSE: Pos for SCLC at station 7.
Plan: Admit to Onc.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"EBUS Staging
Patient: Maria Hernandez
Dx: LUL Adeno
Stations: 4L, 7, 11L
Passes: 3-4 per station.
ROSE: Neg for malignancy.
Plan: Home, wait for final path.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
EBUS for Pamela Isley. We sampled everything 2R 4R 4L 7 and 11R. 4R and 7 were cancer the rest were fine. No PET to guide us so we did them all. Patient okay.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
EMN-guided microwave ablation of left upper lobe peripheral nodule. Patient is a 60-year-old female with small presumed primary NSCLC. superDimension EMN platform used to access 14 mm LUL anterior segment nodule. Radial EBUS showed eccentric view; cone-beam CT confirmed antenna in lesion. Emprint microwave antenna delivered; ablation performed. Mild hemoptysis and small left apical pneumothorax requiring 10 Fr pigtail catheter occurred. Admitted to monitored bed.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"Emergency Bronch Note
Patient: Jacob Carter
1. Intubated for aspiration.
2. Scope down -> Peanut parts in R lung.
3. Used basket and forceps.
4. Pulled out multiple pieces.
5. Suctioned clear.
6. R lung reinflated.
7. Done.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
Emergency bronchoscopy for foreign body aspiration. The patient presented with right lung collapse. Bronchoscopy revealed peanut fragments obstructing the right mainstem. These were removed using a combination of basket and forceps. The airway was cleared of all visible foreign material. Ventilation improved immediately.,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
Endobronchial ultrasound with transbronchial needle aspiration. Station 7 subcarinal node targeted. 31mm short axis. 5 passes with 22G needle. ROSE adequate. No other stations sampled. Patient stable.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Endobronchial ultrasound with transbronchial needle aspiration. Systematic approach. Stations 2R, 4R, 4L, 7, and 11R sampled. ROSE positive for malignancy in 4R and 7. Molecular testing requested. No complications.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"Evaluation of a 29mm LLL mass was conducted. The Galaxy navigational platform facilitated access to the LB6 segment. Intraprocedural TiLT imaging detected a 1.4cm registration drift, which was corrected in real-time. Following 'adjacent' rEBUS confirmation, extensive sampling (TBNA, forceps, brush) yielded a diagnosis of adenocarcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
Flexible bronchoscopy performed for stent migration. The previously placed left mainstem stent was found to have migrated proximally. Using grasping instruments the stent was repositioned distally into the correct location. Balloon dilation was performed within the stent. Final inspection showed adequate patency and position. Patient tolerated well.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
Flexible bronchoscopy was performed at the bedside for mucus plugging. The patient was already intubated. Examination revealed copious thick secretions in the right lung. These were aspirated. Saline was instilled to facilitate removal. The right middle and lower lobes were cleared. The left lung was inspected and found to be patent. The patient's respiratory status improved following the intervention.,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"Flexible bronchoscopy with BAL and mucus plug removal performed at ICU bedside. Patient is a 68-year-old male intubated with lobar collapse. Thick mucus plugs obstructing right lower lobe basal bronchi were identified. Aggressive saline lavage, suctioning, and BAL were performed in RLL. Plugs were removed and airways cleared. Transient desaturation to 84% occurred during lavage, resolved with recruitment. Patient remained intubated.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
Flexible bronchoscopy with BAL and transbronchial biopsies (forceps) for suspected sarcoidosis was performed. Patient is a 48-year-old female with bilateral hilar adenopathy. Findings included cobblestoning and mild nodularity at segmental bronchi. BAL was performed in the right middle lobe. Six fluoroscopy-guided transbronchial biopsies were obtained from the right lower lobe medial basal segment. No significant bleeding occurred. Postprocedure CXR was negative for pneumothorax. Discharged home.,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
Flexible bronchoscopy with electromagnetic navigation and cryoablation of left lower lobe peripheral pulmonary nodule. Patient is a 70-year-old woman with extensive medical comorbidities. General anesthesia induced. Electromagnetic navigation bronchoscopy commenced using Veran SPiN Planning and Navigation System. Target lesion in left lower lobe lateral basal segment identified. Radial EBUS probe advanced through EWC. Cryoablation probe introduced. Three freeze-thaw cycles performed. Post-ablation radial EBUS repeated showing marked hyperechoic changes. No hemorrhage. Patient reversed from anesthesia.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
Flexible bronchoscopy with electromagnetic navigation and radiofrequency ablation. Right lower lobe peripheral pulmonary nodule. General anesthesia. Navigation to RB9. Confirmation with radial EBUS and cone-beam CT. Radiofrequency ablation probe active. Two cycles performed. Ablation zone confirmed. Patient stable.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Flexible bronchoscopy with electromagnetic navigation. Indication: Peripheral LLL nodule. Moderate sedation. EMN localization successful. Radial EBUS concentric. Samples obtained via needle, forceps, and brush. No pneumothorax.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Flexible bronchoscopy with linear EBUS-TBNA under monitored anesthesia care. Patient is a 58-year-old female with LUL adenocarcinoma. Lymph nodes at stations 4L, 7, and 11L identified. A 22G needle was used for TBNA. Four passes were obtained from 7 and 11L, three from 4L. ROSE demonstrated abundant lymphocytes without definite malignant cells. No complications. Discharged home.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Flexible bronchoscopy with linear EBUS-TBNA. Patient is a 64-year-old male with a right upper lobe mass. Enlarged nodes visualized at stations 4R, 7, and 11R. Three passes obtained from each station using a 21G needle. ROSE showed malignant cells at 4R concerning for non-small cell lung cancer; stations 7 and 11R showed benign lymphocytes. Elastography used. No complications. Discharged home.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Henry Peterson, MRN 8050365, a 78-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Community Hospital on 05/13/2025. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 23.3mm solid lesion in the RLL posterior basal (B10), bronchus sign negative, PET SUV max 2.8. The patient was ASA class 2 with smoking history of 25 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (11.9mm, 3 passes, ROSE: Malignant - squamous cell carcinoma); station 4R (21.4mm, 2 passes, ROSE: Suspicious for malignancy); station 7 (16.1mm, 4 passes, ROSE: Granuloma). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.4mm. The robotic catheter was advanced to the RLL posterior basal (B10) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes, no malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 125 minutes. Attending physician: Lisa Thompson, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Angela Gomez
Medical Record: 8521654
Service Date: 07/05/2025
Operator: Katherine Lee, MD

CLINICAL RATIONALE
Left lower lobe nodule and subcarinal adenopathy. Target lesion: 29.8mm ground-glass nodule localized to LUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 10R: Visualized homogeneous node (8.4x29.3mm). Executed 4 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10L: Visualized heterogeneous node (13.7x21.1mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 2L: Visualized homogeneous node (11.1x30.7mm). Executed 3 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.8mm. The articulating catheter was maneuvered to the LUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 8
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Malignant - adenocarcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Katherine Lee, MD
Division of Interventional Pulmonology
Methodist Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Charles Bell
Medical Record: 2878172
Service Date: 11/05/2025
Operator: David Kim, MD

CLINICAL RATIONALE
PET-avid lung mass and mediastinal lymphadenopathy. Target lesion: 23.3mm solid nodule localized to RLL medial basal (B7).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 2R: Visualized heterogeneous node (12.0x33.3mm). Executed 4 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10R: Visualized heterogeneous node (12.9x26.6mm). Executed 3 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2L: Visualized heterogeneous node (13.9x22.9mm). Executed 2 aspiration passes. ROSE yielded: Granuloma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 1.9mm. The articulating catheter was maneuvered to the RLL medial basal (B7) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 5
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Adequate lymphocytes, no malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
David Kim, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: David Hill
Medical Record: 1649097
Service Date: 05/01/2025
Operator: Brian O'Connor, MD

CLINICAL RATIONALE
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy. Target lesion: 14.5mm ground-glass nodule localized to RUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 19-gauge aspiration needle (FNB/ProCore).

Station 11L: Visualized heterogeneous node (13.3x31.3mm). Executed 4 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 7: Visualized homogeneous node (10.0x26.5mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 2L: Visualized homogeneous node (24.9x12.2mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 3.2mm. The articulating catheter was maneuvered to the RUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Atypical cells

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Brian O'Connor, MD
Division of Interventional Pulmonology
Methodist Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Deborah Kim
Medical Record: 7199625
Service Date: 07/12/2025
Operator: Andrew Nakamura, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 25.0mm solid nodule localized to LUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 7: Visualized heterogeneous node (19.5x24.9mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.
Station 11L: Visualized homogeneous node (18.1x17.4mm). Executed 2 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.
Station 10R: Visualized heterogeneous node (17.1x27.3mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.
Station 4L: Visualized homogeneous node (11.5x24.9mm). Executed 3 aspiration passes. ROSE yielded: Atypical cells.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 1.6mm. The articulating catheter was maneuvered to the LUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 4
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Andrew Nakamura, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Donald Carter
Medical Record: 2286211
Service Date: 02/25/2025
Operator: Steven Park, MD

CLINICAL RATIONALE
Combined staging and peripheral nodule diagnosis. Target lesion: 27.5mm ground-glass nodule localized to RLL superior (B6).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).

Station 11R: Visualized homogeneous node (22.0x13.6mm). Executed 2 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 4R: Visualized heterogeneous node (13.7x29.3mm). Executed 4 aspiration passes. ROSE yielded: Atypical cells.
Station 11L: Visualized homogeneous node (18.9x31.0mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 2.8mm. The articulating catheter was maneuvered to the RLL superior (B6) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 4
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Adequate lymphocytes, no malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Steven Park, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Dorothy Baker
Medical Record: 1464511
Service Date: 02/27/2024
Operator: Brian O'Connor, MD

CLINICAL RATIONALE
Mediastinal staging for biopsy-proven lung adenocarcinoma. Target lesion: 22.6mm solid nodule localized to RUL apical (B1).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 11R: Visualized homogeneous node (24.9x17.4mm). Executed 3 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 2L: Visualized heterogeneous node (14.7x16.9mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 4R: Visualized heterogeneous node (13.0x24.5mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 11L: Visualized heterogeneous node (19.1x15.5mm). Executed 3 aspiration passes. ROSE yielded: Suspicious for malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 1.8mm. The articulating catheter was maneuvered to the RUL apical (B1) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 4
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Suspicious for malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Brian O'Connor, MD
Division of Interventional Pulmonology
Veterans Affairs Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Dorothy Baker
Medical Record: 1773250
Service Date: 01/13/2025
Operator: Andrew Nakamura, MD

CLINICAL RATIONALE
Combined staging and peripheral nodule diagnosis. Target lesion: 16.3mm ground-glass nodule localized to RLL superior (B6).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 11L: Visualized heterogeneous node (14.4x23.4mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.
Station 4L: Visualized homogeneous node (21.7x20.3mm). Executed 3 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10L: Visualized homogeneous node (19.2x34.4mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 3.4mm. The articulating catheter was maneuvered to the RLL superior (B6) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Andrew Nakamura, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Douglas Nguyen
Medical Record: 3755795
Service Date: 03/03/2024
Operator: Steven Park, MD

CLINICAL RATIONALE
PET-avid lung mass and mediastinal lymphadenopathy. Target lesion: 30.9mm ground-glass nodule localized to RUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (FNB/ProCore).

Station 4L: Visualized homogeneous node (18.3x28.3mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10R: Visualized heterogeneous node (14.8x23.9mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 4R: Visualized homogeneous node (20.9x20.6mm). Executed 4 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 7: Visualized homogeneous node (24.0x28.4mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.0mm. The articulating catheter was maneuvered to the RUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Granuloma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Steven Park, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Frank Miller
Medical Record: 3900786
Service Date: 02/13/2024
Operator: Sarah Chen, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 30.2mm ground-glass nodule localized to LUL inferior lingula (B5).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).

Station 4R: Visualized heterogeneous node (22.1x22.1mm). Executed 4 aspiration passes. ROSE yielded: Atypical cells.
Station 2R: Visualized heterogeneous node (14.8x16.0mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2L: Visualized homogeneous node (15.4x34.5mm). Executed 2 aspiration passes. ROSE yielded: Granuloma.
Station 10L: Visualized homogeneous node (10.7x16.3mm). Executed 3 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.2mm. The articulating catheter was maneuvered to the LUL inferior lingula (B5) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 8
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Malignant - small cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Sarah Chen, MD
Division of Interventional Pulmonology
Academic Health System",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Jack Campbell
Medical Record: 7134852
Service Date: 05/16/2024
Operator: David Kim, MD

CLINICAL RATIONALE
PET-avid lung mass and mediastinal lymphadenopathy. Target lesion: 20.0mm solid nodule localized to RML medial (B5).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).

Station 2L: Visualized homogeneous node (13.8x21.0mm). Executed 4 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 4R: Visualized heterogeneous node (23.9x31.2mm). Executed 3 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 11R: Visualized heterogeneous node (19.6x30.0mm). Executed 3 aspiration passes. ROSE yielded: Atypical cells.
Station 11L: Visualized heterogeneous node (17.4x22.1mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 2.5mm. The articulating catheter was maneuvered to the RML medial (B5) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RML

ROSE assessment yielded: Malignant - NSCLC NOS

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
David Kim, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Jonathan Jenkins
Medical Record: 3874420
Service Date: 10/14/2024
Operator: Brian O'Connor, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 31.2mm solid nodule localized to LUL inferior lingula (B5).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).

Station 10R: Visualized homogeneous node (16.6x13.8mm). Executed 4 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 4R: Visualized heterogeneous node (13.5x29.3mm). Executed 2 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 2L: Visualized homogeneous node (11.0x19.3mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 2R: Visualized heterogeneous node (21.8x17.2mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 4L: Visualized heterogeneous node (22.9x29.8mm). Executed 3 aspiration passes. ROSE yielded: Atypical cells.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.2mm. The articulating catheter was maneuvered to the LUL inferior lingula (B5) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (5 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Brian O'Connor, MD
Division of Interventional Pulmonology
Cleveland Clinic",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Jonathan Rivera
Medical Record: 4818600
Service Date: 03/27/2025
Operator: Amanda Foster, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 27.1mm solid nodule localized to RLL superior (B6).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (FNB/ProCore).

Station 4L: Visualized heterogeneous node (9.1x13.1mm). Executed 3 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2R: Visualized heterogeneous node (14.9x15.8mm). Executed 3 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 2L: Visualized homogeneous node (13.2x25.8mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.8mm. The articulating catheter was maneuvered to the RLL superior (B6) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 5
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Amanda Foster, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Julie Perry
Medical Record: 8504533
Service Date: 02/14/2024
Operator: Eric Johnson, MD

CLINICAL RATIONALE
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy. Target lesion: 19.5mm solid nodule localized to RLL posterior basal (B10).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 19-gauge aspiration needle (FNB/ProCore).

Station 10R: Visualized heterogeneous node (11.4x28.9mm). Executed 3 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 7: Visualized homogeneous node (8.1x19.7mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 2R: Visualized heterogeneous node (13.6x28.0mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 4R: Visualized heterogeneous node (22.2x33.2mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 3.2mm. The articulating catheter was maneuvered to the RLL posterior basal (B10) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Malignant - NSCLC NOS

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Eric Johnson, MD
Division of Interventional Pulmonology
St. Luke's Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Larry Bailey
Medical Record: 8849913
Service Date: 10/01/2025
Operator: Lisa Thompson, MD

CLINICAL RATIONALE
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy. Target lesion: 31.5mm part-solid nodule localized to RML medial (B5).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 4R: Visualized homogeneous node (23.5x32.6mm). Executed 2 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.
Station 4L: Visualized homogeneous node (14.3x14.4mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 10R: Visualized homogeneous node (11.1x12.3mm). Executed 2 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2L: Visualized heterogeneous node (20.1x33.5mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 3.2mm. The articulating catheter was maneuvered to the RML medial (B5) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 5
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RML

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Lisa Thompson, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Mark Young
Medical Record: 8389948
Service Date: 03/12/2025
Operator: David Kim, MD

CLINICAL RATIONALE
Combined staging and peripheral nodule diagnosis. Target lesion: 16.9mm solid nodule localized to RML lateral (B4).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 10R: Visualized heterogeneous node (9.9x21.4mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 4L: Visualized heterogeneous node (13.8x21.2mm). Executed 2 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 4R: Visualized heterogeneous node (21.4x31.0mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.5mm. The articulating catheter was maneuvered to the RML lateral (B4) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 8
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RML

ROSE assessment yielded: Adequate lymphocytes

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
David Kim, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Matthew Gutierrez
Medical Record: 8370064
Service Date: 10/21/2024
Operator: Jennifer Walsh, MD

CLINICAL RATIONALE
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy. Target lesion: 23.2mm ground-glass nodule localized to LLL lateral basal (B9).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 19-gauge aspiration needle (FNB/ProCore).

Station 11R: Visualized homogeneous node (13.7x15.8mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2L: Visualized heterogeneous node (8.4x22.4mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 4L: Visualized heterogeneous node (19.6x18.4mm). Executed 4 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 2.8mm. The articulating catheter was maneuvered to the LLL lateral basal (B9) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LLL

ROSE assessment yielded: Suspicious for malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Jennifer Walsh, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Melissa Roberts
Medical Record: 3459527
Service Date: 02/11/2025
Operator: Rachel Goldman, MD

CLINICAL RATIONALE
Peripheral nodule and bilateral hilar adenopathy. Target lesion: 14.0mm ground-glass nodule localized to LUL apicoposterior (B1+2).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (FNB/ProCore).

Station 2L: Visualized homogeneous node (14.8x28.3mm). Executed 3 aspiration passes. ROSE yielded: Atypical cells.
Station 4L: Visualized homogeneous node (24.3x25.6mm). Executed 2 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.
Station 10R: Visualized heterogeneous node (12.9x30.7mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10L: Visualized heterogeneous node (18.8x34.6mm). Executed 3 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 11L: Visualized heterogeneous node (18.7x20.8mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.5mm. The articulating catheter was maneuvered to the LUL apicoposterior (B1+2) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Adequate lymphocytes, no malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (5 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Rachel Goldman, MD
Division of Interventional Pulmonology
Academic Health System",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Melissa Taylor
Medical Record: 5436000
Service Date: 10/02/2025
Operator: Steven Park, MD

CLINICAL RATIONALE
Peripheral nodule and bilateral hilar adenopathy. Target lesion: 34.7mm part-solid nodule localized to LUL superior lingula (B4).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 7: Visualized homogeneous node (8.3x24.2mm). Executed 2 aspiration passes. ROSE yielded: Atypical cells.
Station 11R: Visualized homogeneous node (19.4x15.1mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 11L: Visualized homogeneous node (14.1x15.1mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 2.5mm. The articulating catheter was maneuvered to the LUL superior lingula (B4) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 5
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Suspicious for malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Steven Park, MD
Division of Interventional Pulmonology
University Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Michael Wood
Medical Record: 9302205
Service Date: 04/05/2025
Operator: David Kim, MD

CLINICAL RATIONALE
Right upper lobe mass with ipsilateral mediastinal nodes. Target lesion: 27.1mm ground-glass nodule localized to LLL posterior basal (B10).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 19-gauge aspiration needle (FNB/ProCore).

Station 2L: Visualized heterogeneous node (20.2x30.4mm). Executed 4 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.
Station 4R: Visualized homogeneous node (17.2x31.1mm). Executed 4 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 7: Visualized heterogeneous node (11.6x19.3mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 11R: Visualized heterogeneous node (17.2x15.1mm). Executed 3 aspiration passes. ROSE yielded: Granuloma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.9mm. The articulating catheter was maneuvered to the LLL posterior basal (B10) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LLL

ROSE assessment yielded: Atypical cells

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
David Kim, MD
Division of Interventional Pulmonology
UCLA Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Patricia Cox
Medical Record: 5346131
Service Date: 01/08/2025
Operator: Robert Patel, MD

CLINICAL RATIONALE
Peripheral lung nodule with suspicious mediastinal nodes. Target lesion: 24.3mm solid nodule localized to LUL superior lingula (B4).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 4L: Visualized homogeneous node (21.5x32.3mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 10L: Visualized homogeneous node (21.1x12.4mm). Executed 2 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 11L: Visualized homogeneous node (8.8x15.4mm). Executed 3 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.5mm. The articulating catheter was maneuvered to the LUL superior lingula (B4) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 4
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Adequate lymphocytes

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Robert Patel, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Patrick Smith
Medical Record: 1763427
Service Date: 04/19/2024
Operator: Maria Santos, MD

CLINICAL RATIONALE
Combined staging and peripheral nodule diagnosis. Target lesion: 16.3mm part-solid nodule localized to RUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 2L: Visualized homogeneous node (19.0x23.5mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 10L: Visualized heterogeneous node (22.7x13.9mm). Executed 4 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 7: Visualized heterogeneous node (16.8x24.0mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 3.0mm. The articulating catheter was maneuvered to the RUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Malignant - adenocarcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Maria Santos, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Peter Bailey
Medical Record: 3916235
Service Date: 02/01/2024
Operator: Maria Santos, MD

CLINICAL RATIONALE
Right upper lobe mass with ipsilateral mediastinal nodes. Target lesion: 31.9mm ground-glass nodule localized to LLL anteromedial basal (B7+8).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).

Station 11L: Visualized homogeneous node (21.6x19.9mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 2L: Visualized homogeneous node (14.5x12.2mm). Executed 4 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 7: Visualized homogeneous node (21.8x25.3mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 11R: Visualized homogeneous node (15.0x14.3mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.
Station 10R: Visualized heterogeneous node (21.4x18.1mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 3.2mm. The articulating catheter was maneuvered to the LLL anteromedial basal (B7+8) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LLL

ROSE assessment yielded: Suspicious for malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (5 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Maria Santos, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Richard Anderson
Medical Record: 8079533
Service Date: 12/18/2024
Operator: Eric Johnson, MD

CLINICAL RATIONALE
Peripheral lung nodule with suspicious mediastinal nodes. Target lesion: 19.4mm solid nodule localized to RUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 19-gauge aspiration needle (FNB/ProCore).

Station 10R: Visualized heterogeneous node (21.2x29.3mm). Executed 2 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 2L: Visualized homogeneous node (8.8x22.9mm). Executed 2 aspiration passes. ROSE yielded: Atypical cells.
Station 11L: Visualized heterogeneous node (13.8x31.1mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 1.5mm. The articulating catheter was maneuvered to the RUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Granuloma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Eric Johnson, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Ronald Long
Medical Record: 6679212
Service Date: 12/29/2024
Operator: Brian O'Connor, MD

CLINICAL RATIONALE
Lung cancer staging - suspected NSCLC with mediastinal lymphadenopathy. Target lesion: 15.4mm ground-glass nodule localized to RML lateral (B4).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 10R: Visualized homogeneous node (15.1x29.1mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 4L: Visualized homogeneous node (21.5x25.6mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 4R: Visualized heterogeneous node (12.6x19.0mm). Executed 2 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 11L: Visualized heterogeneous node (22.8x27.5mm). Executed 4 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.5mm. The articulating catheter was maneuvered to the RML lateral (B4) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RML

ROSE assessment yielded: Atypical cells

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Brian O'Connor, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Samantha Flores
Medical Record: 5669064
Service Date: 01/02/2025
Operator: Rachel Goldman, MD

CLINICAL RATIONALE
Right upper lobe mass with ipsilateral mediastinal nodes. Target lesion: 20.2mm solid nodule localized to LUL inferior lingula (B5).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 4L: Visualized homogeneous node (24.4x26.8mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 7: Visualized homogeneous node (20.3x30.7mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 10R: Visualized homogeneous node (20.4x33.1mm). Executed 4 aspiration passes. ROSE yielded: Atypical cells.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 2.3mm. The articulating catheter was maneuvered to the LUL inferior lingula (B5) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 7
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LUL

ROSE assessment yielded: Malignant - small cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Rachel Goldman, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Samuel Morris
Medical Record: 2777264
Service Date: 04/10/2025
Operator: Lisa Thompson, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 23.3mm solid nodule localized to RLL posterior basal (B10).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 10R: Visualized homogeneous node (11.9x22.1mm). Executed 3 aspiration passes. ROSE yielded: Malignant - squamous cell carcinoma.
Station 4R: Visualized homogeneous node (21.4x27.6mm). Executed 2 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 7: Visualized heterogeneous node (16.1x28.6mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 2.4mm. The articulating catheter was maneuvered to the RLL posterior basal (B10) target zone.

Radial ultrasound miniprobe was deployed, yielding concentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 3  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Adequate lymphocytes, no malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Lisa Thompson, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Steven Parker
Medical Record: 9219076
Service Date: 09/02/2024
Operator: Brian O'Connor, MD

CLINICAL RATIONALE
Right upper lobe mass with ipsilateral mediastinal nodes. Target lesion: 29.4mm part-solid nodule localized to LLL lateral basal (B9).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 10R: Visualized homogeneous node (15.5x31.6mm). Executed 3 aspiration passes. ROSE yielded: Suspicious for malignancy.
Station 10L: Visualized heterogeneous node (21.7x14.6mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 11R: Visualized homogeneous node (20.5x29.9mm). Executed 3 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.8mm. The articulating catheter was maneuvered to the LLL lateral basal (B9) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 6
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from LLL

ROSE assessment yielded: Malignant - squamous cell carcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Brian O'Connor, MD
Division of Interventional Pulmonology
Northwestern Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Tyler Baker
Medical Record: 3792313
Service Date: 03/05/2024
Operator: Robert Patel, MD

CLINICAL RATIONALE
Peripheral nodule and bilateral hilar adenopathy. Target lesion: 21.6mm ground-glass nodule localized to RUL anterior (B3).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Standard FNA).

Station 10L: Visualized heterogeneous node (13.0x14.3mm). Executed 3 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 4L: Visualized homogeneous node (15.7x23.7mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 11L: Visualized heterogeneous node (19.4x27.5mm). Executed 2 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 1.8mm. The articulating catheter was maneuvered to the RUL anterior (B3) target zone.

Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via cbct.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 8
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RUL

ROSE assessment yielded: Granuloma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Robert Patel, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Zachary Patel
Medical Record: 2009693
Service Date: 08/27/2024
Operator: Lisa Thompson, MD

CLINICAL RATIONALE
Lung nodule evaluation with mediastinal lymphadenopathy workup. Target lesion: 30.4mm solid nodule localized to RML lateral (B4).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (FNB/ProCore).

Station 2R: Visualized heterogeneous node (15.3x24.4mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes.
Station 11R: Visualized heterogeneous node (23.0x31.5mm). Executed 3 aspiration passes. ROSE yielded: Adequate lymphocytes, no malignancy.
Station 4R: Visualized heterogeneous node (15.0x25.3mm). Executed 3 aspiration passes. ROSE yielded: Malignant - NSCLC NOS.
Station 7: Visualized heterogeneous node (13.7x16.2mm). Executed 2 aspiration passes. ROSE yielded: Adequate lymphocytes.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Monarch robotic navigation platform (Auris Health (J&J)) was initialized and calibrated. Registration accuracy measured 2.6mm. The articulating catheter was maneuvered to the RML lateral (B4) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via radial ebus.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 4
- Aspiration needle passes executed: 2  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RML

ROSE assessment yielded: Suspicious for malignancy

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (4 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Lisa Thompson, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT

Patient: Zachary Rogers
Medical Record: 4082732
Service Date: 05/01/2024
Operator: Michael Rodriguez, MD

CLINICAL RATIONALE
Right upper lobe mass with ipsilateral mediastinal nodes. Target lesion: 28.6mm ground-glass nodule localized to RLL lateral basal (B9).

SEDATION DETAILS
General endotracheal sedation administered. 8.0mm airway device deployed orally.

OPERATIVE NARRATIVE

SEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT

The convex-probe ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 21-gauge aspiration needle (Standard FNA).

Station 10R: Visualized heterogeneous node (17.1x25.9mm). Executed 2 aspiration passes. ROSE yielded: Atypical cells.
Station 11R: Visualized homogeneous node (8.4x34.2mm). Executed 2 aspiration passes. ROSE yielded: Granuloma.
Station 11L: Visualized homogeneous node (22.2x34.6mm). Executed 4 aspiration passes. ROSE yielded: Malignant - adenocarcinoma.
Station 2R: Visualized heterogeneous node (21.9x28.9mm). Executed 4 aspiration passes. ROSE yielded: Atypical cells.
Station 4L: Visualized homogeneous node (18.5x22.0mm). Executed 4 aspiration passes. ROSE yielded: Granuloma.

SEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION

The Ion robotic navigation platform (Intuitive Surgical) was initialized and calibrated. Registration accuracy measured 2.6mm. The articulating catheter was maneuvered to the RLL lateral basal (B9) target zone.

Radial ultrasound miniprobe was deployed, yielding adjacent visualization of the lesion. Instrument-within-target was verified via augmented fluoroscopy.

TISSUE ACQUISITION:
- Grasping forceps specimens acquired: 5
- Aspiration needle passes executed: 4  
- Cytology brushings harvested: 2
- Lavage fluid extracted from RLL

ROSE assessment yielded: Malignant - adenocarcinoma

SPECIMEN DISPOSITION
- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry
- Parenchymal samples dispatched to: Surgical pathology, molecular analysis
- Brushings dispatched to: Cytology
- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)

OUTCOME ASSESSMENT
Procedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.

DISPOSITION
Patient conveyed to recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.

SUMMARY
1. EBUS-guided mediastinal staging successfully executed (5 stations sampled)
2. Robotic navigation to peripheral target successfully accomplished
3. Tissue acquisition achieved via multiple modalities
4. Zero procedural complications documented

Electronically attested,
Michael Rodriguez, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Adam Turner
Medical Record Number: 3592324
Date of Birth: 06/06/1984 (Age: 41 years)
Biological Sex: Male
Date of Procedure: 09/25/2025
Institution: Memorial Hospital, Chicago, IL

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 41-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed peripheral lung nodule with suspicious mediastinal nodes. Preprocedural imaging demonstrated a 24.3 mm solid pulmonary parenchymal lesion localized to the LUL superior lingula (B4), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 12.7.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4L demonstrated a homogeneous lymph node measuring 21.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10L demonstrated a homogeneous lymph node measuring 21.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 11L demonstrated a homogeneous lymph node measuring 8.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.5 mm. The robotic catheter was successfully advanced to the target lesion in the LUL superior lingula (B4).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (4 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 108 minutes

Electronically Signed,
Robert Patel, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Amanda Kim
Medical Record Number: 1248551
Date of Birth: 08/07/1957 (Age: 67 years)
Biological Sex: Female
Date of Procedure: 02/05/2024
Institution: Presbyterian Hospital, Houston, TX

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 67-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging demonstrated a 21.6 mm ground-glass pulmonary parenchymal lesion localized to the RUL anterior (B3), with negative bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10L demonstrated a heterogeneous lymph node measuring 13.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 4L demonstrated a homogeneous lymph node measuring 15.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 11L demonstrated a heterogeneous lymph node measuring 19.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.8 mm. The robotic catheter was successfully advanced to the target lesion in the RUL anterior (B3).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (8 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed granuloma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 85 minutes

Electronically Signed,
Robert Patel, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Amy Wood
Medical Record Number: 1102811
Date of Birth: 02/25/1971 (Age: 54 years)
Biological Sex: Female
Date of Procedure: 03/02/2025
Institution: Regional Medical Center, Miami, FL

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 54-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed peripheral lung nodule with suspicious mediastinal nodes. Preprocedural imaging demonstrated a 19.4 mm solid pulmonary parenchymal lesion localized to the RUL anterior (B3), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 6.7.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a heterogeneous lymph node measuring 21.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 2L demonstrated a homogeneous lymph node measuring 8.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed atypical cells. Station 11L demonstrated a heterogeneous lymph node measuring 13.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.5 mm. The robotic catheter was successfully advanced to the target lesion in the RUL anterior (B3).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed granuloma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - adenocarcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 131 minutes

Electronically Signed,
Eric Johnson, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Brandon Morales
Medical Record Number: 4392820
Date of Birth: 08/02/1948 (Age: 77 years)
Biological Sex: Female
Date of Procedure: 10/27/2025
Institution: Baptist Medical Center, Los Angeles, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 77-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 23.2 mm ground-glass pulmonary parenchymal lesion localized to the LLL lateral basal (B9), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 16.0.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11R demonstrated a homogeneous lymph node measuring 13.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2L demonstrated a heterogeneous lymph node measuring 8.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 4L demonstrated a heterogeneous lymph node measuring 19.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.8 mm. The robotic catheter was successfully advanced to the target lesion in the LLL lateral basal (B9).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed suspicious for malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LLL pulmonary lesion
3. Cytological evaluation suggestive of suspicious for malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 105 minutes

Electronically Signed,
Jennifer Walsh, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Daniel Fisher
Medical Record Number: 9667130
Date of Birth: 11/17/1970 (Age: 55 years)
Biological Sex: Female
Date of Procedure: 10/13/2025
Institution: Community Hospital, Cleveland, OH

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 55-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed combined staging and peripheral nodule diagnosis. Preprocedural imaging demonstrated a 16.3 mm ground-glass pulmonary parenchymal lesion localized to the RLL superior (B6), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 6.9.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11L demonstrated a heterogeneous lymph node measuring 14.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma. Station 4L demonstrated a homogeneous lymph node measuring 21.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10L demonstrated a homogeneous lymph node measuring 19.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.4 mm. The robotic catheter was successfully advanced to the target lesion in the RLL superior (B6).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of granuloma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 94 minutes

Electronically Signed,
Andrew Nakamura, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Deborah James
Medical Record Number: 1479396
Date of Birth: 02/19/1961 (Age: 63 years)
Biological Sex: Male
Date of Procedure: 04/18/2024
Institution: Presbyterian Hospital, Los Angeles, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 63-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 15.4 mm ground-glass pulmonary parenchymal lesion localized to the RML lateral (B4), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 4.3.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a homogeneous lymph node measuring 15.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 4L demonstrated a homogeneous lymph node measuring 21.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 4R demonstrated a heterogeneous lymph node measuring 12.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 11L demonstrated a heterogeneous lymph node measuring 22.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.5 mm. The robotic catheter was successfully advanced to the target lesion in the RML lateral (B4).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed atypical cells.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RML pulmonary lesion
3. Cytological evaluation suggestive of adequate lymphocytes
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 105 minutes

Electronically Signed,
Brian O'Connor, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Diane James
Medical Record Number: 8790716
Date of Birth: 06/17/1967 (Age: 57 years)
Biological Sex: Female
Date of Procedure: 10/03/2024
Institution: Presbyterian Hospital, Phoenix, AZ

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 57-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed combined staging and peripheral nodule diagnosis. Preprocedural imaging demonstrated a 16.9 mm solid pulmonary parenchymal lesion localized to the RML lateral (B4), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 16.9.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a heterogeneous lymph node measuring 9.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 4L demonstrated a heterogeneous lymph node measuring 13.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 4R demonstrated a heterogeneous lymph node measuring 21.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.5 mm. The robotic catheter was successfully advanced to the target lesion in the RML lateral (B4).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (8 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RML pulmonary lesion
3. Cytological evaluation suggestive of adequate lymphocytes, no malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 100 minutes

Electronically Signed,
David Kim, MD
Division of Interventional Pulmonology
Presbyterian Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Donna Vasquez
Medical Record Number: 2778498
Date of Birth: 02/25/1972 (Age: 53 years)
Biological Sex: Male
Date of Procedure: 06/12/2025
Institution: Regional Medical Center, Atlanta, GA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 53-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 20.0 mm solid pulmonary parenchymal lesion localized to the RML medial (B5), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 6.5.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2L demonstrated a homogeneous lymph node measuring 13.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 4R demonstrated a heterogeneous lymph node measuring 23.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 11R demonstrated a heterogeneous lymph node measuring 19.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed atypical cells. Station 11L demonstrated a heterogeneous lymph node measuring 17.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.5 mm. The robotic catheter was successfully advanced to the target lesion in the RML medial (B5).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - nsclc nos.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RML pulmonary lesion
3. Cytological evaluation suggestive of malignant - small cell carcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 87 minutes

Electronically Signed,
David Kim, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Douglas Jones
Medical Record Number: 6550068
Date of Birth: 11/28/1953 (Age: 71 years)
Biological Sex: Male
Date of Procedure: 11/27/2024
Institution: Northwestern Memorial Hospital, Cleveland, OH

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 71-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging demonstrated a 29.4 mm part-solid pulmonary parenchymal lesion localized to the LLL lateral basal (B9), with negative bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a homogeneous lymph node measuring 15.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 10L demonstrated a heterogeneous lymph node measuring 21.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 11R demonstrated a homogeneous lymph node measuring 20.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.8 mm. The robotic catheter was successfully advanced to the target lesion in the LLL lateral basal (B9).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LLL pulmonary lesion
3. Cytological evaluation suggestive of suspicious for malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 81 minutes

Electronically Signed,
Brian O'Connor, MD
Division of Interventional Pulmonology
Northwestern Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Ethan Lewis
Medical Record Number: 4025945
Date of Birth: 12/10/1948 (Age: 76 years)
Biological Sex: Female
Date of Procedure: 02/07/2024
Institution: Veterans Affairs Medical Center, Minneapolis, MN

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 76-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed mediastinal staging for biopsy-proven lung adenocarcinoma. Preprocedural imaging demonstrated a 22.6 mm solid pulmonary parenchymal lesion localized to the RUL apical (B1), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 9.7.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11R demonstrated a homogeneous lymph node measuring 24.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 2L demonstrated a heterogeneous lymph node measuring 14.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 4R demonstrated a heterogeneous lymph node measuring 13.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 11L demonstrated a heterogeneous lymph node measuring 19.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.8 mm. The robotic catheter was successfully advanced to the target lesion in the RUL apical (B1).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (4 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed suspicious for malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - adenocarcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 131 minutes

Electronically Signed,
Brian O'Connor, MD
Division of Interventional Pulmonology
Veterans Affairs Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Jennifer Ross
Medical Record Number: 5509129
Date of Birth: 12/03/1975 (Age: 49 years)
Biological Sex: Male
Date of Procedure: 11/27/2024
Institution: Baptist Medical Center, Boston, MA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 49-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 30.4 mm solid pulmonary parenchymal lesion localized to the RML lateral (B4), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 13.0.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2R demonstrated a heterogeneous lymph node measuring 15.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 11R demonstrated a heterogeneous lymph node measuring 23.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 4R demonstrated a heterogeneous lymph node measuring 15.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 7 demonstrated a heterogeneous lymph node measuring 13.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.6 mm. The robotic catheter was successfully advanced to the target lesion in the RML lateral (B4).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (4 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed suspicious for malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RML pulmonary lesion
3. Cytological evaluation suggestive of adequate lymphocytes
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 79 minutes

Electronically Signed,
Lisa Thompson, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Jessica Wilson
Medical Record Number: 7280954
Date of Birth: 08/22/1968 (Age: 56 years)
Biological Sex: Female
Date of Procedure: 03/05/2024
Institution: Regional Medical Center, Los Angeles, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 56-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 23.3 mm solid pulmonary parenchymal lesion localized to the RLL medial basal (B7), with negative bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2R demonstrated a heterogeneous lymph node measuring 12.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10R demonstrated a heterogeneous lymph node measuring 12.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2L demonstrated a heterogeneous lymph node measuring 13.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.9 mm. The robotic catheter was successfully advanced to the target lesion in the RLL medial basal (B7).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (5 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes, no malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 139 minutes

Electronically Signed,
David Kim, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Joseph Kim
Medical Record Number: 7893814
Date of Birth: 10/02/1976 (Age: 48 years)
Biological Sex: Female
Date of Procedure: 06/08/2024
Institution: St. Luke's Medical Center, San Francisco, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 48-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 19.5 mm solid pulmonary parenchymal lesion localized to the RLL posterior basal (B10), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 5.4.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a heterogeneous lymph node measuring 11.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 7 demonstrated a homogeneous lymph node measuring 8.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 2R demonstrated a heterogeneous lymph node measuring 13.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 4R demonstrated a heterogeneous lymph node measuring 22.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.2 mm. The robotic catheter was successfully advanced to the target lesion in the RLL posterior basal (B10).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - nsclc nos.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of malignant - adenocarcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 91 minutes

Electronically Signed,
Eric Johnson, MD
Division of Interventional Pulmonology
St. Luke's Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Joyce Lopez
Medical Record Number: 5225684
Date of Birth: 05/01/1946 (Age: 78 years)
Biological Sex: Female
Date of Procedure: 02/16/2024
Institution: Community Hospital, Atlanta, GA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 78-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging demonstrated a 20.2 mm solid pulmonary parenchymal lesion localized to the LUL inferior lingula (B5), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 16.9.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4L demonstrated a homogeneous lymph node measuring 24.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 7 demonstrated a homogeneous lymph node measuring 20.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 10R demonstrated a homogeneous lymph node measuring 20.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed atypical cells.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.3 mm. The robotic catheter was successfully advanced to the target lesion in the LUL inferior lingula (B5).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - small cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of adequate lymphocytes, no malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 113 minutes

Electronically Signed,
Rachel Goldman, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Kenneth Morales
Medical Record Number: 5624093
Date of Birth: 05/25/1965 (Age: 60 years)
Biological Sex: Female
Date of Procedure: 04/21/2025
Institution: University Medical Center, Philadelphia, PA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 60-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging demonstrated a 34.7 mm part-solid pulmonary parenchymal lesion localized to the LUL superior lingula (B4), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 12.7.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 7 demonstrated a homogeneous lymph node measuring 8.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed atypical cells. Station 11R demonstrated a homogeneous lymph node measuring 19.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 11L demonstrated a homogeneous lymph node measuring 14.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.5 mm. The robotic catheter was successfully advanced to the target lesion in the LUL superior lingula (B4).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (5 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed suspicious for malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of atypical cells
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 122 minutes

Electronically Signed,
Steven Park, MD
Division of Interventional Pulmonology
University Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Mark Cox
Medical Record Number: 5246824
Date of Birth: 07/12/1980 (Age: 45 years)
Biological Sex: Male
Date of Procedure: 01/06/2025
Institution: Academic Health System, Phoenix, AZ

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 45-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 30.2 mm ground-glass pulmonary parenchymal lesion localized to the LUL inferior lingula (B5), with positive bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4R demonstrated a heterogeneous lymph node measuring 22.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed atypical cells. Station 2R demonstrated a heterogeneous lymph node measuring 14.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2L demonstrated a homogeneous lymph node measuring 15.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed granuloma. Station 10L demonstrated a homogeneous lymph node measuring 10.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.2 mm. The robotic catheter was successfully advanced to the target lesion in the LUL inferior lingula (B5).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (8 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - small cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of atypical cells
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 98 minutes

Electronically Signed,
Sarah Chen, MD
Division of Interventional Pulmonology
Academic Health System",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Mark Howard
Medical Record Number: 4600834
Date of Birth: 10/26/1976 (Age: 48 years)
Biological Sex: Female
Date of Procedure: 06/16/2024
Institution: Memorial Hospital, Dallas, TX

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 48-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging demonstrated a 28.6 mm ground-glass pulmonary parenchymal lesion localized to the RLL lateral basal (B9), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 8.9.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a heterogeneous lymph node measuring 17.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed atypical cells. Station 11R demonstrated a homogeneous lymph node measuring 8.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma. Station 11L demonstrated a homogeneous lymph node measuring 22.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 2R demonstrated a heterogeneous lymph node measuring 21.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed atypical cells. Station 4L demonstrated a homogeneous lymph node measuring 18.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.6 mm. The robotic catheter was successfully advanced to the target lesion in the RLL lateral basal (B9).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (5 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - adenocarcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 5 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of atypical cells
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 92 minutes

Electronically Signed,
Michael Rodriguez, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Nicholas Powell
Medical Record Number: 4896975
Date of Birth: 01/15/1967 (Age: 58 years)
Biological Sex: Male
Date of Procedure: 05/17/2025
Institution: Baptist Medical Center, Miami, FL

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 58-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 27.1 mm solid pulmonary parenchymal lesion localized to the RLL superior (B6), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 6.1.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC190F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4L demonstrated a heterogeneous lymph node measuring 9.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2R demonstrated a heterogeneous lymph node measuring 14.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 2L demonstrated a homogeneous lymph node measuring 13.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.8 mm. The robotic catheter was successfully advanced to the target lesion in the RLL superior (B6).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (5 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of suspicious for malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 108 minutes

Electronically Signed,
Amanda Foster, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Nicole James
Medical Record Number: 3722419
Date of Birth: 06/04/1967 (Age: 57 years)
Biological Sex: Male
Date of Procedure: 02/13/2024
Institution: Regional Medical Center, Chicago, IL

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 57-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed pet-avid lung mass and mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 30.9 mm ground-glass pulmonary parenchymal lesion localized to the RUL anterior (B3), with negative bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4L demonstrated a homogeneous lymph node measuring 18.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10R demonstrated a heterogeneous lymph node measuring 14.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 4R demonstrated a homogeneous lymph node measuring 20.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 7 demonstrated a homogeneous lymph node measuring 24.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.0 mm. The robotic catheter was successfully advanced to the target lesion in the RUL anterior (B3).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed granuloma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 77 minutes

Electronically Signed,
Steven Park, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Pamela Williams
Medical Record Number: 6427287
Date of Birth: 07/05/1955 (Age: 69 years)
Biological Sex: Female
Date of Procedure: 08/02/2024
Institution: Baptist Medical Center, Denver, CO

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 69-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed combined staging and peripheral nodule diagnosis. Preprocedural imaging demonstrated a 27.5 mm ground-glass pulmonary parenchymal lesion localized to the RLL superior (B6), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 16.3.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11R demonstrated a homogeneous lymph node measuring 22.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 4R demonstrated a heterogeneous lymph node measuring 13.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed atypical cells. Station 11L demonstrated a homogeneous lymph node measuring 18.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.8 mm. The robotic catheter was successfully advanced to the target lesion in the RLL superior (B6).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (4 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes, no malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of malignant - small cell carcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 100 minutes

Electronically Signed,
Steven Park, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Peter Gray
Medical Record Number: 3606919
Date of Birth: 10/09/1969 (Age: 55 years)
Biological Sex: Female
Date of Procedure: 02/03/2024
Institution: Cleveland Clinic, Boston, MA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 55-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 31.2 mm solid pulmonary parenchymal lesion localized to the LUL inferior lingula (B5), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 5.0.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a homogeneous lymph node measuring 16.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 4R demonstrated a heterogeneous lymph node measuring 13.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 2L demonstrated a homogeneous lymph node measuring 11.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 2R demonstrated a heterogeneous lymph node measuring 21.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 4L demonstrated a heterogeneous lymph node measuring 22.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed atypical cells.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.2 mm. The robotic catheter was successfully advanced to the target lesion in the LUL inferior lingula (B5).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 5 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 78 minutes

Electronically Signed,
Brian O'Connor, MD
Division of Interventional Pulmonology
Cleveland Clinic",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Rebecca Stewart
Medical Record Number: 1825180
Date of Birth: 10/19/1945 (Age: 79 years)
Biological Sex: Male
Date of Procedure: 08/31/2024
Institution: Academic Health System, Miami, FL

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 79-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed peripheral nodule and bilateral hilar adenopathy. Preprocedural imaging demonstrated a 14.0 mm ground-glass pulmonary parenchymal lesion localized to the LUL apicoposterior (B1+2), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 17.6.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2L demonstrated a homogeneous lymph node measuring 14.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed atypical cells. Station 4L demonstrated a homogeneous lymph node measuring 24.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma. Station 10R demonstrated a heterogeneous lymph node measuring 12.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10L demonstrated a heterogeneous lymph node measuring 18.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 11L demonstrated a heterogeneous lymph node measuring 18.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.5 mm. The robotic catheter was successfully advanced to the target lesion in the LUL apicoposterior (B1+2).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes, no malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 5 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of atypical cells
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 114 minutes

Electronically Signed,
Rachel Goldman, MD
Division of Interventional Pulmonology
Academic Health System",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Robert Ward
Medical Record Number: 5382548
Date of Birth: 09/10/1950 (Age: 75 years)
Biological Sex: Female
Date of Procedure: 05/05/2025
Institution: Memorial Hospital, San Francisco, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 75-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed combined staging and peripheral nodule diagnosis. Preprocedural imaging demonstrated a 16.3 mm part-solid pulmonary parenchymal lesion localized to the RUL anterior (B3), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 12.4.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC180F) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2L demonstrated a homogeneous lymph node measuring 19.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 10L demonstrated a heterogeneous lymph node measuring 22.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 7 demonstrated a heterogeneous lymph node measuring 16.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.0 mm. The robotic catheter was successfully advanced to the target lesion in the RUL anterior (B3).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - adenocarcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - adenocarcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 75 minutes

Electronically Signed,
Maria Santos, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Ronald James
Medical Record Number: 4266178
Date of Birth: 02/17/1973 (Age: 51 years)
Biological Sex: Male
Date of Procedure: 12/05/2024
Institution: Memorial Hospital, Los Angeles, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 51-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging demonstrated a 31.9 mm ground-glass pulmonary parenchymal lesion localized to the LLL anteromedial basal (B7+8), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 13.4.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11L demonstrated a homogeneous lymph node measuring 21.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2L demonstrated a homogeneous lymph node measuring 14.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 7 demonstrated a homogeneous lymph node measuring 21.8 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 11R demonstrated a homogeneous lymph node measuring 15.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma. Station 10R demonstrated a heterogeneous lymph node measuring 21.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Acquire needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.2 mm. The robotic catheter was successfully advanced to the target lesion in the LLL anteromedial basal (B7+8).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed suspicious for malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 5 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LLL pulmonary lesion
3. Cytological evaluation suggestive of suspicious for malignancy
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 119 minutes

Electronically Signed,
Maria Santos, MD
Division of Interventional Pulmonology
Memorial Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Ronald Russell
Medical Record Number: 7011543
Date of Birth: 08/05/1964 (Age: 61 years)
Biological Sex: Female
Date of Procedure: 01/24/2025
Institution: Methodist Hospital, New York, NY

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 61-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 14.5 mm ground-glass pulmonary parenchymal lesion localized to the RUL anterior (B3), with positive bronchus sign on computed tomographic assessment. 

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 11L demonstrated a heterogeneous lymph node measuring 13.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 7 demonstrated a homogeneous lymph node measuring 10.0 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 2L demonstrated a homogeneous lymph node measuring 24.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - small cell carcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.2 mm. The robotic catheter was successfully advanced to the target lesion in the RUL anterior (B3).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed atypical cells.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 136 minutes

Electronically Signed,
Brian O'Connor, MD
Division of Interventional Pulmonology
Methodist Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Samantha Davis
Medical Record Number: 9808285
Date of Birth: 05/06/1961 (Age: 63 years)
Biological Sex: Male
Date of Procedure: 04/17/2024
Institution: Regional Medical Center, San Francisco, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 63-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 25.0 mm solid pulmonary parenchymal lesion localized to the LUL anterior (B3), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 9.6.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 3. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 7 demonstrated a heterogeneous lymph node measuring 19.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma. Station 11L demonstrated a homogeneous lymph node measuring 18.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma. Station 10R demonstrated a heterogeneous lymph node measuring 17.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma. Station 4L demonstrated a homogeneous lymph node measuring 11.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed atypical cells.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.6 mm. The robotic catheter was successfully advanced to the target lesion in the LUL anterior (B3).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (4 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of granuloma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 123 minutes

Electronically Signed,
Andrew Nakamura, MD
Division of Interventional Pulmonology
Regional Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Shirley Kim
Medical Record Number: 8473156
Date of Birth: 04/12/1940 (Age: 85 years)
Biological Sex: Male
Date of Procedure: 08/21/2025
Institution: Baptist Medical Center, San Francisco, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 85-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung cancer staging - suspected nsclc with mediastinal lymphadenopathy. Preprocedural imaging demonstrated a 31.5 mm part-solid pulmonary parenchymal lesion localized to the RML medial (B5), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 7.9.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 4. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 4R demonstrated a homogeneous lymph node measuring 23.5 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma. Station 4L demonstrated a homogeneous lymph node measuring 14.3 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 10R demonstrated a homogeneous lymph node measuring 11.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 2L demonstrated a heterogeneous lymph node measuring 20.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 22-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Monarch robotic bronchoscopy platform (Auris Health (J&J)) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 3.2 mm. The robotic catheter was successfully advanced to the target lesion in the RML medial (B5).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via augmented fluoroscopy.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (5 specimens), transbronchial needle aspiration (4 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - squamous cell carcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RML pulmonary lesion
3. Cytological evaluation suggestive of malignant - squamous cell carcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 105 minutes

Electronically Signed,
Lisa Thompson, MD
Division of Interventional Pulmonology
Baptist Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Shirley Mendoza
Medical Record Number: 7144622
Date of Birth: 08/16/1960 (Age: 65 years)
Biological Sex: Male
Date of Procedure: 02/08/2025
Institution: UCLA Medical Center, Dallas, TX

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 65-year-old male patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed right upper lobe mass with ipsilateral mediastinal nodes. Preprocedural imaging demonstrated a 27.1 mm ground-glass pulmonary parenchymal lesion localized to the LLL posterior basal (B10), with positive bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 15.4.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Olympus BF-UC260F-OL8) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 2L demonstrated a heterogeneous lymph node measuring 20.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma. Station 4R demonstrated a homogeneous lymph node measuring 17.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma. Station 7 demonstrated a heterogeneous lymph node measuring 11.6 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed adequate lymphocytes. Station 11R demonstrated a heterogeneous lymph node measuring 17.2 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 19-gauge FNB/ProCore needle. Rapid on-site cytological evaluation revealed granuloma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.9 mm. The robotic catheter was successfully advanced to the target lesion in the LLL posterior basal (B10).

Radial endobronchial ultrasonography demonstrated eccentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via radial ebus.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (7 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed atypical cells.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 4 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LLL pulmonary lesion
3. Cytological evaluation suggestive of malignant - squamous cell carcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 85 minutes

Electronically Signed,
David Kim, MD
Division of Interventional Pulmonology
UCLA Medical Center",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Thomas Alvarez
Medical Record Number: 9796306
Date of Birth: 09/21/1946 (Age: 78 years)
Biological Sex: Female
Date of Procedure: 09/22/2024
Institution: Community Hospital, San Francisco, CA

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 78-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed lung nodule evaluation with mediastinal lymphadenopathy workup. Preprocedural imaging demonstrated a 23.3 mm solid pulmonary parenchymal lesion localized to the RLL posterior basal (B10), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 2.8.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a homogeneous lymph node measuring 11.9 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - squamous cell carcinoma. Station 4R demonstrated a homogeneous lymph node measuring 21.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 2 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed suspicious for malignancy. Station 7 demonstrated a heterogeneous lymph node measuring 16.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed granuloma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Galaxy robotic bronchoscopy platform (Noah Medical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 2.4 mm. The robotic catheter was successfully advanced to the target lesion in the RLL posterior basal (B10).

Radial endobronchial ultrasonography demonstrated concentric visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (6 specimens), transbronchial needle aspiration (3 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed adequate lymphocytes, no malignancy.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of RLL pulmonary lesion
3. Cytological evaluation suggestive of malignant - squamous cell carcinoma
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 125 minutes

Electronically Signed,
Lisa Thompson, MD
Division of Interventional Pulmonology
Community Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"INTERVENTIONAL PULMONOLOGY PROCEDURE DOCUMENTATION

Patient Identification: Thomas Baker
Medical Record Number: 6529432
Date of Birth: 04/08/1953 (Age: 72 years)
Biological Sex: Female
Date of Procedure: 06/29/2025
Institution: Methodist Hospital, Cleveland, OH

CLINICAL PRESENTATION AND PROCEDURAL INDICATION

This 72-year-old female patient with a pertinent oncologic history presented for comprehensive bronchoscopic evaluation. The primary indication for this procedure encompassed left lower lobe nodule and subcarinal adenopathy. Preprocedural imaging demonstrated a 29.8 mm ground-glass pulmonary parenchymal lesion localized to the LUL anterior (B3), with negative bronchus sign on computed tomographic assessment. Positron emission tomography demonstrated metabolic hyperactivity with standardized uptake value maximum of 13.7.

ANESTHETIC CONSIDERATIONS

The patient was classified as American Society of Anesthesiologists physical status 2. General endotracheal anesthesia was administered, with successful orotracheal intubation utilizing a 8.0 mm endotracheal tube.

PROCEDURAL TECHNIQUE

COMPONENT I: ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION

The convex-probe endobronchial ultrasound bronchoscope (Pentax EB-1990i) was advanced through the endotracheal tube into the tracheobronchial tree. Systematic mediastinal and hilar lymph node evaluation was performed according to established staging protocols.

Station 10R demonstrated a homogeneous lymph node measuring 8.4 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 4 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - nsclc nos. Station 10L demonstrated a heterogeneous lymph node measuring 13.7 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed adequate lymphocytes, no malignancy. Station 2L demonstrated a homogeneous lymph node measuring 11.1 mm in short axis diameter. Transbronchial needle aspiration was performed utilizing 3 passes with a 21-gauge Standard FNA needle. Rapid on-site cytological evaluation revealed malignant - adenocarcinoma.

COMPONENT II: ROBOTIC-ASSISTED BRONCHOSCOPIC NAVIGATION

Following completion of mediastinal staging, the Ion robotic bronchoscopy platform (Intuitive Surgical) was deployed. Electromagnetic navigation registration achieved acceptable accuracy with registration error of 1.8 mm. The robotic catheter was successfully advanced to the target lesion in the LUL anterior (B3).

Radial endobronchial ultrasonography demonstrated adjacent visualization of the target lesion. Tool-in-lesion confirmation was achieved via cbct.

Tissue acquisition was performed utilizing multiple modalities: transbronchial forceps biopsy (8 specimens), transbronchial needle aspiration (2 passes), and bronchial brushings (2 specimens). Bronchoalveolar lavage was obtained for microbiological analysis.

RAPID ON-SITE CYTOLOGICAL EVALUATION

On-site cytopathological assessment of the peripheral lesion specimens revealed malignant - adenocarcinoma.

PROCEDURAL OUTCOMES AND COMPLICATIONS

The procedure was completed without complication. Hemostasis was achieved spontaneously with minimal blood loss (<10 mL). Post-procedural chest radiography demonstrated no evidence of pneumothorax or other acute pulmonary parenchymal abnormality.

IMPRESSION AND RECOMMENDATIONS

1. Successful endobronchial ultrasound-guided mediastinal staging with sampling of 3 lymph node stations
2. Successful robotic-assisted bronchoscopic biopsy of LUL pulmonary lesion
3. Cytological evaluation suggestive of malignant - nsclc nos
4. Recommend correlation with final surgical pathology and consideration of molecular profiling if malignancy confirmed

Total Procedure Duration: 103 minutes

Electronically Signed,
Katherine Lee, MD
Division of Interventional Pulmonology
Methodist Hospital",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Indication: 10mm RLL met.
Platform: Ion Robotic.
Guidance: Radial EBUS + Cone Beam CT (Tool-in-lesion).
Action: RF Ablation (40W, 480s, 85C).
Result: Ablation zone confirmed on CBCT (5mm margin).
Complication: Minor hemorrhage, stable.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Indication: 12mm LLL nodule.
Nav: Galaxy + TiLT.
Div: 2.1cm (atelectasis).
Tools: rEBUS (concentric), TBNA, Brush.
ROSE: Atypical.
Result: No complications.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Indication: 18mm RLL nodule.
Nav: Ion Robotic + CT-body registration.
Guidance: REBUS (concentric) + CBCT.
Sampling: TBNA (21G) + TBBx (x6) + Brush.
ROSE: Suspicious for NSCLC.
Result: No pneumo.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"Indication: 2 nodules (RUL, RLL).
Proc: Robotic Nav + REBUS + TBBx.
Targets: RUL post (1.6cm), RLL sup (2.1cm).
Action: Navigated, confirmed REBUS. Biopsied both.
Result: Samples obtained.
Plan: D/C.",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Indication: 24mm RUL nodule.
System: Galaxy Robot.
Verif: Fluoro + rEBUS (Adjacent).
Sampling: TBNA x6, Forceps x4, Brush.
ROSE: Granulomatous.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Indication: 9mm RLL nodule.
System: Galaxy.
Verif: Fluoro + rEBUS (Concentric).
Action: TBNA x4, Bx x6, Brush, BAL (RB10).
ROSE: Negative.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Indication: Aspiration (Peanut).
Proc: Foreign Body Removal.
Findings: R main/RLL occluded by nuts.
Action: Basket/Forceps removal piecemeal.
Result: Airways cleared.
Plan: CXR, extubate tomorrow.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"Indication: Dx bronch + EBUS.
Procedure: EBUS (4R, 7) + RUL Biopsy.
EBUS: 4R/7 positive.
RUL: Biopsy x4, Brush x2.
Codes: 31652, 31625.
Plan: Path pending.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Indication: Exudative effusion, nodules.
Proc: Med Thoracoscopy + Biopsy.
Findings: Diffuse nodules parietal pleura.
Action: Drained 900cc. 10 biopsies taken.
Result: No complications. Pigtail removed.
Plan: Admit.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Indication: Fibrotic ILD.
Anesthesia: General, 8.5 ETT.
Guidance: Radial EBUS (parenchymal view).
Action: 3 cryobiopsies (1.9mm probe) + 1 forceps biopsy from LLL basal segment.
Safety: Prophylactic bronchial blocker used.
Result: Mild bleeding controlled. No pneumo.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"Indication: Hypoxemia, mucus plugging.
Proc: Therapeutic bronchoscopy.
Findings: Thick secretions R lung.
Action: Suctioned R main/RML/RLL. Saline lavage.
Result: Airways patent. Improved saturations.
Plan: Wean vent.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"Indication: LLL nodule 19mm.
Procedure: EMN Bronchoscopy.
Findings: Concentric REBUS view.
Sampling: Needle x3, Biopsy x4, Brush x2.
Result: Tool-in-lesion confirmed. Samples sent.
Plan: Clinic f/u.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Indication: LLL nodule, 2.6cm, PET+. Surgically ineligible.
Procedure: Flexible bronchoscopy, EMN (Veran), Radial EBUS, Cryoablation.
Target: LLL lateral basal segment.
Action: Navigated to lesion. Confirmed w/ REBUS (concentric). Cryoprobe inserted. 3 cycles freeze/thaw performed (-165C). Ice ball visualized.
Complications: None.
Plan: Admit, CXR, CT in 24h.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Indication: LUL GGO 9mm.
Procedure: EMN Bronchoscopy + R-EBUS.
Sampling: Needle x2, Forceps x4, Brush x1.
Fluoroscopy: 2.8 min.
Result: Tool-in-lesion confirmed. Samples sent.
Complications: None.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Indication: LUL NSCLC (nonsurgical).
Nav: superDimension + REBUS + CBCT.
Action: MWA (Emprint, 65W, 360s).
Complication: Pneumothorax.
Intervention: 10Fr pigtail catheter placed under fluoro.
Plan: Admit.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"Indication: Large PTX.
Proc: Chest Tube (28Fr).
Site: R 5th ICS.
Result: Air rush, lung re-expanded.
Plan: Admit, suction -20.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"Indication: Lobar collapse, hypoxemia.
Setting: MICU, intubated.
Findings: RLL basal bronchi obstructed by mucus.
Action: Aggressive BAL and suction in RLL.
Result: Plugs removed, airways patent.
Complication: Transient desat, resolved.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"Indication: Lung-RADS 4B mass.
Technique: Galaxy navigation to LLL. TiLT+ rectified 1.4cm error. Sampled via TBNA, forceps, and brush. ROSE: Adenocarcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Indication: Lung-RADS 4B nodule, Lingula.
Anesthesia: GA, ETT.
Device: Noah Galaxy.
Action: Navigated to LB4. TiLT+ sweep showed 1.8cm divergence. Adjusted. Confirmed via rEBUS (adjacent).
Sampling:
- TBNA 22G: 5 passes.
- Forceps: 4 samples.
- Brush: 1 sample.
ROSE: SqCC.
Plan: Recovery. CXR.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Indication: Lung-RADS 4X lesion.
Procedure: Galaxy navigation to RLL. Position validated with TiLT overlay. Lesion sampled via TBNA, forceps, and brush. Lavaged. Marker deployed. ROSE: Adenocarcinoma.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Indication: Lung-RADS 4X mass.
Technique: The Galaxy scope was steered to the RUL target. TiLT+ imaging rectified a 1.4cm discrepancy. rEBUS verified the location. The lesion was sampled via TBNA and lavage. A marker was deployed for SBRT. ROSE analysis indicated benign tissue.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"Indication: Lung-RADS 4X nodule (22mm RUL).
Procedure: Bronchoscopy with Galaxy robotic navigation.
- Navigated to RUL (RB3). Reg error 3.6mm.
- TiLT+ used to correct 1.4cm divergence.
- rEBUS: Eccentric view.
- TBNA (22G) x 6 passes.
- BAL RUL: 60cc in/22cc out.
- Fiducial placed.
ROSE: Benign respiratory epithelium.
Plan: Recovery, D/C.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"Indication: Mediastinal LAD.
Proc: EBUS-TBNA.
Stations: 7, 11R.
ROSE: Granulomas.
Result: 2 stations sampled.
Plan: D/C.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"Indication: Mediastinal adenopathy.
Procedure: EBUS-TBNA.
Stations Sampled: 2R, 4R, 4L, 7, 11R.
Findings: 4R/7 positive for carcinoma. 2R/4L/11R benign.
Code: 31653 (3+ stations).",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"Indication: Migrated L main stent.
Proc: Stent Revision.
Findings: Stent proximal migration.
Action: Grasped w/ forceps, pushed distal. Balloon dilated 12mm.
Result: Stent re-centered. Good position.
Plan: Admit.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"Indication: Multiple nodules, dominant RLL 25mm.
Robot: Galaxy.
TiLT+: 1.5cm divergence (respiratory motion). Corrected.
rEBUS: Adjacent.
Action: TBNA x5, Brush.
ROSE: Negative for malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Indication: PET-avid mass.
Operation: Galaxy navigation to LUL. TiLT+ adjusted for 1.0cm divergence. Lesion localized with rEBUS. Sampled via TBNA and brush. Lavaged. Marker implanted. ROSE: Atypical.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Indication: Peripheral nodule.
Procedure: Galaxy navigation to Lingula. TiLT+ rectified 1.1cm error. Lesion sampled via TBNA and brush. ROSE: Squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Indication: Pleural effusion (HF).
Proc: US Thoracentesis.
Site: Left, 8th ICS.
Amount: 1.3L clear fluid.
Labs: Sent.
Complication: None.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Indication: Post-biopsy hemorrhage RUL.
Procedure: Bronchoscopy + RFA.
Findings: Blood in RUL. No active bronchial source.
Action: Navigated to tumor site. RFA probe inserted. Coagulation mode (40W) then Ablation mode (90C). 
Result: Hemostasis achieved. Tumor ablated. Chest tube output decreased.
Plan: ICU, wean chest tube.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Indication: RLL nodule (21mm, 4X).
Nav: Galaxy. Reg error 2.7mm.
Verify: TiLT+ & Fluoroscopy.
Biopsy: TBNA, Forceps (4 specs), Brush, BAL.
Marker: Fiducial placed.
ROSE: Adenocarcinoma.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Indication: RLL nodule (Brock high risk).
Tools: Galaxy, TiLT+, 22G Needle, Forceps, Fiducial.
Nav: 1.7cm divergence found on TiLT. Corrected.
Actions: rEBUS concentric. TBNA x7. Forceps x4. Brush. Gold fiducial placed.
ROSE: Suspicious for malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Indication: RLL nodule (RB9). Adenocarcinoma.
Procedure: RFA Ablation via EMN.
Protocol: 2 overlapping cycles. Cycle 1: 90C x 8 min. Cycle 2: 90C x 6 min (pulled back 5mm).
Verification: R-EBUS & Cone Beam CT.
Complications: None.
Plan: Admit, CXR 4h, CT 24h.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Indication: RUL Adenocarcinoma.
Procedure: Microwave Ablation.
Probe: Neuwave 14mm.
Settings: 60W, 6 min.
Guidance: ENB + R-EBUS.
Result: Good ablation zone. No complications.
Plan: Discharge tomorrow.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Indication: RUL NSCLC (high risk).
System: Monarch Robotic.
Guidance: REBUS + CBCT.
Action: Cryoablation (2.4mm probe, 2 freeze-thaw cycles, 360s each).
Result: Ice ball visualized on CBCT.
Complication: Mild hemoptysis, self-limited.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Indication: RUL posterior nodule (2.3cm). High risk surgical candidate.
Procedure: EMN Bronchoscopy + Microwave Ablation.
Equipment: SuperDimension, Emprint 2.0 probe.
Action: Navigated to RB1. Confirmed w/ R-EBUS & Cone Beam. Ablated 65W x 5 min (Max temp 85C).
Result: Hyperechoic zone on R-EBUS (necrosis).
Plan: Admit, CT 6h.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Indication: Recurrent SCLC?
Procedure: EBUS-TBNA.
Stations: 2R, 4R, 7, 10R (4 stations).
ROSE: Station 7 positive for Small Cell. Others neg.
Plan: Oncology.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Indication: Severe Asthma.
Proc: Bronchial Thermoplasty (Session 2/3).
Target: RLL, LLL.
Activations: 92 total.
Complication: Mild bronchospasm (treated).
Plan: D/C.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"Indication: Staging LUL Adeno.
Procedure: EBUS-TBNA.
Stations: 4L, 7, 11L (3 stations).
Needle: 22G.
ROSE: Lymphocytes present, no malignancy seen.
Disposition: D/C home.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Indication: Staging RUL mass.
Procedure: EBUS-TBNA.
Stations: 4R, 7, 11R (3 stations).
Sampling: 3 passes/station. 21G needle.
ROSE: 4R Malignant (NSCLC). 7/11R Benign.
Complication: None.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Indication: Station 7 adenopathy.
Procedure: EBUS-TBNA.
Target: Station 7 only (31mm).
Sampling: 5 passes.
ROSE: Adequate.
Code: 31652 (1 station).
Result: Samples sent.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Indication: Suspected malignancy.
Procedure: Galaxy navigation to RUL. TiLT+ rectified 0.8cm error. Sampled via TBNA, forceps, and lavage. Marker deployed. ROSE: Adenocarcinoma.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"Indication: Suspected sarcoidosis.
Procedure: Bronchoscopy with BAL and TBBx.
Actions:
- Scope inserted.
- Inspection: Cobblestoning noted.
- BAL: Right Middle Lobe.
- Biopsy: 6 samples, RLL medial basal segment (forceps).
Complications: None. No pneumothorax.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"Indication: Tracheal stenosis.
Proc: Balloon Dilation.
Findings: 60% subglottic stenosis.
Action: CRE balloon (8/10/12mm). Serial inflations.
Result: 80% patency.
Plan: D/C.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Intervention: Bronchial thermal remodeling.
Indication: Refractory reactive airway disease.
Technique: Radiofrequency energy application to the distal airways of the lower lobes.
Outcome: Successful completion of protocol session 2.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"Intervention: Bronchoscopic airway clearance.
Reason: Compromised oxygenation due to bronchial obstruction.
Technique: The endoscope was navigated through the airway. Copious exudate was evacuated from the right hemithorax using suction and lavage. The bronchial lumen was restored. 
Outcome: Improved aeration.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"Intervention: Endoscopic tracheal expansion.
Pathology: Subglottic stricture.
Technique: Radial force applied via pneumatic dilator. 
Outcome: Luminal enlargement achieved.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Intervention: Tube thoracostomy.
Indication: Pneumothorax.
Technique: Surgical insertion of pleural drain.
Outcome: Re-expansion of pulmonary parenchyma.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"Interventional Pulmonology Procedure Note. Procedures performed: Flexible bronchoscopy, Linear EBUS-TBNA. Patient is a 71-year-old male with suspected recurrent small cell lung cancer. Stations 2R, 4R, 7, and 10R identified. TBNA performed. ROSE showed malignant cells at 7 consistent with small cell carcinoma; other stations with lymphocytes. No complications. Admitted to oncology ward.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Jack Brooks, MRN 3293967, a 54-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Regional Medical Center on 11/27/2024. The indication was peripheral lung nodule with suspicious mediastinal nodes with a 19.4mm solid lesion in the RUL anterior (B3), bronchus sign positive, PET SUV max 6.7. The patient was ASA class 2 with smoking history of 54 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC180F bronchoscope with 19-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (21.2mm, 2 passes, ROSE: Malignant - adenocarcinoma); station 2L (8.8mm, 2 passes, ROSE: Atypical cells); station 11L (13.8mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.5mm. The robotic catheter was advanced to the RUL anterior (B3) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed granuloma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 131 minutes. Attending physician: Eric Johnson, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Jacob Gonzales, MRN 3090774, a 59-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at University Medical Center on 05/06/2025. The indication was peripheral nodule and bilateral hilar adenopathy with a 34.7mm part-solid lesion in the LUL superior lingula (B4), bronchus sign positive, PET SUV max 12.7. The patient was ASA class 3 with smoking history of 29 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 7 (8.3mm, 2 passes, ROSE: Atypical cells); station 11R (19.4mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy); station 11L (14.1mm, 4 passes, ROSE: Granuloma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.5mm. The robotic catheter was advanced to the LUL superior lingula (B4) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (5 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed suspicious for malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 122 minutes. Attending physician: Steven Park, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
James is here for staging of his RUL mass. We did the EBUS under GA. Poked nodes at 4R 7 and 11R. Used the 21 gauge needle. Pathologist said 4R looks like cancer. The others were just lymph cells. No bleeding no issues. Going home today.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Jason James, MRN 7329799, a 64-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Regional Medical Center on 11/11/2024. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 25.0mm solid lesion in the LUL anterior (B3), bronchus sign positive, PET SUV max 9.6. The patient was ASA class 3 with smoking history of 40 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 7 (19.5mm, 4 passes, ROSE: Granuloma); station 11L (18.1mm, 2 passes, ROSE: Malignant - squamous cell carcinoma); station 10R (17.1mm, 4 passes, ROSE: Granuloma); station 4L (11.5mm, 3 passes, ROSE: Atypical cells). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.6mm. The robotic catheter was advanced to the LUL anterior (B3) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (4 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 123 minutes. Attending physician: Andrew Nakamura, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Jennifer needs a diagnosis for her fibrosis so we did the cryo biopsy today. put her to sleep with a big tube 8.5. went to the left lower lobe used the radial ebus to make sure no vessels were there. took three freeze biopsies and one regular one. blocked the airway with a balloon for bleeding which was mild. no pneumothorax on the xray sending her to the floor.,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"Justin Henderson, MRN 7236022, a 43-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Baptist Medical Center on 03/20/2025. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 30.4mm solid lesion in the RML lateral (B4), bronchus sign negative, PET SUV max 13.0. The patient was ASA class 2 with smoking history of 46 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC260F-OL8 bronchoscope with 22-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2R (15.3mm, 3 passes, ROSE: Adequate lymphocytes); station 11R (23.0mm, 3 passes, ROSE: Adequate lymphocytes, no malignancy); station 4R (15.0mm, 3 passes, ROSE: Malignant - NSCLC NOS); station 7 (13.7mm, 2 passes, ROSE: Adequate lymphocytes). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.6mm. The robotic catheter was advanced to the RML lateral (B4) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (4 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed suspicious for malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 79 minutes. Attending physician: Lisa Thompson, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Kevin has a met in the RLL we treated it with the robot today. Ion system worked well registration was 2mm. Found it with the radial probe and the cone beam ct. Cooked it with the RF catheter 40 watts for almost 10 minutes. Got a good burn zone on the scan after. Little bit of bleeding but stopped on its own. Admitting to telemetry.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"LLL Nodule (12mm).
- Galaxy nav to LB9.
- TiLT: 2.1cm shift (atelectasis).
- rEBUS: Concentric.
- TBNA x7, Brush.
- ROSE: Atypical/Suspicious.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"LLL Nodule (13mm).
- Galaxy to LB10.
- TiLT: 1.9cm shift.
- rEBUS: Adjacent.
- TBNA x6.
- ROSE: Suspicious NSCLC.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Larry Gray, MRN 1800685, a 61-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Methodist Hospital on 01/31/2025. The indication was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy with a 14.5mm ground-glass lesion in the RUL anterior (B3), bronchus sign positive. The patient was ASA class 3 with smoking history of 50 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 19-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11L (13.3mm, 4 passes, ROSE: Malignant - NSCLC NOS); station 7 (10.0mm, 2 passes, ROSE: Adequate lymphocytes); station 2L (24.9mm, 3 passes, ROSE: Malignant - small cell carcinoma). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.2mm. The robotic catheter was advanced to the RUL anterior (B3) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed atypical cells.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 136 minutes. Attending physician: Brian O'Connor, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Left diagnostic pleuroscopy executed. Observed fibrinous synechiae and trapped lung. Effusion drained. Catheter deployed. Lung re-expansion confirmed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Left medical thoracoscopy was performed. Inflammatory changes were noted without nodularity. Twelve biopsies were obtained from the parietal pleura, along with diaphragmatic biopsies. Fluid was evacuated and a chest tube was placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Left medical thoracoscopy was performed. Visceral pleural tumor implants were visualized. Eleven biopsies were obtained from the parietal pleura, along with diaphragmatic biopsies. Talc poudrage was performed for pleurodesis. Fluid was evacuated and a chest tube was placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Left pleuroscopy performed. Inflammatory alterations observed. Twelve tissue samples harvested from parietal pleura; diaphragm also sampled. Effusion drained. Catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
Left pleuroscopy performed. Visceral tumor implants observed. Eleven tissue samples harvested from parietal pleura; diaphragm also sampled. Talc insufflation executed. Fluid drained and catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Linda Rivera, MRN 3786812, a 50-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Memorial Hospital on 08/13/2024. The indication was right upper lobe mass with ipsilateral mediastinal nodes with a 31.9mm ground-glass lesion in the LLL anteromedial basal (B7+8), bronchus sign negative, PET SUV max 13.4. The patient was ASA class 3 with smoking history of 57 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 22-gauge Acquire needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11L (21.6mm, 4 passes, ROSE: Suspicious for malignancy); station 2L (14.5mm, 4 passes, ROSE: Suspicious for malignancy); station 7 (21.8mm, 3 passes, ROSE: Adequate lymphocytes); station 11R (15.0mm, 3 passes, ROSE: Malignant - small cell carcinoma); station 10R (21.4mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.2mm. The robotic catheter was advanced to the LLL anteromedial basal (B7+8) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed suspicious for malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 119 minutes. Attending physician: Maria Santos, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Linear EBUS bronchoscopy performed for mediastinal staging. Lymph nodes at station 7 and 11R were identified and sampled via transbronchial needle aspiration. Rapid on-site evaluation showed granulomatous inflammation. No complications occurred.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"Lingula Nodule (8mm).
- Galaxy Nav to LB4.
- TiLT: 1.1cm divergence.
- rEBUS: Eccentric.
- TBNA x8, Brush.
- ROSE: Squamous Cell.
Stable.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
Lung-RADS 4B nodule 14mm in RML. General anesthesia. Noah Galaxy bronchoscope introduced. Registration error 3.9mm. TiLT+ sweep performed showing 2.1cm divergence. Target updated. rEBUS concentric. TBNA 21G performed. ROSE necrotic debris. Patient tolerated well.,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Lung-RADS 4B nodule 29mm in LLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB6. TiLT+ sweep showed 1.4cm divergence due to registration drift. Corrected. rEBUS adjacent. TBNA 21G, Transbronchial forceps biopsy, Cytology brushings performed. ROSE Malignant cells identified.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Lung-RADS 4B nodule. 26mm nodule in Lingula. General anesthesia. Noah Galaxy bronchoscope introduced. Navigational registration performed. Scope navigated to LB4. Tool-in-Lesion Tomosynthesis (TiLT+) sweep performed. 1.8cm divergence noted and corrected. Radial EBUS view: Adjacent. Transbronchial needle aspiration (22G, 5 passes). Transbronchial forceps biopsy (4 specimens). Cytology brushings. ROSE Result: Malignant cells identified, consistent with squamous cell carcinoma. No complications.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Lung-RADS 4X nodule 21mm in RLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB7. Fluoroscopic guidance with TiLT overlay. rEBUS eccentric. TBNA 22G, Forceps biopsy, Cytology brush, BAL, and Fiducial marker placement performed. ROSE Malignant cells identified consistent with adenocarcinoma.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
Lung-RADS 4X nodule. 22mm nodule in LUL. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB1+2. TiLT+ sweep revealed 1.5cm divergence. Target updated. rEBUS view: Eccentric. TBNA performed. Transbronchial forceps biopsy performed. Cytology brushings obtained. Gold fiducial marker placed. ROSE Result: Lymphocytes and benign cells.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Margaret Chavez, MRN 9098178, a 75-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Veterans Affairs Medical Center on 08/19/2024. The indication was mediastinal staging for biopsy-proven lung adenocarcinoma with a 22.6mm solid lesion in the RUL apical (B1), bronchus sign negative, PET SUV max 9.7. The patient was ASA class 3 with smoking history of None pack-years (never). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11R (24.9mm, 3 passes, ROSE: Malignant - adenocarcinoma); station 2L (14.7mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 4R (13.0mm, 3 passes, ROSE: Malignant - small cell carcinoma); station 11L (19.1mm, 3 passes, ROSE: Suspicious for malignancy). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.8mm. The robotic catheter was advanced to the RUL apical (B1) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (4 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed suspicious for malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 131 minutes. Attending physician: Brian O'Connor, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Maria Brooks, MRN 2245091, a 51-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Regional Medical Center on 05/29/2024. The indication was pet-avid lung mass and mediastinal lymphadenopathy with a 30.9mm ground-glass lesion in the RUL anterior (B3), bronchus sign negative. The patient was ASA class 3 with smoking history of 20 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 22-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4L (18.3mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 10R (14.8mm, 4 passes, ROSE: Suspicious for malignancy); station 4R (20.9mm, 4 passes, ROSE: Malignant - adenocarcinoma); station 7 (24.0mm, 2 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.0mm. The robotic catheter was advanced to the RUL anterior (B3) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed granuloma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 77 minutes. Attending physician: Steven Park, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Maria has LUL cancer needs staging. We did EBUS with MAC anesthesia LMA. Sampled 4L 7 and 11L with the 22 needle. Cytology said just lymphocytes no cancer seen yet. She did fine no bleeding. Discharged.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Matthew Barnes, MRN 4124884, a 49-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Regional Medical Center on 05/31/2024. The indication was pet-avid lung mass and mediastinal lymphadenopathy with a 20.0mm solid lesion in the RML medial (B5), bronchus sign negative, PET SUV max 6.5. The patient was ASA class 4 with smoking history of 23 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 22-gauge Acquire needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2L (13.8mm, 4 passes, ROSE: Malignant - small cell carcinoma); station 4R (23.9mm, 3 passes, ROSE: Malignant - adenocarcinoma); station 11R (19.6mm, 3 passes, ROSE: Atypical cells); station 11L (17.4mm, 2 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.5mm. The robotic catheter was advanced to the RML medial (B5) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - nsclc nos.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 87 minutes. Attending physician: David Kim, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Matthew Ross, MRN 7465133, a 85-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Baptist Medical Center on 07/20/2024. The indication was lung cancer staging - suspected nsclc with mediastinal lymphadenopathy with a 31.5mm part-solid lesion in the RML medial (B5), bronchus sign positive, PET SUV max 7.9. The patient was ASA class 4 with smoking history of 57 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4R (23.5mm, 2 passes, ROSE: Malignant - squamous cell carcinoma); station 4L (14.3mm, 4 passes, ROSE: Suspicious for malignancy); station 10R (11.1mm, 2 passes, ROSE: Suspicious for malignancy); station 2L (20.1mm, 2 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.2mm. The robotic catheter was advanced to the RML medial (B5) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (5 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 105 minutes. Attending physician: Lisa Thompson, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Medical thoracoscopy performed for pleural effusion. Right pleural space accessed. 900cc fluid removed. Parietal pleura showed diffuse studding; multiple biopsies taken. No pleurodesis performed. Catheter removed at conclusion. Patient stable.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Michael Gomez, MRN 1145427, a 48-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Community Hospital on 05/14/2024. The indication was combined staging and peripheral nodule diagnosis with a 16.3mm ground-glass lesion in the RLL superior (B6), bronchus sign positive, PET SUV max 6.9. The patient was ASA class 2 with smoking history of 23 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC190F bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11L (14.4mm, 4 passes, ROSE: Granuloma); station 4L (21.7mm, 3 passes, ROSE: Malignant - NSCLC NOS); station 10L (19.2mm, 2 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 3.4mm. The robotic catheter was advanced to the RLL superior (B6) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 94 minutes. Attending physician: Andrew Nakamura, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Mr. Edwards had a robotic procedure to freeze a small tumor in his right lung. Because of his COPD, this was safer than surgery. We used the robot to get there, checked our spot with ultrasound, and then froze the tumor twice to make sure it was destroyed. We could actually see the ice ball on the scanner. He had a tiny bit of coughing up blood, but it stopped quickly.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Mr. Green underwent a robotic biopsy of his right middle lobe nodule. We used the Galaxy system and achieved good registration accuracy. We confirmed our position with fluoroscopy and ultrasound, which showed a concentric view. We took multiple samples. The initial pathology showed atypical cells.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Mr. Jones underwent a right diagnostic medical thoracoscopy. Upon inspection, we noted thickened parietal pleura with nodules. We visualized the visceral and diaphragmatic surfaces as well. We evacuated all remaining fluid under direct visualization and placed a chest tube. The lung expanded appropriately.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Mr. Joseph Black had a complication from his lung biopsy yesterday and was bleeding into his chest. We took him to the bronchoscopy suite urgently. Using a special navigation system, we guided a radiofrequency probe to the bleeding tumor. We used the heat from the probe first to seal the bleeding vessels and then to destroy the tumor itself. It worked perfectly, and the bleeding stopped immediately.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
Mr. Kenny Bania underwent a bronchoscopy today. We used the ultrasound scope to check his lymph nodes first; stations 4R and 7 both showed cancer cells. We then looked at the main tumor in the right upper lobe and took direct biopsies and brushings. This confirms the diagnosis and stage.,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Mr. Kevin Lee came in for ablation of his right upper lobe lung cancer. We used a microwave probe inserted through the bronchoscope. After finding the tumor with navigation and ultrasound, we applied microwave energy for 6 minutes. This heated the tumor enough to destroy it. He is recovering well.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Mr. Lee underwent an EBUS procedure to check for recurring cancer. We sampled four different lymph node stations: 2R, 4R, 7, and 10R. The sample from station 7 unfortunately showed small cell cancer cells. We admitted him to the hospital to start planning his treatment with the oncology team.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Mr. Lopez underwent a left diagnostic medical thoracoscopy. We observed fibrinous adhesions and evidence of trapped lung. We visualized the pleural surfaces and evacuated the remaining fluid. A chest tube was placed, and the lung expanded without air leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Mr. Rodriguez underwent a robotic biopsy. The Galaxy system's TiLT+ feature helped us correct a 2.3cm error caused by lung collapse. We sampled the area with a needle, forceps, and wash, and placed a marker. It looks suspicious for lung cancer.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"Mr. Rogers was struggling with oxygenation in the ICU due to a collapsed right lower lobe. We performed a bedside bronchoscopy and found thick mucus plugging up the airways. We used saline lavage to break up the mucus and suctioned it out, clearing the blockage. His oxygen levels dipped briefly during the washing but recovered quickly once the airways were open.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
Mr. Taylor had a biopsy of his right upper lobe nodule today using the Galaxy robot. We navigated to the site and confirmed with fluoroscopy and ultrasound. We took needle and forceps samples. The preliminary results point towards inflammation (granulomas) rather than cancer.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Mr. White underwent a robotic procedure to treat a tumor in his right lower lung. We used the Ion robot to steer a catheter directly to the spot, confirming the location with both ultrasound and a CT scan right in the room. We then used radiofrequency energy to heat and destroy the tumor. The final scan showed we covered the whole area well. There was a tiny bit of bleeding, but he remained stable.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Mr. Young underwent a right medical thoracoscopy. We observed inflammatory changes but no nodules. We performed talc poudrage for pleurodesis after draining the fluid. A chest tube was placed, and the lung expanded.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Mrs. Cook had a 13mm nodule in the back of the left lower lobe. We used the Galaxy robot. The TiLT scan showed it was almost 2cm away from where we expected due to her breathing, so we updated the target and found it. We did six needle passes. It looks suspicious for cancer.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Mrs. Gonzalez had a robotic biopsy of her small RLL nodule. We used the Galaxy system, confirmed position with fluoroscopy and ultrasound, and took samples including a lung wash (BAL). Preliminary results are negative.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Mrs. White had a robotic biopsy of her right lower lobe nodule. We used the Galaxy system. The TiLT+ scan showed the target had moved 1.5cm due to breathing, so we updated our navigation. We confirmed the spot with ultrasound and took needle and brush samples. The preliminary check didn't show cancer.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Mrs. White underwent robotic bronchoscopy for her LLL nodule today. Using the Galaxy system, we navigated to the lower lobe. We performed a TiLT+ spin which showed the nodule had shifted by 1.3cm due to atelectasis. We adjusted our targeting, confirmed with ultrasound, and took samples using a needle and brush. Preliminary results suggest granulomatous inflammation.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
Ms. Brown underwent robotic biopsy of her RLL nodule. The Galaxy system with TiLT+ identified a 1.8cm positioning error which we corrected. We obtained excellent samples and placed a fiducial marker. The preliminary pathology confirms squamous cell carcinoma.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Ms. Cassandra Cain underwent a full lymph node staging procedure today. Since we didn't have a PET scan, we sampled five different lymph node stations in her chest (2R, 4R, 4L, 7, 11R) to be thorough. We found cancer cells in the station 4R and 7 nodes, but the others appeared clear. This helps us accurately stage her disease.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
Ms. Elinor Dashwood needed a biopsy of a large lymph node under her windpipe (station 7). We performed an EBUS procedure and focused solely on that node as requested by her oncologist. We took five good samples and the pathologist confirmed we had enough tissue for testing.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Ms. Flores presented for biopsy of a 26mm Lingular nodule. We utilized the Noah Galaxy robotic system. After intubation, we navigated to the target but noted a 1.8cm divergence on the TiLT+ spin, which we corrected. We confirmed the location with rEBUS and proceeded to sample the lesion using a needle, forceps, and brush. The on-site pathologist confirmed squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Ms. Hernandez came in for staging of her left lung cancer. Using the EBUS scope, we sampled lymph nodes in three areas: 4L, 7, and 11L. The preliminary check in the room didn't show any cancer in those nodes, which is a good sign, but we have to wait for the final results. She woke up quickly and went home.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
Ms. Johnson had a robotic bronchoscopy today to biopsy two spots in her right lung. We used the robot to steer the camera deep into the lung to reach the spots in the upper and lower lobes. We confirmed we were in the right place with ultrasound and took biopsies from both. She did very well.,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Ms. Keller had her windpipe dilated today. She has a narrowing just below her vocal cords. We used a special balloon that we inflated inside the narrow part to stretch it open. We did this three times with increasing pressure. The airway is much wider now, which should help her breathing.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Ms. Kelly has a history of cancer and a new 11mm spot in the right upper lobe. We used the Galaxy system to reach it and confirmed with fluoroscopy. We took samples with needles and forceps. The preliminary read shows granulomas, which is a relief as it suggests inflammation rather than cancer.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Ms. King arrived for a diagnostic bronchoscopy to investigate her hilar adenopathy. We used moderate sedation to ensure her comfort. Upon entering the airways, we noticed cobblestoning, which is often a sign of sarcoidosis. We washed the right middle lobe to collect cells and then moved to the right lower lobe to take six small tissue samples using forceps under X-ray guidance. She did very well, had no bleeding, and her chest X-ray afterwards was clear.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"Ms. Martina Flores presented for treatment of her left lung cancer. Because surgery wasn't safe for her, we proceeded with a bronchoscopic ablation. After she was asleep, we used a navigation system to guide a catheter out to the tumor in the lower part of her left lung. We double-checked the position with ultrasound. Then, we inserted a freezing probe right into the tumor and ran three cycles of extreme cold to destroy the cancer cells. Everything went smoothly, and she woke up well.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
Ms. Morgan came in for her second bronchial thermoplasty treatment for her asthma. Today we treated the bottom sections of both lungs. We used a special catheter to warm the airway walls to reduce muscle thickness. We did 92 treatments in total. She had a little asthma flare during the procedure but we treated it quickly and she is doing fine now.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"Ms. Rivera underwent a right medical thoracoscopy. The inspection revealed inflammatory changes but no distinct nodularity. We obtained twelve biopsies from the parietal pleura and additional samples from the diaphragm to ensure a comprehensive evaluation. All fluid was evacuated, and a chest tube was placed. No pleurodesis was performed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Ms. Robinson had a suspicious spot in her right lower lung. We used the Galaxy system to guide us right to it. We double-checked our position with x-ray and the TiLT system. We took several different types of samples including needle, forceps, and brush. Unfortunately, the preliminary check in the room showed it is adenocarcinoma. We placed a marker for future treatment.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Ms. Walker underwent a robotic biopsy of her left upper lobe nodule. Using the Galaxy system and TiLT+ technology, we identified and corrected a 1.5cm discrepancy in the target location caused by breathing. We obtained samples using a needle, forceps, and brush, and placed a fiducial marker. Preliminary results show benign cells.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
Multiple pulmonary nodules. 22mm nodule in RLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB10. TiLT+ sweep revealed 2.3cm divergence due to atelectasis. Target updated. rEBUS view: Adjacent. TBNA (22G). Transbronchial forceps biopsy. Bronchoalveolar lavage. Gold fiducial marker placed. ROSE Result: Suspicious for non-small cell carcinoma.,1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
Multiple pulmonary nodules. 24mm nodule in RUL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB2. Fluoroscopic guidance used. rEBUS view: Adjacent. Transbronchial needle aspiration (21G). Transbronchial forceps biopsy. Cytology brushings. ROSE Result: Granulomatous inflammation.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
Multiple pulmonary nodules. 25mm nodule in RLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB9. TiLT+ sweep revealed 1.5cm divergence due to respiratory motion. Augmented reality target updated. rEBUS view: Adjacent. Transbronchial needle aspiration (22G). Cytology brushings. ROSE Result: No evidence of malignant neoplasm.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Nancy Nguyen, MRN 5694950, a 42-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Memorial Hospital on 02/09/2024. The indication was peripheral lung nodule with suspicious mediastinal nodes with a 24.3mm solid lesion in the LUL superior lingula (B4), bronchus sign negative, PET SUV max 12.7. The patient was ASA class 4 with smoking history of 49 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 4L (21.5mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 10L (21.1mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 11L (8.8mm, 3 passes, ROSE: Malignant - squamous cell carcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.5mm. The robotic catheter was advanced to the LUL superior lingula (B4) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (4 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 108 minutes. Attending physician: Robert Patel, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Nancy Reyes, MRN 9308712, a 64-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Baptist Medical Center on 03/15/2025. The indication was combined staging and peripheral nodule diagnosis with a 27.5mm ground-glass lesion in the RLL superior (B6), bronchus sign negative, PET SUV max 16.3. The patient was ASA class 4 with smoking history of 34 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 22-gauge Acquire needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 11R (22.0mm, 2 passes, ROSE: Malignant - small cell carcinoma); station 4R (13.7mm, 4 passes, ROSE: Atypical cells); station 11L (18.9mm, 3 passes, ROSE: Malignant - small cell carcinoma). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.8mm. The robotic catheter was advanced to the RLL superior (B6) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (4 specimens), transbronchial needle aspiration (3 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes, no malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 100 minutes. Attending physician: Steven Park, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"OPERATIVE NARRATIVE: The patient underwent a right-sided medical thoracoscopy under moderate sedation. Inspection of the pleural cavity revealed diffuse nodularity involving the parietal surface. Histological sampling was performed, yielding seven distinct specimens from the parietal pleura, alongside diaphragmatic sampling. Following biopsy, chemical pleurodesis was achieved via talc insufflation (poudrage) to address the malignant effusion. A chest tube was secured post-evacuation.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"OPERATIVE NARRATIVE: The patient, currently mechanically ventilated in the MICU, developed acute right lower lobe atelectasis. Bedside flexible bronchoscopy was initiated to restore airway patency. Visualization confirmed complete obstruction of the RLL basal segments by tenacious secretions. Therapeutic bronchial lavage and suctioning were vigorously applied, resulting in the successful extraction of significant mucus plugs and restoration of lobar aeration.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"OPERATIVE NOTE: Bronchial Thermoplasty, Session 2.
INDICATION: Refractory asthma.
PROCEDURE: The lower lobes were targeted for this session. The Alair catheter was deployed systematically in the segmental and subsegmental bronchi of the right and left lower lobes. A total of 92 radiofrequency activations were delivered. The patient tolerated the procedure with only mild, transient bronchospasm managed pharmacologically.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"OPERATIVE NOTE: Ms. Brown presented for biopsy of a 31mm RLL nodule. The Galaxy system was used. TiLT+ tomosynthesis revealed a 1.8cm divergence due to patient positioning, which was corrected intra-operatively. rEBUS showed a concentric view. We performed TBNA, forceps biopsy, and brushing. A fiducial was placed for SBRT planning. ROSE confirmed squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"OPERATIVE NOTE: Robotic Navigational Bronchoscopy.
INDICATION: Bilateral pulmonary nodules.
PROCEDURE: A pre-operative CT was utilized for path planning. Using the robotic platform, the bronchoscope was navigated sequentially to the RUL posterior and RLL superior segments. Radial EBUS confirmed lesion location at both sites. Transbronchial biopsies were obtained from both targets without complication.",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"OPERATIVE NOTE: Targeted EBUS-TBNA.
INDICATION: Isolated subcarinal lymphadenopathy.
PROCEDURE: The EBUS scope was introduced. Station 7 was identified, measuring 31mm. Five needle passes were performed. ROSE confirmed adequacy. Per oncology request, no other stations were sampled. Procedure tolerated well.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"OPERATIVE NOTE: The patient underwent robotic-assisted bronchoscopic cryoablation. The Monarch system was utilized to navigate to the subpleural RUL apical lesion. Positional confirmation was established via radial EBUS and Cone-Beam CT. A flexible cryoprobe was introduced, and two freeze-thaw cycles were completed. Intraprocedural CBCT confirmed the formation of an ice ball encompassing the target volume.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"OPERATIVE REPORT: Bronchoscopic Microwave Ablation.
CLINICAL SUMMARY: Patient with medically inoperable RUL adenocarcinoma.
PROCEDURE: The target lesion in the RUL anterior segment was localized using electromagnetic navigation and confirmed via radial EBUS (contact view). A Neuwave microwave antenna was deployed. Microwave energy was delivered at 60 Watts for 6 minutes. Post-ablation imaging verified adequate coverage of the lesion. The patient tolerated the procedure well.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"OPERATIVE REPORT: Bronchoscopic Radiofrequency Ablation.
INDICATION: 73-year-old male with RLL adenocarcinoma.
PROCEDURE: Under general anesthesia, the RB9 segment was navigated using the Veran SPiN system. Cone-beam CT confirmed guide sheath placement 8mm from the lesion center. An RFA probe (Vivant) was introduced. Two overlapping ablation cycles were performed (90C for 8 min, then 90C for 6 min) to ensure adequate margins. Post-ablation R-EBUS demonstrated a 'ice-cream cone' sign consistent with successful ablation.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"OPERATIVE REPORT: Electromagnetic Navigation Bronchoscopy with Microwave Ablation.
INDICATION: Primary lung adenocarcinoma, RUL posterior segment, in a patient with severe COPD.
TECHNIQUE: General anesthesia was induced. Using the SuperDimension system, the RUL posterior target was cannulated. Radial EBUS and Cone-Beam CT verified probe placement within 5mm of the lesion center. A microwave ablation catheter was advanced. Energy was delivered (65W, 5 min) achieving a peak tip temperature of 85C. Post-ablation imaging confirmed coagulative necrosis encompassing the tumor.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"OPERATIVE REPORT: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
INDICATION: Staging of mediastinal lymphadenopathy.
PROCEDURE: A systematic evaluation of the mediastinum was performed. Lymph node stations 2R, 4R, 4L, 7, and 11R were visualized and sampled. ROSE confirmed metastatic carcinoma in stations 4R and 7. Stations 2R, 4L, and 11R showed reactive changes. The procedure was uncomplicated.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"OPERATIVE REPORT: Left medical thoracoscopy was performed for suspected malignancy. Inflammatory changes were noted without distinct nodularity. Twelve biopsies were harvested from the parietal pleura, with additional diaphragmatic sampling. Fluid was evacuated. No pleurodesis was performed. A chest tube was placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"OPERATIVE REPORT: Medical Thoracoscopy.
INDICATION: Undiagnosed pleural effusion.
FINDINGS: Visual inspection of the right pleural space revealed diffuse nodularity of the parietal pleura. 
PROCEDURE: The space was accessed via a single port. 900 mL of fluid was evacuated. Multiple forceps biopsies were obtained from the parietal pleura for diagnostic evaluation. The lung was re-expanded and the catheter removed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"OPERATIVE REPORT: Mr. Green presented for biopsy of a PET-avid RML nodule. The Galaxy robotic system was navigated to RB4. Registration error was 2.1mm. Position was confirmed via fluoroscopy and concentric rEBUS view. Sampling proceeded with 21G TBNA, forceps biopsy, and brushing. ROSE indicated atypical cells, malignancy not excluded.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"OPERATIVE REPORT: Mr. Norris presented with symptomatic migration of a left mainstem bronchial stent. Under general anesthesia, bronchoscopy revealed the covered metal stent protruding into the distal trachea. The stent was manipulated distally using alligator forceps and repositioned into the appropriate anatomic location. Balloon dilation was performed to ensure apposition to the bronchial wall. The airway is now patent.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"OPERATIVE REPORT: Right medical thoracoscopy was performed for persistent effusion. Multiple nodules with a malignant appearance were identified on the parietal pleura. Ten biopsies were harvested from the parietal surface, with additional sampling of the diaphragm. Talc poudrage was performed for pleurodesis. The chest was drained and a tube placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
OPERATIVE REPORT: The patient presented for focal therapy of an oligometastatic RLL lesion. The Ion robotic platform facilitated navigation to the lateral basal segment. Target confirmation was achieved via concentric radial EBUS view and Cone-Beam CT (CBCT) verification of tool-in-lesion. Radiofrequency ablation was delivered via catheter at 40 Watts for 480 seconds. Post-ablation CBCT demonstrated a satisfactory ablation zone encompassing the tumor with margins.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"OPERATIVE REPORT: The patient underwent a right medical thoracoscopy for staging. A distinct mass lesion was identified on the diaphragmatic pleura. Twelve biopsies were excised from the parietal pleura, with additional targeted sampling of the diaphragmatic mass. Given the findings, palliative pleurodesis was induced via talc poudrage. The hemithorax was drained and a chest tube inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"OPERATIVE REPORT: The patient was brought to the endoscopy suite for investigation of a Lingular nodule. Following the induction of general anesthesia, the Noah Galaxy robotic platform was deployed. Initial registration yielded a 2.1mm accuracy. Intraprocedural Tool-in-Lesion Tomosynthesis (TiLT+) identified a significant divergence of 1.8cm, likely secondary to positioning. The target was realigned utilizing augmented fluoroscopy. Radial EBUS confirmed an adjacent signature. Extensive sampling was performed via transbronchial needle aspiration and forceps biopsy. Rapid On-Site Evaluation was positive for malignant cells consistent with squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"OPERATIVE SUMMARY: Bronchoscopic Cryoablation of Peripheral Pulmonary Malignancy.
The patient, a 70-year-old female with significant comorbidities precluding surgical resection, underwent palliative ablation of a PET-avid left lower lobe nodule. Under general anesthesia, the airway was secured. Utilizing electromagnetic navigation (Veran SPiN) and radial endobronchial ultrasound confirmation, the target lesion in the lateral basal segment was localized. A cryoablation probe was advanced into the tumor core. A modified protocol utilizing three freeze-thaw cycles was executed to ensure adequate tumoricidal effect given the lesion diameter (>2.5cm). Post-procedural imaging via radial EBUS confirmed a hyperechoic ablation zone extending beyond the tumor margins.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"OPERATIVE SUMMARY: Emergent bronchoscopy was performed for acute airway obstruction. Inspection confirmed a foreign body (peanut fragments) occluding the right mainstem bronchus. Using a retrieval basket and forceps, the foreign material was extracted piecemeal. Following removal, the distal airways were inspected and found to be patent and free of residual debris.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"OPERATIVE SUMMARY: Mr. Rodriguez underwent robotic bronchoscopy for a 22mm RLL nodule. The Galaxy system was deployed to RB10. TiLT+ imaging revealed a significant 2.3cm divergence due to atelectasis, which was corrected. rEBUS showed an adjacent view. We performed TBNA, forceps biopsy, and BAL. A fiducial marker was placed for SBRT. ROSE suggests non-small cell carcinoma.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"OPERATIVE SUMMARY: Ms. Walker presented for biopsy of a 22mm LUL nodule. Under GA, the Galaxy bronchoscope was navigated to LB1+2. Intra-operative TiLT+ tomosynthesis revealed a 1.5cm divergence secondary to respiratory motion. Following target update, an eccentric rEBUS view was obtained. Diagnostic sampling included TBNA, forceps biopsy, and brushing. A fiducial marker was placed to facilitate SBRT if needed. ROSE cytology showed benign lymphocytes.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"OPERATIVE SUMMARY: The patient underwent right-sided medical thoracoscopy. The pleural surfaces exhibited inflammatory changes without distinct nodularity. Eleven biopsies were obtained from the parietal pleura, with additional sampling of the diaphragm. Talc poudrage was administered for pleurodesis. The chest was drained and a tube secured.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Operation: Bronchoscopy with tumor destruction.
Technique: Cryotherapy.
Action: The LLL lateral basal tumor was localized via electromagnetic guidance. The cryoprobe was positioned centrally. Three cycles of freezing were administered to ablate the tissue. 
Outcome: Successful destruction of target lesion with adequate margins.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Operation: Robotic-assisted bronchoscopy.
Target: LLL mass.
Details: The Galaxy scope was steered to the target. TiLT+ imaging uncovered a 1.3cm shift. We realigned the virtual target. The site was sampled via needle aspiration and brushing.
Finding: Granulomas on ROSE.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"PET-avid lung nodule 28mm in LUL. General anesthesia. Noah Galaxy bronchoscope used. Navigated to LB3. TiLT+ sweep revealed 1.0cm divergence. Corrected. rEBUS eccentric. TBNA 22G, Cytology brush, BAL, and Gold fiducial placement performed. ROSE necrotic debris with rare atypical cells. Discharged stable.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
PET-avid lung nodule. 31mm nodule in RML. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB4. Registration accuracy: 2.1mm. Fluoroscopic guidance used to confirm scope position. rEBUS view: Concentric. Transbronchial needle aspiration (21G). Transbronchial forceps biopsy. Cytology brushings. ROSE Result: Atypical cells.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"PROCEDURE NARRATIVE: The subject, with a history of malignancy, presented for evaluation of an 11mm LLL nodule. Under general anesthesia, the Galaxy robotic bronchoscope was advanced to the LB7+8 segment. Intraoperative tomosynthesis (TiLT) revealed a 1.3cm target divergence attributable to atelectasis. Following virtual target update, tool position was verified. Sampling via 22G TBNA and cytology brush yielded granulomatous inflammation on preliminary review.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Adam Butler | MRN: 2590875 | DOB: 12/26/1981
Date of Service: 04/16/2025
Performing Physician: Michael Rodriguez, MD
Facility: Memorial Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC260F-OL8 linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 5 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 2 passes, short axis 17.1mm
     * Station 11R: 2 passes, short axis 8.4mm
     * Station 11L: 4 passes, short axis 22.2mm
     * Station 2R: 4 passes, short axis 21.9mm
     * Station 4L: 4 passes, short axis 18.5mm
   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.6 mm
   - Navigation to peripheral lesion: RLL lateral basal (B9)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 28.6mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 5 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:30 - 11:02 (92 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Michael Rodriguez, MD
04/16/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Adam Gray | MRN: 7189780 | DOB: 03/17/1971
Date of Service: 11/09/2025
Performing Physician: David Kim, MD
Facility: Regional Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2R: 4 passes, short axis 12.0mm
     * Station 10R: 3 passes, short axis 12.9mm
     * Station 2L: 2 passes, short axis 13.9mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.9 mm
   - Navigation to peripheral lesion: RLL medial basal (B7)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 23.3mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 5 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 10:30 - 12:49 (139 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

David Kim, MD
11/09/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Amanda Torres | MRN: 6864062 | DOB: 08/17/1975
Date of Service: 03/24/2024
Performing Physician: Andrew Nakamura, MD
Facility: Community Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11L: 4 passes, short axis 14.4mm
     * Station 4L: 3 passes, short axis 21.7mm
     * Station 10L: 2 passes, short axis 19.2mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 3.4 mm
   - Navigation to peripheral lesion: RLL superior (B6)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 16.3mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:15 - 09:49 (94 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Andrew Nakamura, MD
03/24/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Ashley Lewis | MRN: 5647458 | DOB: 09/13/1977
Date of Service: 06/28/2025
Performing Physician: Robert Patel, MD
Facility: Memorial Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4L: 2 passes, short axis 21.5mm
     * Station 10L: 2 passes, short axis 21.1mm
     * Station 11L: 3 passes, short axis 8.8mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.5 mm
   - Navigation to peripheral lesion: LUL superior lingula (B4)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 24.3mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 4 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:30 - 10:18 (108 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Robert Patel, MD
06/28/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Betty Bennett | MRN: 4977152 | DOB: 12/09/1967
Date of Service: 02/19/2024
Performing Physician: Brian O'Connor, MD
Facility: Methodist Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 19-gauge FNB/ProCore (Standard FNA)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11L: 4 passes, short axis 13.3mm
     * Station 7: 2 passes, short axis 10.0mm
     * Station 2L: 3 passes, short axis 24.9mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 3.2 mm
   - Navigation to peripheral lesion: RUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 14.5mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:15 - 11:31 (136 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Brian O'Connor, MD
02/19/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Brenda Howard | MRN: 8858293 | DOB: 11/18/1971
Date of Service: 07/17/2025
Performing Physician: Eric Johnson, MD
Facility: Regional Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC180F linear EBUS bronchoscope
   - Needle: 19-gauge FNB/ProCore (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 2 passes, short axis 21.2mm
     * Station 2L: 2 passes, short axis 8.8mm
     * Station 11L: 3 passes, short axis 13.8mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 1.5 mm
   - Navigation to peripheral lesion: RUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 19.4mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:30 - 11:41 (131 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Eric Johnson, MD
07/17/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Catherine Brooks | MRN: 7692229 | DOB: 05/07/1976
Date of Service: 07/31/2024
Performing Physician: Lisa Thompson, MD
Facility: Baptist Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC260F-OL8 linear EBUS bronchoscope
   - Needle: 22-gauge FNB/ProCore (Standard FNA)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2R: 3 passes, short axis 15.3mm
     * Station 11R: 3 passes, short axis 23.0mm
     * Station 4R: 3 passes, short axis 15.0mm
     * Station 7: 2 passes, short axis 13.7mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.6 mm
   - Navigation to peripheral lesion: RML lateral (B4)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 30.4mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RML lobe
   - Forceps biopsies obtained: 4 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:30 - 10:49 (79 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Lisa Thompson, MD
07/31/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Christina Jimenez | MRN: 5832480 | DOB: 09/06/1967
Date of Service: 02/12/2024
Performing Physician: David Kim, MD
Facility: Presbyterian Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 3 passes, short axis 9.9mm
     * Station 4L: 2 passes, short axis 13.8mm
     * Station 4R: 3 passes, short axis 21.4mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.5 mm
   - Navigation to peripheral lesion: RML lateral (B4)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 16.9mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RML lobe
   - Forceps biopsies obtained: 8 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:00 - 09:40 (100 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

David Kim, MD
02/12/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Debra Thomas | MRN: 4765883 | DOB: 04/13/1979
Date of Service: 04/04/2025
Performing Physician: Eric Johnson, MD
Facility: St. Luke's Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 19-gauge FNB/ProCore (FNB/ProCore)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 3 passes, short axis 11.4mm
     * Station 7: 3 passes, short axis 8.1mm
     * Station 2R: 2 passes, short axis 13.6mm
     * Station 4R: 3 passes, short axis 22.2mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 3.2 mm
   - Navigation to peripheral lesion: RLL posterior basal (B10)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 19.5mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:15 - 10:46 (91 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Eric Johnson, MD
04/04/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Diane Hall | MRN: 3940932 | DOB: 04/10/1968
Date of Service: 06/02/2024
Performing Physician: Brian O'Connor, MD
Facility: Cleveland Clinic

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC180F linear EBUS bronchoscope
   - Needle: 22-gauge Acquire (FNB/ProCore)
   - STATIONS SAMPLED: 5 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 4 passes, short axis 16.6mm
     * Station 4R: 2 passes, short axis 13.5mm
     * Station 2L: 4 passes, short axis 11.0mm
     * Station 2R: 4 passes, short axis 21.8mm
     * Station 4L: 3 passes, short axis 22.9mm
   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.2 mm
   - Navigation to peripheral lesion: LUL inferior lingula (B5)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 31.2mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:15 - 08:33 (78 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Brian O'Connor, MD
06/02/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Edward Mendoza | MRN: 3451018 | DOB: 07/26/1941
Date of Service: 06/13/2025
Performing Physician: Lisa Thompson, MD
Facility: Community Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Acquire)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 3 passes, short axis 11.9mm
     * Station 4R: 2 passes, short axis 21.4mm
     * Station 7: 4 passes, short axis 16.1mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.4 mm
   - Navigation to peripheral lesion: RLL posterior basal (B10)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 23.3mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:00 - 10:05 (125 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Lisa Thompson, MD
06/13/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Elizabeth Martinez | MRN: 5918228 | DOB: 07/02/1973
Date of Service: 12/23/2024
Performing Physician: David Kim, MD
Facility: Regional Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 22-gauge Acquire (FNB/ProCore)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2L: 4 passes, short axis 13.8mm
     * Station 4R: 3 passes, short axis 23.9mm
     * Station 11R: 3 passes, short axis 19.6mm
     * Station 11L: 2 passes, short axis 17.4mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.5 mm
   - Navigation to peripheral lesion: RML medial (B5)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 20.0mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RML lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 10:45 - 12:12 (87 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

David Kim, MD
12/23/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Heather Ramos | MRN: 4131845 | DOB: 01/13/1969
Date of Service: 02/21/2025
Performing Physician: Amanda Foster, MD
Facility: Baptist Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 22-gauge FNB/ProCore (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4L: 3 passes, short axis 9.1mm
     * Station 2R: 3 passes, short axis 14.9mm
     * Station 2L: 2 passes, short axis 13.2mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.8 mm
   - Navigation to peripheral lesion: RLL superior (B6)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 27.1mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 5 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:15 - 11:03 (108 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Amanda Foster, MD
02/21/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Heather Turner | MRN: 5220444 | DOB: 06/07/1956
Date of Service: 10/16/2024
Performing Physician: Andrew Nakamura, MD
Facility: Regional Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 7: 4 passes, short axis 19.5mm
     * Station 11L: 2 passes, short axis 18.1mm
     * Station 10R: 4 passes, short axis 17.1mm
     * Station 4L: 3 passes, short axis 11.5mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 1.6 mm
   - Navigation to peripheral lesion: LUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 25.0mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 4 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:30 - 09:33 (123 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Andrew Nakamura, MD
10/16/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Helen Henderson | MRN: 7143762 | DOB: 01/24/1944
Date of Service: 11/04/2024
Performing Physician: Brian O'Connor, MD
Facility: Veterans Affairs Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11R: 3 passes, short axis 24.9mm
     * Station 2L: 2 passes, short axis 14.7mm
     * Station 4R: 3 passes, short axis 13.0mm
     * Station 11L: 3 passes, short axis 19.1mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.8 mm
   - Navigation to peripheral lesion: RUL apical (B1)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 22.6mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 4 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:45 - 09:56 (131 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Brian O'Connor, MD
11/04/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Kyle Ross | MRN: 2071096 | DOB: 10/08/1961
Date of Service: 08/12/2024
Performing Physician: Robert Patel, MD
Facility: Presbyterian Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10L: 3 passes, short axis 13.0mm
     * Station 4L: 2 passes, short axis 15.7mm
     * Station 11L: 2 passes, short axis 19.4mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.8 mm
   - Navigation to peripheral lesion: RUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 21.6mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 8 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:15 - 09:40 (85 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Robert Patel, MD
08/12/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Laura Martin | MRN: 8897222 | DOB: 04/16/1947
Date of Service: 01/08/2025
Performing Physician: Jennifer Walsh, MD
Facility: Baptist Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC180F linear EBUS bronchoscope
   - Needle: 19-gauge FNB/ProCore (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11R: 4 passes, short axis 13.7mm
     * Station 2L: 2 passes, short axis 8.4mm
     * Station 4L: 4 passes, short axis 19.6mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.8 mm
   - Navigation to peripheral lesion: LLL lateral basal (B9)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 23.2mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LLL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:45 - 10:30 (105 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Jennifer Walsh, MD
01/08/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Margaret Murphy | MRN: 7563411 | DOB: 07/27/1971
Date of Service: 11/01/2024
Performing Physician: Maria Santos, MD
Facility: Memorial Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 22-gauge Acquire (Standard FNA)
   - STATIONS SAMPLED: 5 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11L: 4 passes, short axis 21.6mm
     * Station 2L: 4 passes, short axis 14.5mm
     * Station 7: 3 passes, short axis 21.8mm
     * Station 11R: 3 passes, short axis 15.0mm
     * Station 10R: 4 passes, short axis 21.4mm
   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 3.2 mm
   - Navigation to peripheral lesion: LLL anteromedial basal (B7+8)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 31.9mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LLL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:15 - 10:14 (119 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Maria Santos, MD
11/01/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Mark James | MRN: 2530243 | DOB: 06/21/1959
Date of Service: 04/11/2024
Performing Physician: Steven Park, MD
Facility: University Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 7: 2 passes, short axis 8.3mm
     * Station 11R: 4 passes, short axis 19.4mm
     * Station 11L: 4 passes, short axis 14.1mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.5 mm
   - Navigation to peripheral lesion: LUL superior lingula (B4)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 34.7mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 5 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:00 - 09:02 (122 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Steven Park, MD
04/11/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Michelle Watson | MRN: 4507663 | DOB: 06/09/1940
Date of Service: 11/13/2025
Performing Physician: Lisa Thompson, MD
Facility: Baptist Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (Standard FNA)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4R: 2 passes, short axis 23.5mm
     * Station 4L: 4 passes, short axis 14.3mm
     * Station 10R: 2 passes, short axis 11.1mm
     * Station 2L: 2 passes, short axis 20.1mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 3.2 mm
   - Navigation to peripheral lesion: RML medial (B5)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 31.5mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RML lobe
   - Forceps biopsies obtained: 5 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:30 - 10:15 (105 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Lisa Thompson, MD
11/13/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Nancy Evans | MRN: 2100673 | DOB: 05/17/1977
Date of Service: 10/18/2024
Performing Physician: Sarah Chen, MD
Facility: Academic Health System

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC190F linear EBUS bronchoscope
   - Needle: 22-gauge Acquire (Acquire)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4R: 4 passes, short axis 22.1mm
     * Station 2R: 4 passes, short axis 14.8mm
     * Station 2L: 2 passes, short axis 15.4mm
     * Station 10L: 3 passes, short axis 10.7mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.2 mm
   - Navigation to peripheral lesion: LUL inferior lingula (B5)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 30.2mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 8 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:30 - 10:08 (98 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Sarah Chen, MD
10/18/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Nancy Smith | MRN: 7880751 | DOB: 04/01/1967
Date of Service: 03/03/2025
Performing Physician: Brian O'Connor, MD
Facility: Presbyterian Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Acquire)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 3 passes, short axis 15.1mm
     * Station 4L: 2 passes, short axis 21.5mm
     * Station 4R: 2 passes, short axis 12.6mm
     * Station 11L: 4 passes, short axis 22.8mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.5 mm
   - Navigation to peripheral lesion: RML lateral (B4)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 15.4mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RML lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 09:00 - 10:45 (105 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Brian O'Connor, MD
03/03/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Peter Reyes | MRN: 9331329 | DOB: 04/25/1948
Date of Service: 01/01/2025
Performing Physician: Maria Santos, MD
Facility: Memorial Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC180F linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2L: 2 passes, short axis 19.0mm
     * Station 10L: 4 passes, short axis 22.7mm
     * Station 7: 4 passes, short axis 16.8mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 3.0 mm
   - Navigation to peripheral lesion: RUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 16.3mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Augmented fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:30 - 08:45 (75 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Maria Santos, MD
01/01/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Rachel Castillo | MRN: 2839223 | DOB: 11/08/1973
Date of Service: 10/15/2025
Performing Physician: Steven Park, MD
Facility: Regional Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 22-gauge FNB/ProCore (FNB/ProCore)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4L: 2 passes, short axis 18.3mm
     * Station 10R: 4 passes, short axis 14.8mm
     * Station 4R: 4 passes, short axis 20.9mm
     * Station 7: 2 passes, short axis 24.0mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Monarch Robotic Bronchoscopy System (Auris Health (J&J))
   - Registration method: CT-to-body
   - Registration accuracy: 2.0 mm
   - Navigation to peripheral lesion: RUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 30.9mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RUL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:15 - 09:32 (77 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Steven Park, MD
10/15/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Rebecca Richardson | MRN: 3827147 | DOB: 02/12/1952
Date of Service: 03/12/2025
Performing Physician: Katherine Lee, MD
Facility: Methodist Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 4 passes, short axis 8.4mm
     * Station 10L: 3 passes, short axis 13.7mm
     * Station 2L: 3 passes, short axis 11.1mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.8 mm
   - Navigation to peripheral lesion: LUL anterior (B3)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 29.8mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 8 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 10:15 - 11:58 (103 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Katherine Lee, MD
03/12/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Robert Cruz | MRN: 7013670 | DOB: 07/03/1958
Date of Service: 05/28/2024
Performing Physician: Steven Park, MD
Facility: Baptist Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Fujifilm EB-580S linear EBUS bronchoscope
   - Needle: 22-gauge Acquire (Standard FNA)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 11R: 2 passes, short axis 22.0mm
     * Station 4R: 4 passes, short axis 13.7mm
     * Station 11L: 3 passes, short axis 18.9mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.8 mm
   - Navigation to peripheral lesion: RLL superior (B6)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 27.5mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: RLL lobe
   - Forceps biopsies obtained: 4 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: CBCT
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:30 - 10:10 (100 minutes)
ANESTHESIA: General anesthesia (ASA 4)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Steven Park, MD
05/28/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Ryan Watson | MRN: 6180156 | DOB: 06/01/1959
Date of Service: 03/20/2025
Performing Physician: Brian O'Connor, MD
Facility: Northwestern Memorial Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 22-gauge Standard FNA (FNB/ProCore)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 10R: 3 passes, short axis 15.5mm
     * Station 10L: 2 passes, short axis 21.7mm
     * Station 11R: 3 passes, short axis 20.5mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.8 mm
   - Navigation to peripheral lesion: LLL lateral basal (B9)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Adjacent view of 29.4mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LLL lobe
   - Forceps biopsies obtained: 6 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 10:15 - 11:36 (81 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Brian O'Connor, MD
03/20/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Samantha Coleman | MRN: 2526522 | DOB: 03/26/1961
Date of Service: 10/15/2024
Performing Physician: David Kim, MD
Facility: UCLA Medical Center

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Olympus BF-UC260F-OL8 linear EBUS bronchoscope
   - Needle: 19-gauge FNB/ProCore (Acquire)
   - STATIONS SAMPLED: 4 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2L: 4 passes, short axis 20.2mm
     * Station 4R: 4 passes, short axis 17.2mm
     * Station 7: 3 passes, short axis 11.6mm
     * Station 11R: 3 passes, short axis 17.2mm

   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.9 mm
   - Navigation to peripheral lesion: LLL posterior basal (B10)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Eccentric view of 27.1mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LLL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 3 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 10:30 - 11:55 (85 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

David Kim, MD
10/15/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Sharon Ward | MRN: 9758601 | DOB: 06/20/1950
Date of Service: 07/25/2024
Performing Physician: Rachel Goldman, MD
Facility: Community Hospital

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 21-gauge Standard FNA (Acquire)
   - STATIONS SAMPLED: 3 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 4L: 2 passes, short axis 24.4mm
     * Station 7: 3 passes, short axis 20.3mm
     * Station 10R: 4 passes, short axis 20.4mm


   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Galaxy Robotic Bronchoscopy System (Noah Medical)
   - Registration method: CT-to-body
   - Registration accuracy: 2.3 mm
   - Navigation to peripheral lesion: LUL inferior lingula (B5)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 20.2mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 4 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Radial EBUS
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 07:45 - 09:38 (113 minutes)
ANESTHESIA: General anesthesia (ASA 3)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Rachel Goldman, MD
07/25/2024",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE - CODING DOCUMENTATION

Patient: Stephen James | MRN: 5664513 | DOB: 01/10/1945
Date of Service: 08/17/2025
Performing Physician: Rachel Goldman, MD
Facility: Academic Health System

PROCEDURES PERFORMED WITH CPT CODE JUSTIFICATION:

1. ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (CPT 31653)
   - Equipment: Pentax EB-1990i linear EBUS bronchoscope
   - Needle: 22-gauge FNB/ProCore (Acquire)
   - STATIONS SAMPLED: 5 DISTINCT MEDIASTINAL/HILAR LYMPH NODE STATIONS
     * Station 2L: 3 passes, short axis 14.8mm
     * Station 4L: 2 passes, short axis 24.3mm
     * Station 10R: 2 passes, short axis 12.9mm
     * Station 10L: 3 passes, short axis 18.8mm
     * Station 11L: 2 passes, short axis 18.7mm
   - ROSE performed at each station: YES
   - Code justification: ≥3 mediastinal/hilar lymph node stations sampled under real-time ultrasound guidance

2. COMPUTER-ASSISTED IMAGE-GUIDED NAVIGATION (CPT +31627)
   - Platform: Ion Robotic Bronchoscopy System (Intuitive Surgical)
   - Registration method: CT-to-body
   - Registration accuracy: 1.5 mm
   - Navigation to peripheral lesion: LUL apicoposterior (B1+2)
   - Code justification: Computer-assisted electromagnetic navigation used to guide bronchoscope to peripheral lung lesion beyond direct visualization

3. ENDOBRONCHIAL ULTRASOUND FOR PERIPHERAL LESION (CPT +31654)
   - Equipment: 20 MHz radial EBUS miniprobe
   - Probe visualization: Concentric view of 14.0mm lesion
   - Used to confirm catheter position relative to peripheral target
   - Code justification: Radial EBUS performed to localize peripheral pulmonary lesion during bronchoscopic intervention

4. TRANSBRONCHIAL LUNG BIOPSY, SINGLE LOBE (CPT 31628)
   - Location: LUL lobe
   - Forceps biopsies obtained: 7 specimens
   - Additional TBNA: 2 passes
   - Brushings: 2 specimens
   - Tool-in-lesion confirmed via: Fluoroscopy
   - Code justification: Multiple transbronchial biopsies obtained from single lobe for tissue diagnosis

SPECIMEN DOCUMENTATION:
- EBUS-TBNA specimens: Cytology, cell block, flow cytometry
- Transbronchial biopsies: Surgical pathology, molecular testing
- Brushings: Cytology
- BAL: Bacterial, fungal, AFB cultures

PROCEDURE TIME: 08:15 - 10:09 (114 minutes)
ANESTHESIA: General anesthesia (ASA 2)
COMPLICATIONS: None

CPT CODES SUBMITTED: 31653, 31627, 31654, 31628
TOTAL FACILITY RVU: 18.41
ESTIMATED FACILITY PAYMENT: $595

Attestation: I personally performed all documented procedures. Documentation supports medical necessity and code selection.

Rachel Goldman, MD
08/17/2025",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"PROCEDURE NOTE: Bedside Therapeutic Bronchoscopy.
INDICATION: Acute hypoxemic respiratory failure secondary to severe pneumonia and suspected mucus plugging.
PROCEDURE: The bronchoscope was introduced via the endotracheal tube. Significant tenacious, purulent secretions were identified obstructing the right bronchial tree. Extensive therapeutic aspiration and saline lavage were performed until the airways were patent. The left lung was relatively clear. 
IMPRESSION: Successful clearance of mucous plugs leading to immediate improvement in ventilator mechanics.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"PROCEDURE NOTE: Bronchoscopic Dilation of Tracheal Stenosis.
INDICATION: Symptomatic idiopathic subglottic stenosis.
FINDINGS: A circumferential stricture was identified in the proximal trachea reducing the lumen by 60%. 
INTERVENTION: Radial dilation was performed using a CRE wire-guided balloon with progressive inflation to 12mm. Post-dilation inspection revealed significant improvement in airway caliber to approximately 80% of normal.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"PROCEDURE NOTE: Combined EBUS-TBNA and Endobronchial Biopsy.
INDICATION: Lung mass with adenopathy.
EBUS: Stations 4R and 7 were sampled and ROSE confirmed malignancy.
BRONCHOSCOPY: The RUL lesion was visualized endobronchially. Forceps biopsy and brushing were performed. 
SUMMARY: N2 disease with RUL primary.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"PROCEDURE NOTE: Diagnostic Bronchoscopy with Electromagnetic Navigation.
INDICATION: 19mm PET-positive LLL nodule.
TECHNIQUE: Navigation was performed to the target lesion. Radial EBUS confirmed a concentric orientation. Transbronchial needle aspiration, forceps biopsy, and brushing were performed. Fluoroscopy time was 5.1 minutes. Post-procedure chest x-ray was negative for pneumothorax.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
PROCEDURE NOTE: Left-sided diagnostic thoracoscopy was undertaken. Examination revealed extensive fibrinous adhesions consistent with trapped lung physiology. Parietal and visceral surfaces were inspected. Fluid was evacuated. A chest tube was placed to water seal. The lung was noted to expand.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"PROCEDURE NOTE: Left-sided medical thoracoscopy revealed tumor implants on the visceral pleura. Eleven biopsies were obtained from the parietal pleura, along with diaphragmatic sampling. Talc poudrage was utilized for pleurodesis. Fluid was evacuated and a chest tube positioned.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
PROCEDURE NOTE: Right-sided diagnostic medical thoracoscopy was performed. Inspection revealed significant thickening of the parietal pleura studded with nodularity. The visceral and diaphragmatic surfaces were visualized. Fluid was completely evacuated under direct vision. A thoracostomy tube was placed to water seal. The lung was observed to re-expand.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
PROCEDURE NOTE: Right-sided medical thoracoscopy was performed. Inspection revealed inflammatory changes without nodularity. Parietal and visceral surfaces were visualized. Talc poudrage was performed for pleurodesis. Fluid was evacuated. A chest tube was placed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"PROCEDURE NOTE: The patient underwent robotic bronchoscopy for a dominant 25mm RLL nodule. The Galaxy system was employed. Navigation to RB9 was successful, though TiLT+ imaging revealed a 1.5cm divergence requiring adjustment. Verification was achieved via adjacent rEBUS signal. TBNA and brushing were performed. Rapid on-site evaluation showed no evidence of malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"PROCEDURE NOTE: The patient, a 48-year-old female presenting with bilateral hilar lymphadenopathy, underwent flexible fiberoptic bronchoscopy. Under moderate sedation, the tracheobronchial tree was visualized, revealing diffuse mucosal nodularity consistent with a granulomatous process. A bronchoalveolar lavage (BAL) was performed in the right middle lobe. Subsequently, fluoroscopically guided transbronchial forceps biopsies were obtained from the right lower lobe medial basal segment to secure a histological diagnosis. The patient tolerated the procedure without adverse events.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"PROCEDURE NOTE: Tube Thoracostomy.
INDICATION: Primary spontaneous pneumothorax.
PROCEDURE: The right hemithorax was prepped. Local anesthesia was infiltrated. A 28 French chest tube was inserted via blunt dissection at the 5th intercostal space. Significant air release was confirmed. The tube was secured and placed to suction. Post-procedure imaging confirmed lung re-expansion.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"PROCEDURE NOTE: Ultrasound-Guided Left Thoracentesis.
INDICATION: Symptomatic pleural effusion refractory to diuretic therapy.
DESCRIPTION: The largest fluid pocket was localized via bedside ultrasound. Under local anesthesia, a catheter was introduced using Seldinger technique. 1300 mL of serous fluid was drained for symptomatic relief and diagnostic analysis. Post-procedure ultrasound ruled out pneumothorax.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"PROCEDURE RECORD: Right-sided medical thoracoscopy was initiated for exudative effusion. Visual inspection demonstrated significant inflammatory changes lacking distinct nodularity. Extensive sampling was conducted, with twelve biopsies harvested from the parietal pleura and additional tissue from the diaphragm for immunohistochemistry. Fluid was fully evacuated. No chemical pleurodesis was undertaken. A thoracostomy tube was positioned.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"PROCEDURE: A 9mm RLL nodule was investigated using the Galaxy robotic scope. Navigation to RB10 was verified with fluoroscopy and a concentric rEBUS view. Diagnostic maneuvers included TBNA, forceps biopsy, brushing, and a bronchoalveolar lavage (BAL) of the target segment. ROSE was negative for malignancy.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"PROCEDURE: Electromagnetic Navigation Bronchoscopy with Radial EBUS and Biopsy.
INDICATION: 9mm ground-glass nodule, LUL.
FINDINGS: The lesion was successfully localized using electromagnetic navigation. Radial EBUS demonstrated a concentric return, confirming tool-in-lesion status. Diagnostic sampling was performed via transbronchial needle aspiration, forceps biopsy, and cytology brush. No immediate complications were noted.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"PROCEDURE: Electromagnetic navigation bronchoscopy (superDimension) was employed to access a peripheral LUL nodule. Localization was verified with radial EBUS and cone-beam CT. Microwave ablation was performed using the Emprint system (65W, 360s). Post-procedural imaging revealed a left apical pneumothorax. A 10 French pigtail thoracostomy tube was inserted using fluoroscopic guidance without difficulty.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"PROCEDURE: Emergent Bronchoscopy with Radiofrequency Ablation for Hemostasis and Tumor Control.
INDICATION: 72-year-old male status post complicated TTNA with active hemothorax and parenchymal bleeding.
DESCRIPTION: Under general anesthesia, the airway was inspected. Utilizing ENB, the RFA catheter was advanced to the site of the bleeding tumor in the RUL. A modified RFA protocol was employed: initially low-wattage energy was applied to effect hemostasis via tissue coagulation, followed by standard high-temperature ablation to treat the underlying malignancy. Immediate cessation of bleeding was observed.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"PROCEDURE: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
FINDINGS: The mediastinum was systematically staged. Enlarged lymph nodes were identified at stations 7 (subcarinal) and 11R (right interlobar). TBNA was performed at both stations under real-time ultrasound guidance. Cytopathology suggests a granulomatous process consistent with sarcoidosis.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"PROCEDURE: Evaluation of a 24mm RUL nodule was performed using the Noah Galaxy robotic platform. Navigation to RB2 was achieved with 3.2mm accuracy. Fluoroscopy confirmed alignment. rEBUS demonstrated an adjacent lesion signature. TBNA and forceps biopsies were obtained, along with brushings. ROSE suggested granulomatous inflammation.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"PROCEDURE: Linear endobronchial ultrasound (EBUS) was performed for mediastinal staging. The bronchoscope was advanced, and lymph node stations 4R, 7, and 11R were systematically identified and sampled using a 21-gauge aspiration needle. Rapid On-Site Evaluation (ROSE) confirmed malignancy at station 4R, consistent with non-small cell lung cancer, while stations 7 and 11R yielded benign lymphocytes.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"PROCEDURE: Robotic-assisted bronchoscopy was performed for a right lower lobe pulmonary nodule. The Ion system was utilized with successful registration. Radial EBUS confirmed a concentric solid lesion. Sampling was conducted via transbronchial needle aspiration, cytology brushing, and forceps biopsies under fluoroscopic and Cone-Beam CT guidance. Rapid on-site evaluation suggested non-small cell carcinoma.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"PROCEDURE: The patient presented for staging of a left upper lobe adenocarcinoma. Linear EBUS was utilized to visualize and sample lymph nodes at stations 4L, 7, and 11L. A 22-gauge needle was employed for transbronchial needle aspiration. Rapid on-site evaluation demonstrated adequate lymphocytic cellularity in all samples without definitive evidence of metastatic disease.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"PROCEDURE: The patient underwent bronchoscopic evaluation for interstitial lung disease. Following intubation, the bronchoscope was navigated to the left lower lobe. Radial endobronchial ultrasound (R-EBUS) was utilized to select a biopsy site free of major vascular structures. A 1.9 mm cryoprobe was employed to obtain three transbronchial cryobiopsies, supplemented by one standard forceps biopsy. A bronchial blocker was deployed for prophylactic hemorrhage control.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"PROCEDURE: The patient was intubated for robotic bronchoscopy targeting a 9mm RLL nodule. The Galaxy system was utilized. Registration was performed (3.8mm error). Crucially, a TiLT+ spin demonstrated 1.7cm of target divergence. The virtual target was updated to match reality. rEBUS showed a concentric view. We performed TBNA, forceps biopsies, and brushing. A gold fiducial marker was deployed under TiLT-augmented fluoroscopy for future SBRT.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"PROCEDURE: The patient, with a history of small cell lung cancer, presented with mediastinal adenopathy. Systematic EBUS examination identified targetable nodes at stations 2R, 4R, 7, and 10R. TBNA was performed at all four stations using a 21-gauge needle. Cytopathology confirmed recurrent small cell carcinoma at station 7.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
Patricia has a spot in the RLL used the ion robot to get there. Radial probe showed it nicely. Did a needle stick and then grabbed some biopsies with the forceps and a brush. Pathologist thinks its cancer. No bleeding or popped lung. She went home.,1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
Peripheral pulmonary nodule 13mm in LLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB10. TiLT+ sweep revealed 1.9cm divergence. Corrected. rEBUS adjacent. TBNA 21G performed. ROSE Suspicious for non-small cell carcinoma.,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
Peripheral pulmonary nodule 8mm in Lingula. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB4. TiLT+ sweep revealed 1.1cm divergence. Corrected. rEBUS eccentric. TBNA 22G and Cytology brushings performed. ROSE Malignant cells identified consistent with squamous cell carcinoma.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Peripheral pulmonary nodule. 31mm nodule in RLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB9. TiLT+ sweep revealed 1.8cm divergence. Target updated. rEBUS view: Concentric. TBNA (21G). Transbronchial forceps biopsy. Cytology brushings. Gold fiducial marker placed. ROSE Result: Malignant cells identified, consistent with squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
Peripheral pulmonary nodule. 9mm nodule in RLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB10. Fluoroscopic guidance used. rEBUS view: Concentric. TBNA (22G). Transbronchial forceps biopsy. Cytology brushings. Bronchoalveolar lavage performed. ROSE Result: No evidence of malignant neoplasm.,1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Peter Brown, MRN 8319821, a 60-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Cleveland Clinic on 09/29/2024. The indication was lung nodule evaluation with mediastinal lymphadenopathy workup with a 31.2mm solid lesion in the LUL inferior lingula (B5), bronchus sign positive, PET SUV max 5.0. The patient was ASA class 2 with smoking history of None pack-years (never). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC180F bronchoscope with 22-gauge Acquire needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (16.6mm, 4 passes, ROSE: Malignant - NSCLC NOS); station 4R (13.5mm, 2 passes, ROSE: Malignant - small cell carcinoma); station 2L (11.0mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy); station 2R (21.8mm, 4 passes, ROSE: Adequate lymphocytes, no malignancy); station 4L (22.9mm, 3 passes, ROSE: Atypical cells). Rapid on-site evaluation was available for all stations.

The Monarch robotic bronchoscopy system (Auris Health (J&J)) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.2mm. The robotic catheter was advanced to the LUL inferior lingula (B5) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 78 minutes. Attending physician: Brian O'Connor, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Proc: Lt Diagnostic Thoracoscopy.
Findings: Fibrinous adhesions, trapped lung.
Actions:
- Adhesions visualized.
- Fluid evacuated.
- Chest tube placed.
Status: Lung expanded (despite trapped lung diagnosis, note says lung expanded - sticking to source text).",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Proc: Lt Thoracoscopy w/ Biopsy & Talc.
Findings: Visceral tumor implants.
Actions:
- 11 biopsies parietal pleura.
- Diaphragmatic biopsies.
- Talc poudrage.
- Tube placed.
Status: No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Proc: Lt Thoracoscopy w/ Biopsy.
Findings: Inflammatory changes.
Actions:
- 12 biopsies parietal pleura.
- Diaphragmatic biopsies.
- Fluid evacuated.
- Tube placed.
- No talc.
Status: No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Proc: Rt Diagnostic Thoracoscopy.
Findings: Thickened parietal pleura, nodules.
Actions:
- Visual inspection.
- Fluid evacuated.
- Chest tube placed.
Status: Lung expanded. No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Proc: Rt Med Thoracoscopy w/ Biopsy & Talc.
Findings: Diffuse pleural nodularity.
Actions:
- 7 biopsies taken from parietal pleura.
- Diaphragmatic biopsies taken.
- Talc poudrage performed.
- Fluid evacuated.
- Chest tube placed.
Status: Hemostasis achieved. No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Proc: Rt Med Thoracoscopy w/ Biopsy.
Findings: Inflammatory changes. No nodules.
Actions:
- 12 biopsies from parietal pleura.
- Diaphragmatic biopsies taken.
- Fluid evacuated.
- Chest tube placed.
- No pleurodesis performed.
Status: Stable.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Proc: Rt Thoracoscopy w/ Biopsy & Talc.
Findings: Inflammatory changes.
Actions:
- 11 biopsies parietal pleura.
- Diaphragmatic biopsies.
- Talc poudrage.
- Tube placed.
Status: No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Proc: Rt Thoracoscopy w/ Biopsy & Talc.
Findings: Malignant nodules.
Actions:
- 10 biopsies parietal pleura.
- Diaphragmatic biopsies.
- Talc poudrage.
- Tube placed.
Status: No leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Proc: Rt Thoracoscopy w/ Pleurodesis.
Findings: Inflammatory changes.
Actions:
- Visualization.
- Talc poudrage.
- Fluid evacuated.
- Tube placed.
Status: Lung expanded.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Proc: Rt Thoracoscopy, Biopsy, Pleurodesis.
Findings: Mass on diaphragmatic pleura.
Actions:
- 12 biopsies parietal pleura.
- Diaphragmatic biopsies.
- Talc poudrage.
- Tube placed.
Status: Hemostasis confirmed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Procedure Codes Justification:
- 31629 (TBNA): Performed on Lingula lesion using 22G needle.
- 31623 (Brush): Cytology brushing performed on same site.
- 31627 (Navigational Bronchoscopy): Galaxy robotic system used for guidance.
- 31654 (rEBUS): Radial probe used for localization.
Note: TiLT+ tomosynthesis was utilized for divergence correction (1.8cm).",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Procedure Note
Patient: Christopher Davis
Attending: Dr. Chen
Steps:
1. GA/Intubation.
2. Navigated to RUL posterior nodule.
3. Confirmed with REBUS and Cone Beam CT.
4. Microwave ablation: 65W for 5 mins.
5. Re-imaged: Good ablation zone.
6. Extubated.
Plan: Admit.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure Note
Patient: Marvin Android
Procedure: RFA RLL.
Steps:
1. Navigated to RLL basal segment.
2. Confirmed with CBCT.
3. RFA Cycle 1: 8 mins @ 90C.
4. Repositioned 5mm proximal.
5. RFA Cycle 2: 6 mins @ 90C.
6. Extubated.
Plan: Admit.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure Note
Patient: Ms. King
Attending: Dr. Allen
Steps:
1. Moderate sedation administered.
2. Airway inspected; cobblestoning seen.
3. BAL performed in RML.
4. Transbronchial biopsies taken from RLL (medial basal) under fluoro.
5. Hemostasis achieved.
6. Post-op CXR negative.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"Procedure Note - Pulmonary
Patient: Isabella Torres
Attending: Dr. Zhang

Steps:
1. Time out. GA induced. 8.0 ETT placed.
2. Scope passed. Airways patent.
3. Veran navigation to LLL lateral basal nodule.
4. Radial EBUS confirmed lesion (26mm).
5. Cryoprobe placed. 3 freeze cycles performed.
6. No bleeding. Extubated.

Plan: Admit for obs.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure Note: Right Thoracoscopy
Steps:
1. Time out/Sedation.
2. Port created 6th ICS mid-axillary.
3. Scope inserted; diffuse nodules seen.
4. Biopsies x7 taken from parietal pleura; additional from diaphragm.
5. Talc poudrage performed for pleurodesis.
6. Chest tube placed to suction.
Complications: None.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Procedure: BT Session 2
Patient: Danielle Morgan
1. General Anesthesia.
2. Treated RLL (48 hits) and LLL (44 hits).
3. Total 92 activations.
4. Pt got wheezy, gave albuterol/solumedrol.
5. Improved.
6. Extubated.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"Procedure: Bronchoscopic thermal ablation.
Modality: Radiofrequency energy.
Action: The RLL target was localized. The RFA electrode was deployed. Overlapping thermal treatments were administered to destroy the malignancy. 
Result: Successful tumor ablation.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure: Bronchoscopic thermal therapy.
Indication: Iatrogenic hemorrhage and malignancy.
Action: The hemorrhagic site was accessed via navigation. Thermal energy was applied to coagulate vessels and destroy neoplastic tissue. 
Result: Hemostasis and tumor ablation achieved.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure: Bronchoscopic tumor destruction.
Modality: Microwave energy.
Action: The RUL neoplasm was targeted. The microwave antenna was positioned. Thermal energy was delivered to ablate the mass. 
Result: Therapeutic destruction of the tumor.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure: Bronchoscopy (ICU)
Resident: Dr. Resident
Attending: Dr. Holloway
1. Time out.
2. Scope down ETT.
3. R lung full of mucus. Suctioned.
4. Lavaged with saline.
5. Cleared RML/RLL.
6. L lung okay.
7. Pt tolerated well.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"Procedure: Chest Tube
Patient: Thomas Nguyen
1. Prep R chest.
2. Lidocaine/Fentanyl.
3. Cut at 5th ICS.
4. Clamp dissection into pleura.
5. Finger sweep.
6. Tube (28Fr) in.
7. Stitch and tape.
8. CXR: Lung up.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"Procedure: Computer-assisted navigational bronchoscopy.
Targets: RUL and RLL peripheral lesions.
Verification: Radial endobronchial ultrasound.
Intervention: Transbronchial biopsy of multiple lobes.
Outcome: Tissue acquisition successful.",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Procedure: Cryobiopsy ILD
Patient: Jennifer Adams, 56F
Steps:
1. GA, 8.5 ETT.
2. Scope to LLL.
3. Radial EBUS to clear site.
4. Freezing: 3 passes with cryoprobe.
5. Forceps: 1 pass.
6. Balloon up for bleeding control.
Plan: Admit for obs.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"Procedure: Diagnostic pleuroscopy with tissue sampling.
Findings: Diffuse pleural nodularity.
Action: Evacuation of effusion and biopsy of parietal pleura.
Disposition: Hospital admission.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Procedure: EBUS
Patient: Catherine Earnshaw
Station 7: 31mm. 5 passes. ROSE adequate.
No other stations sampled.
Plan: Path pending.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Procedure: EBUS
Patient: Harleen Quinzel
Stations:
- 2R: Benign
- 4R: Malignant
- 4L: Benign
- 7: Malignant
- 11R: Benign
Plan: Oncology.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"Procedure: EBUS + RUL Bx
Patient: Newman Post
Steps:
1. EBUS 4R (Pos).
2. EBUS 7 (Pos).
3. Standard bronch RUL.
4. Biopsied mass x 4.
5. Brush x 2.
Plan: Discharge.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Procedure: EMN Bronch + MWA + Chest Tube
Patient: Teresa Murphy
Steps:
1. Navigated to LUL nodule with superDimension.
2. Confirmed with REBUS/CBCT.
3. Microwave ablation done.
4. Patient developed pneumothorax.
5. Placed pigtail chest tube.
Plan: Admit, watch chest tube.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"Procedure: EMN-guided microwave destruction of LUL nodule.
Details: The lesion was accessed via the superDimension platform. Ablation was executed at 65W. 
Adverse Event: Pneumothorax ensued.
Resolution: A pigtail catheter was inserted under imaging guidance. The patient was admitted.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"Procedure: Endosonographic nodal sampling.
Technique: Transbronchial needle aspiration under linear ultrasound guidance.
Targets: Subcarinal and right interlobar nodes.
Pathology: Granulomatous inflammation detected.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"Procedure: Flexible bronchoscopy with lavage and secretion clearance.
Context: ICU patient with atelectasis.
Findings: Inspissated mucus obstructing RLL.
Intervention: Vigorous lavage and aspiration performed. Obstructions eradicated.
Result: Airways patent.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"Procedure: Flexible bronchoscopy with lavage and transbronchial sampling.
Subject: Female with pulmonary nodules.
Findings: Mucosal nodularity.
Technique: Lavage was executed in the right middle lobe. Six transbronchial specimens were harvested from the right lower lobe medial basal segment utilizing fluoroscopy. 
Outcome: No hemorrhage or pneumothorax.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"Procedure: Galaxy RLL Biopsy
Pt: R. White
Target: 25mm RLL
1. Nav to RB9.
2. TiLT spin -> 1.5cm divergence.
3. Updated target.
4. rEBUS adjacent.
5. Needle x5, Brush x1.
6. ROSE negative.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Procedure: Image-guided tumor destruction.
Device: Microwave antenna.
Action: The RUL lesion was accessed via electromagnetic guidance. The probe was inserted and activated (65W). Thermal ablation was performed. 
Result: Coagulative necrosis of the target.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure: LLL Biopsy
Pt: 62F.
- Galaxy Nav to LB6.
- TiLT: 1.4cm divergence fixed.
- rEBUS: Adjacent.
- TBNA x7, Forceps x4, Brush.
- ROSE positive for Adeno.
Stable.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Procedure: LUL biopsy (Galaxy)
Steps:
- ETT.
- Nav to LB3.
- TiLT sweep: 1.0cm shift.
- rEBUS: Eccentric.
- TBNA x8.
- Brush x1.
- BAL.
- Marker placed.
ROSE: Atypical cells.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Procedure: Left Thoracoscopy
Steps:
1. Sedation.
2. Scope inserted left 6th ICS.
3. Findings: Inflammation.
4. Biopsies: 12 parietal + diaphragm.
5. Fluid drained.
6. Chest tube placed.
Plan: Path review.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Procedure: Linear EBUS-TBNA.
Scope: Four nodal stations (2R, 4R, 7, 10R) were aspirated.
Diagnosis: Recurrent small cell carcinoma identified at station 7.
Disposition: Admitted.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Procedure: Linear EBUS-TBNA.
Stations: 4R, 7, 11R.
Action: Aspiration of three nodal stations.
Findings: Malignancy detected at 4R. Other stations benign.
Disposition: Discharged.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Procedure: Linear EBUS-TBNA.
Target: Stations 4L, 7, 11L.
Action: Transbronchial needle aspiration performed at three distinct sites.
Findings: Lymphocytic material obtained; preliminary negative for metastasis.
Disposition: Discharged.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Procedure: Microwave Ablation
Patient: Minh Nguyen
Location: RUL anterior.
Steps:
1. Navigated to lesion (SuperDimension).
2. Confirmed with Radial EBUS.
3. Inserted Microwave catheter.
4. Ablated 60W for 6 mins.
5. Checked airway - clear.
Plan: Post-op CT.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Procedure: Navigational bronchoscopy with multimodal sampling.
Action: The LUL opacity was localized. The lesion was interrogated with radial ultrasound. Specimens were acquired via needle aspiration, forceps extraction, and mucosal brushing. 
Result: Diagnostic material obtained.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Procedure: Navigational bronchoscopy.
Action: The LLL lesion was localized. Concentric ultrasound confirmation was achieved. Tissue was harvested via aspiration, biopsy, and brushing. 
Result: Diagnostic procedure completed.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Procedure: Pleuroscopy
Patient: Evelyn Sanders
1. Port in R 6th ICS.
2. Drained 900cc fluid.
3. Saw nodules everywhere.
4. Biopsied x10.
5. Lung expanded.
6. Pulled tube, closed skin.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"Procedure: Repositioning of bronchial prosthesis.
Indication: Displacement of airway device.
Method: The device was mobilized and translocated to the target site using endoscopic tools. Radial expansion was applied to secure the device. 
Result: Restoration of airway architecture.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"Procedure: Retrieval of aspirated foreign material.
Target: Right bronchial tree.
Method: Extraction utilizing wire basket and forceps.
Outcome: Restoration of bronchial patency.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"Procedure: Right Thoracoscopy
Steps:
1. Sedation.
2. Scope inserted right 6th ICS.
3. Findings: Inflammation.
4. Biopsies: 11 parietal + diaphragm.
5. Talc poudrage.
6. Chest tube placed.
Plan: Admit.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Procedure: Right Thoracoscopy
Steps:
1. Sedation.
2. Scope inserted right 6th ICS.
3. Findings: Malignant nodules.
4. Biopsies: 10 parietal + diaphragm.
5. Talc poudrage.
6. Chest tube placed.
Plan: Oncology consult.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Procedure: Right Thoracoscopy + Biopsy + Talc
Steps:
1. Sedation start.
2. Entry right 6th ICS.
3. Findings: Diaphragmatic mass.
4. Biopsies: 12 parietal + diaphragm.
5. Intervention: Talc poudrage.
6. Tube placed.
Plan: Admit.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Procedure: Robotic Bronch
Patient: Teresa Johnson
1. Navigated to RUL nodule -> REBUS confirm -> Biopsy x3.
2. Navigated to RLL nodule -> REBUS confirm -> Biopsy x4.
3. Fluoroscopy used.
4. No pneumo.
5. Good samples.",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Procedure: Robotic Bronch (Galaxy)
Patient: L. White
Indication: LLL Nodule
Steps:
1. Intubation.
2. Nav to LLL (LB7+8).
3. TiLT+ spin -> 1.3cm divergence found.
4. Updated path.
5. rEBUS adjacent.
6. TBNA x5, Brush x1.
7. ROSE: Granulomas.
Plan: Discharge if CXR clear.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Procedure: Robotic Bronchoscopy (Galaxy)
Target: RUL nodule
Steps:
1. GA/ETT.
2. Registration (3.6mm error).
3. Navigated to RUL anterior segment.
4. TiLT spin showed 1.4cm divergence; updated target.
5. Confirmed with rEBUS (eccentric).
6. TBNA x6, BAL performed.
7. Fiducial dropped.
8. ROSE benign.
Plan: Discharge.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"Procedure: Robotic Cryoablation
Patient: Brian Edwards
Steps:
1. Monarch robot to RUL.
2. Verified with EBUS/CT.
3. Used cryoprobe to freeze tumor x2 cycles.
4. Saw ice ball on scan.
5. Little bit of blood, stopped on its own.
Plan: Admit overnight.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Procedure: Robotic RLL biopsy + marker.
Correction: TiLT+ fixed 2.3cm offset.
Sampling: TBNA, forceps, BAL.
Marker: Fiducial implanted.
Result: Suspicious for NSCLC.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"Procedure: Robotic RLL biopsy and marking.
Correction: 1.8cm divergence fixed via TiLT+.
Sampling: Needle, forceps, brush.
Addition: Fiducial implanted.
Result: Squamous cell carcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Procedure: Robotic RML biopsy.
Tools: Galaxy, 21G needle, forceps, brush.
Verification: Fluoroscopy and rEBUS (concentric).
Result: Atypical cells on ROSE.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Procedure: Robotic navigation and sampling.
Lesion: 9mm RLL.
Correction: TiLT+ detected a 1.7cm drift; we compensated.
Sampling: Needle aspiration, forceps extraction, and brushing were executed. A fiducial was implanted.
Outcome: ROSE suspicious.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Procedure: Robotic navigational bronchoscopy with cryodestruction.
Target: RUL subpleural lesion.
Technique: Monarch system navigation. Cryoprobe application (2 cycles). 
Verification: Ice ball visualized via CBCT. 
Outcome: Lesion ablated. Transient hemoptysis resolved.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Procedure: Robotic navigational bronchoscopy with multimodal sampling.
Target: RLL peripheral nodule.
Technique: Navigation, Radial EBUS, CBCT.
Actions: Transbronchial needle aspiration and forceps biopsies executed.
Findings: Malignancy suspected on ROSE.
Outcome: No complications.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"Procedure: Robotic navigational bronchoscopy with thermal destruction of RLL metastasis.
Technique: Navigation via Ion system. Confirmation via Radial EBUS and CBCT. 
Intervention: RF energy applied to the lesion. 
Outcome: Tumor ablated with appropriate margins. Minor perilesional hemorrhage noted.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Procedure: Robotic sampling RLL.
Correction: TiLT+ offset of 1.5cm noted and fixed.
Tools: Galaxy scope, 22G needle, brush.
Outcome: ROSE negative for malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Procedure: Staging EBUS and airway biopsy.
Action: Nodal stations 4R and 7 were aspirated. The RUL endobronchial mass was biopsied and brushed. 
Result: Tissue obtained from primary and nodes.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"Procedure: Stent Revision
Patient: Samuel Norris
1. ETT 8.0.
2. Scope inserted.
3. Stent migrated proximal.
4. Used forceps/snare to push it back.
5. Ballooned it (12mm).
6. Looks good now.
7. No bleeding.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"Procedure: Systematic EBUS-guided nodal aspiration.
Action: Five mediastinal and hilar stations were identified and sampled (2R, 4R, 4L, 7, 11R). 
Result: Diagnosis of N2 disease (positive 4R/7).",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"Procedure: Targeted nodal aspiration.
Action: Station 7 was identified via EBUS. Five aspirations were performed. 
Result: Adequate tissue obtained.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"Procedure: Thoracentesis
Patient: Anil Patel
1. Sitting up.
2. US check: Left effusion.
3. Prepped/numbed 8th ICS.
4. Needle in -> fluid -> catheter in.
5. Drained 1.3L straw fluid.
6. Pulled catheter.
7. Bandaged.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Procedure: Transbronchial cryosampling for ILD.
Method: The scope was guided to the LLL. Radial EBUS verified a safe parenchymal site. Three cryosamples and one forceps sample were extracted. A bronchial blocker was utilized to manage mild hemorrhage.
Disposition: Admitted for monitoring.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"Procedure: Ultrasound-guided pleural drainage.
Indication: Pleural effusion causing dyspnea.
Action: Percutaneous catheter insertion. Evacuation of 1300mL effusate.
Outcome: Symptomatic improvement.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"Procedure: Urgent RFA
Patient: Richard Coleman
Indication: Bleeding after IR biopsy.
Steps:
1. Intubated. Bronch to RUL.
2. Navigated to biopsy site.
3. Inserted RFA probe.
4. Cauterized bleeding (40W).
5. Ablated tumor (90C).
6. Bleeding stopped.
Plan: ICU, keep chest tube.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Pt: Alexander Castillo | MRN: 9259215 | 64yo M
Date: 01/21/2025
Attending: Brian O'Connor

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 10R (3x), 4L (2x), 4R (2x), 11L (4x)
• Nav to RML lateral (B4)
• rEBUS: Adjacent view
• TIL confirmed: Radial EBUS
• Bx x7, TBNA x4
• ROSE+: Adequate lymphocytes

Complications: None
EBL: <10mL
Dispo: Home

Brian O'Connor MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Amanda Peterson | MRN: 6637236 | 49yo M
Date: 04/19/2024
Attending: Robert Patel

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 4L (2x), 10L (2x), 11L (3x)
• Nav to LUL superior lingula (B4)
• rEBUS: Eccentric view
• TIL confirmed: Augmented fluoroscopy
• Bx x4, TBNA x2
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Robert Patel MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Angela Foster | MRN: 3138545 | 60yo M
Date: 02/10/2025
Attending: David Kim

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Olympus BF-UC260F-OL8
• Stations: 2L (4x), 4R (4x), 7 (3x), 11R (3x)
• Nav to LLL posterior basal (B10)
• rEBUS: Eccentric view
• TIL confirmed: Radial EBUS
• Bx x7, TBNA x3
• ROSE+: squamous cell carcinoma

Complications: None
EBL: <10mL
Dispo: Home

David Kim MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Barbara Roberts | MRN: 6148150 | 50yo F
Date: 11/01/2024
Attending: Michael Rodriguez

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Olympus BF-UC260F-OL8
• Stations: 10R (2x), 11R (2x), 11L (4x), 2R (4x), 4L (4x)
• Nav to RLL lateral basal (B9)
• rEBUS: Adjacent view
• TIL confirmed: Augmented fluoroscopy
• Bx x5, TBNA x4
• ROSE+: Atypical cells

Complications: None
EBL: <10mL
Dispo: Home

Michael Rodriguez MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Brian Williams | MRN: 8237747 | 50yo F
Date: 12/06/2024
Attending: Eric Johnson

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 10R (3x), 7 (3x), 2R (2x), 4R (3x)
• Nav to RLL posterior basal (B10)
• rEBUS: Adjacent view
• TIL confirmed: Fluoroscopy
• Bx x7, TBNA x3
• ROSE+: adenocarcinoma

Complications: None
EBL: <10mL
Dispo: Home

Eric Johnson MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Carol Taylor | MRN: 8035621 | 59yo F
Date: 08/17/2025
Attending: David Kim

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 10R (3x), 4L (2x), 4R (3x)
• Nav to RML lateral (B4)
• rEBUS: Concentric view
• TIL confirmed: Augmented fluoroscopy
• Bx x8, TBNA x4
• ROSE+: Adequate lymphocytes, no malignancy

Complications: None
EBL: <10mL
Dispo: Home

David Kim MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Christina Russell | MRN: 1490801 | 58yo M
Date: 01/04/2025
Attending: Steven Park

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 4L (2x), 10R (4x), 4R (4x), 7 (2x)
• Nav to RUL anterior (B3)
• rEBUS: Adjacent view
• TIL confirmed: Fluoroscopy
• Bx x6, TBNA x4
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Steven Park MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Cynthia Carter | MRN: 8916224 | 56yo F
Date: 04/03/2024
Attending: Eric Johnson

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC180F
• Stations: 10R (2x), 2L (2x), 11L (3x)
• Nav to RUL anterior (B3)
• rEBUS: Concentric view
• TIL confirmed: Augmented fluoroscopy
• Bx x6, TBNA x3
• ROSE+: adenocarcinoma

Complications: None
EBL: <10mL
Dispo: Home

Eric Johnson MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Daniel Lee | MRN: 5214250 | 43yo M
Date: 05/09/2025
Attending: Lisa Thompson

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC260F-OL8
• Stations: 2R (3x), 11R (3x), 4R (3x), 7 (2x)
• Nav to RML lateral (B4)
• rEBUS: Adjacent view
• TIL confirmed: Radial EBUS
• Bx x4, TBNA x2
• ROSE+: Adequate lymphocytes

Complications: None
EBL: <10mL
Dispo: Home

Lisa Thompson MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: David Miller | MRN: 2480663 | 77yo F
Date: 04/08/2025
Attending: Jennifer Walsh

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Olympus BF-UC180F
• Stations: 11R (4x), 2L (2x), 4L (4x)
• Nav to LLL lateral basal (B9)
• rEBUS: Eccentric view
• TIL confirmed: Radial EBUS
• Bx x7, TBNA x2
• ROSE+: Suspicious for malignancy

Complications: None
EBL: <10mL
Dispo: Home

Jennifer Walsh MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Debra Wood | MRN: 6558611 | 61yo F
Date: 03/21/2025
Attending: Brian O'Connor

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC180F
• Stations: 10R (4x), 4R (2x), 2L (4x), 2R (4x), 4L (3x)
• Nav to LUL inferior lingula (B5)
• rEBUS: Concentric view
• TIL confirmed: CBCT
• Bx x6, TBNA x2
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Brian O'Connor MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Donald Parker | MRN: 2724128 | 52yo F
Date: 07/15/2024
Attending: Andrew Nakamura

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 11L (4x), 4L (3x), 10L (2x)
• Nav to RLL superior (B6)
• rEBUS: Adjacent view
• TIL confirmed: Radial EBUS
• Bx x6, TBNA x4
• ROSE+: Granuloma

Complications: None
EBL: <10mL
Dispo: Home

Andrew Nakamura MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Dorothy Green | MRN: 5816158 | 58yo M
Date: 01/31/2024
Attending: David Kim

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 2L (4x), 4R (3x), 11R (3x), 11L (2x)
• Nav to RML medial (B5)
• rEBUS: Adjacent view
• TIL confirmed: Augmented fluoroscopy
• Bx x7, TBNA x2
• ROSE+: small cell carcinoma

Complications: None
EBL: <10mL
Dispo: Home

David Kim MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Edward Parker | MRN: 3492872 | 77yo F
Date: 09/04/2024
Attending: Lisa Thompson

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 10R (3x), 4R (2x), 7 (4x)
• Nav to RLL posterior basal (B10)
• rEBUS: Concentric view
• TIL confirmed: CBCT
• Bx x6, TBNA x3
• ROSE+: squamous cell carcinoma

Complications: None
EBL: <10mL
Dispo: Home

Lisa Thompson MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Gary Gutierrez | MRN: 1395844 | 76yo M
Date: 09/10/2025
Attending: Lisa Thompson

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 4R (2x), 4L (4x), 10R (2x), 2L (2x)
• Nav to RML medial (B5)
• rEBUS: Adjacent view
• TIL confirmed: Augmented fluoroscopy
• Bx x5, TBNA x4
• ROSE+: squamous cell carcinoma

Complications: None
EBL: <10mL
Dispo: Home

Lisa Thompson MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Gregory Diaz | MRN: 9942473 | 45yo M
Date: 09/27/2024
Attending: Sarah Chen

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 4R (4x), 2R (4x), 2L (2x), 10L (3x)
• Nav to LUL inferior lingula (B5)
• rEBUS: Eccentric view
• TIL confirmed: CBCT
• Bx x8, TBNA x4
• ROSE+: Atypical cells

Complications: None
EBL: <10mL
Dispo: Home

Sarah Chen MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Joseph Bell | MRN: 2783660 | 56yo F
Date: 01/16/2025
Attending: David Kim

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 2R (4x), 10R (3x), 2L (2x)
• Nav to RLL medial basal (B7)
• rEBUS: Adjacent view
• TIL confirmed: Radial EBUS
• Bx x5, TBNA x4
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

David Kim MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Joseph Moore | MRN: 7996909 | 69yo M
Date: 09/03/2025
Attending: Brian O'Connor

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 10R (3x), 10L (2x), 11R (3x)
• Nav to LLL lateral basal (B9)
• rEBUS: Adjacent view
• TIL confirmed: Fluoroscopy
• Bx x6, TBNA x2
• ROSE+: Suspicious for malignancy

Complications: None
EBL: <10mL
Dispo: Home

Brian O'Connor MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Joshua Roberts | MRN: 3836339 | 57yo M
Date: 06/09/2025
Attending: Maria Santos

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 11L (4x), 2L (4x), 7 (3x), 11R (3x), 10R (4x)
• Nav to LLL anteromedial basal (B7+8)
• rEBUS: Adjacent view
• TIL confirmed: Fluoroscopy
• Bx x6, TBNA x3
• ROSE+: Suspicious for malignancy

Complications: None
EBL: <10mL
Dispo: Home

Maria Santos MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Kyle Harris | MRN: 6318941 | 76yo F
Date: 11/02/2024
Attending: Katherine Lee

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 10R (4x), 10L (3x), 2L (3x)
• Nav to LUL anterior (B3)
• rEBUS: Adjacent view
• TIL confirmed: CBCT
• Bx x8, TBNA x2
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Katherine Lee MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Kyle Powell | MRN: 3768071 | 77yo M
Date: 09/18/2025
Attending: Rachel Goldman

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 2L (3x), 4L (2x), 10R (2x), 10L (3x), 11L (2x)
• Nav to LUL apicoposterior (B1+2)
• rEBUS: Concentric view
• TIL confirmed: Fluoroscopy
• Bx x7, TBNA x2
• ROSE+: Atypical cells

Complications: None
EBL: <10mL
Dispo: Home

Rachel Goldman MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Larry Patel | MRN: 3630859 | 61yo F
Date: 04/23/2025
Attending: Robert Patel

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 10L (3x), 4L (2x), 11L (2x)
• Nav to RUL anterior (B3)
• rEBUS: Eccentric view
• TIL confirmed: CBCT
• Bx x8, TBNA x4
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Robert Patel MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Lauren Brooks | MRN: 8637258 | 80yo F
Date: 06/01/2025
Attending: Brian O'Connor

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 11R (3x), 2L (2x), 4R (3x), 11L (3x)
• Nav to RUL apical (B1)
• rEBUS: Concentric view
• TIL confirmed: CBCT
• Bx x4, TBNA x4
• ROSE+: adenocarcinoma

Complications: None
EBL: <10mL
Dispo: Home

Brian O'Connor MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Patrick Davis | MRN: 3311679 | 66yo F
Date: 02/12/2024
Attending: Steven Park

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 11R (2x), 4R (4x), 11L (3x)
• Nav to RLL superior (B6)
• rEBUS: Eccentric view
• TIL confirmed: CBCT
• Bx x4, TBNA x3
• ROSE+: small cell carcinoma

Complications: None
EBL: <10mL
Dispo: Home

Steven Park MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Paul Diaz | MRN: 3345858 | 61yo F
Date: 04/27/2025
Attending: Steven Park

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 7 (2x), 11R (4x), 11L (4x)
• Nav to LUL superior lingula (B4)
• rEBUS: Adjacent view
• TIL confirmed: Radial EBUS
• Bx x5, TBNA x3
• ROSE+: Atypical cells

Complications: None
EBL: <10mL
Dispo: Home

Steven Park MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Sandra Chavez | MRN: 6214892 | 77yo F
Date: 09/12/2025
Attending: Maria Santos

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Olympus BF-UC180F
• Stations: 2L (2x), 10L (4x), 7 (4x)
• Nav to RUL anterior (B3)
• rEBUS: Eccentric view
• TIL confirmed: Augmented fluoroscopy
• Bx x6, TBNA x2
• ROSE+: adenocarcinoma

Complications: None
EBL: <10mL
Dispo: Home

Maria Santos MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Sandra Ross | MRN: 1986754 | 61yo M
Date: 04/13/2025
Attending: Andrew Nakamura

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 7 (4x), 11L (2x), 10R (4x), 4L (3x)
• Nav to LUL anterior (B3)
• rEBUS: Eccentric view
• TIL confirmed: Fluoroscopy
• Bx x4, TBNA x3
• ROSE+: Granuloma

Complications: None
EBL: <10mL
Dispo: Home

Andrew Nakamura MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Timothy Martinez | MRN: 5752744 | 56yo M
Date: 02/15/2025
Attending: Amanda Foster

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Ion)

• GA/ETT
• Linear EBUS: Olympus BF-UC190F
• Stations: 4L (3x), 2R (3x), 2L (2x)
• Nav to RLL superior (B6)
• rEBUS: Adjacent view
• TIL confirmed: Augmented fluoroscopy
• Bx x5, TBNA x2
• ROSE+: Suspicious for malignancy

Complications: None
EBL: <10mL
Dispo: Home

Amanda Foster MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Victoria Wood | MRN: 3710765 | 57yo F
Date: 12/25/2024
Attending: Brian O'Connor

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Monarch)

• GA/ETT
• Linear EBUS: Fujifilm EB-580S
• Stations: 11L (4x), 7 (2x), 2L (3x)
• Nav to RUL anterior (B3)
• rEBUS: Concentric view
• TIL confirmed: Radial EBUS
• Bx x7, TBNA x4
• ROSE+: NSCLC NOS

Complications: None
EBL: <10mL
Dispo: Home

Brian O'Connor MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Pt: Zachary Garcia | MRN: 4694863 | 81yo F
Date: 08/17/2025
Attending: Rachel Goldman

Dx: Lung Cancer Staging
Proc: EBUS-TBNA + Robotic Bronch (Galaxy)

• GA/ETT
• Linear EBUS: Pentax EB-1990i
• Stations: 4L (2x), 7 (3x), 10R (4x)
• Nav to LUL inferior lingula (B5)
• rEBUS: Concentric view
• TIL confirmed: Radial EBUS
• Bx x7, TBNA x4
• ROSE+: Adequate lymphocytes, no malignancy

Complications: None
EBL: <10mL
Dispo: Home

Rachel Goldman MD",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
Pulmonary nodule 11mm in RUL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB2. Fluoroscopic guidance. rEBUS eccentric. TBNA 22G and Transbronchial forceps biopsy performed. ROSE Granulomatous inflammation.,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Pulmonary nodule in patient with prior malignancy. 11mm nodule in LLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB7+8. TiLT+ sweep revealed 1.3cm divergence due to atelectasis. Target updated. rEBUS view: Adjacent. Transbronchial needle aspiration (22G, 5 passes). Cytology brushings. ROSE Result: Granulomatous inflammation. Disposition: Recovery.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
RFA procedure for Slartibartfast Magrathea RLL tumor. Used the veran system. Cone beam looked good 8mm from center. Did two burns first one 8 mins second one 6 mins at 90 degrees. Impedance looked good. No issues patient did great.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"RLL Nodule Biopsy.
- Navigated to RB7 using Galaxy.
- Validated with TiLT/Fluoro.
- rEBUS eccentric.
- Needles, Forceps, Brush, BAL done.
- Fiducial dropped.
- ROSE: Adeno.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"RUL Mass (25mm).
- Galaxy Nav to RB2.
- TiLT: 0.8cm shift.
- rEBUS: Eccentric.
- TBNA x7, Forceps x7, BAL.
- Fiducial placed.
- ROSE: Adeno.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"RUL Nodule (11mm).
- Galaxy Nav to RB2.
- Fluoro confirm.
- rEBUS: Eccentric.
- TBNA x5, Forceps x6.
- ROSE: Granuloma.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Rachel Davis, MRN 7951980, a 53-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Regional Medical Center on 03/13/2025. The indication was pet-avid lung mass and mediastinal lymphadenopathy with a 23.3mm solid lesion in the RLL medial basal (B7), bronchus sign negative. The patient was ASA class 3 with smoking history of None pack-years (never). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2R (12.0mm, 4 passes, ROSE: Malignant - NSCLC NOS); station 10R (12.9mm, 3 passes, ROSE: Suspicious for malignancy); station 2L (13.9mm, 2 passes, ROSE: Granuloma). Rapid on-site evaluation was available for all stations.

The Galaxy robotic bronchoscopy system (Noah Medical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.9mm. The robotic catheter was advanced to the RLL medial basal (B7) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by radial ebus. Transbronchial forceps biopsies (5 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes, no malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 139 minutes. Attending physician: David Kim, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Reason: High Brock score nodule.
Action: Galaxy navigation to LLL. TiLT+ adjusted for 2.1cm atelectasis shift. Localized via rEBUS. Sampled via TBNA and brush. ROSE: Atypical.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Reason: Lung-RADS 4B lesion.
Action: The Galaxy system was guided to the RML. A 2.1cm divergence was rectified using TiLT+. The nodule was localized via rEBUS. Samples were acquired using a 21G needle.
Result: ROSE showed atypical cells.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Reason: Peripheral nodule.
Action: Galaxy navigation to LLL. TiLT+ adjusted for 1.9cm shift. Sampled via TBNA. ROSE: Suspicious for NSCLC.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Reason: Pulmonary nodule.
Action: Galaxy navigation to RUL. Position verified via fluoroscopy. Sampled via TBNA and forceps. ROSE: Granulomatous inflammation.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Resident Note
Patient: Dana Scully
Procedure: Nav Bronch.
Steps:
1. Nav to LLL.
2. REBUS concentric.
3. TBNA x 3.
4. Bx x 4.
5. Brush x 2.
No complications.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Resident Note
Patient: Dong-Wook Lee
Procedure: Nav Bronch LUL.
Steps:
1. Navigated to LUL apical-posterior.
2. R-EBUS: Concentric view.
3. TBNA x 2.
4. Biopsy x 4.
5. Brush x 1.
Plan: Follow up path.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"Resident Note
Patient: S. Walker, 82F
Target: LUL 22mm
Steps:
1. Galaxy nav to LB1+2.
2. TiLT+ showed 1.5cm divergence.
3. Re-aligned.
4. rEBUS eccentric.
5. Samples: Needle, Forceps, Brush.
6. Fiducial placed.
ROSE: Benign so far.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Resident Note
Pt: A. Brown
RLL Nodule 31mm
1. Galaxy nav RB9.
2. TiLT showed 1.8cm error.
3. Fixed target.
4. rEBUS concentric.
5. Samples + Fiducial.
6. ROSE: Cancer (SqCC).",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Resident Note
Pt: C. Rodriguez
RLL 22mm
1. Galaxy to RB10.
2. TiLT found 2.3cm error (atelectasis).
3. Adjusted.
4. rEBUS adjacent.
5. TBNA, Bx, BAL.
6. Fiducial placed.
ROSE: Suspicious NSCLC.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"Resident Note
Pt: E. Lewis
Case: RLL Nodule Biopsy + Fiducial
1. GA/ETT.
2. Nav to RB6.
3. TiLT showed 1.7cm divergence (atelectasis).
4. Adjusted.
5. rEBUS concentric (good view).
6. Samples: TBNA, Bx, Brush.
7. Dropped 1 fiducial.
8. ROSE: Suspicious.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Resident Note
Pt: M. Taylor
RUL Nodule
1. Galaxy nav to RB2.
2. Fluoro check.
3. rEBUS adjacent.
4. TBNA, Bx, Brush.
5. ROSE: Granulomas.
Stable.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Resident Note
Pt: R. Green
Site: RML (RB4)
1. Galaxy Nav.
2. Fluoro check good.
3. rEBUS concentric.
4. TBNA x6, Bx x4, Brush.
5. ROSE: Atypical.
Plan: Wait for final path.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Resident Note
Pt: S. Gonzalez
RLL 9mm
1. Galaxy to RB10.
2. Fluoro ok.
3. rEBUS concentric.
4. TBNA, Bx, Brush.
5. BAL performed.
6. ROSE negative.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Resident Note:
Attending: Dr. Thompson
Pt: 65F, RML nodule.
1. ETT placed.
2. Galaxy nav to RB4.
3. TiLT spin -> updated target (2.1cm shift).
4. rEBUS concentric.
5. TBNA x7.
6. ROSE: Atypical.
Stable.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Resident Note: Airway Dilation
Patient: Hannah Keller
1. ETT 6.5.
2. Stenosis seen subglottic (60%).
3. Balloon catheter passed.
4. Inflated 8mm -> 10mm -> 12mm.
5. Mucosa split slightly (expected).
6. Airway much more open now.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"Resident Note: Left Diagnostic Pleuroscopy
Steps:
1. Sedation.
2. Port 6th ICS.
3. Findings: Adhesions, trapped lung.
4. Fluid drained.
5. Chest tube placed.
Plan: Monitor.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Resident Note: Left Thoracoscopy
Steps:
1. Sedation.
2. Entry left 6th ICS.
3. Findings: Tumor implants.
4. Biopsies: 11 parietal + diaphragm.
5. Talc poudrage.
6. Chest tube placed.
Plan: Admit.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Resident Note: Right Diagnostic Pleuroscopy
Steps:
1. Sedation.
2. Single port 6th ICS.
3. Exam: Thickened pleura with nodules.
4. Drainage: All fluid removed.
5. Closure: Chest tube placed.
Plan: Path review (if fluid sent).",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Resident Note: Right Medical Thoracoscopy
Steps:
1. Moderate sedation.
2. Trocar placement right chest.
3. Visualization: Inflammatory changes, no masses.
4. Biopsy: 12 parietal specimens + diaphragm samples.
5. Fluid drainage complete.
6. Chest tube secured. No air leak.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Resident Note: Right Thoracoscopy + Talc
Steps:
1. Sedation.
2. Entry right 6th ICS.
3. Findings: Inflammation.
4. Talc poudrage.
5. Fluid drained.
6. Chest tube placed.
Plan: Monitor.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Resident Procedure Note
Patient: Anthony Rogers (ICU)
Indication: RLL collapse.
Procedure:
1. Time out.
2. Scope passed via ETT.
3. Found thick mucus plugs in RLL.
4. Performed BAL and suctioned out plugs.
5. Re-expanded lung.
Status: Stable, sat improved.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"Resident Procedure Note
Patient: J. Flores
Attending: Dr. Wilson
Procedure: Robotic Bronchoscopy (Galaxy)
Steps:
1. ETT placed.
2. Galaxy registered (2.1mm error).
3. TiLT+ sweep done; found 1.8cm divergence.
4. Adjusted to new target.
5. rEBUS: Adjacent.
6. Biopsied: TBNA x5, Forceps x4, Brush.
7. ROSE positive for SqCC.
No complications.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
Right diagnostic pleuroscopy executed. Observed thickened parietal membrane with nodules. Effusion drained. Catheter deployed. Lung re-expansion confirmed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"Right medical thoracoscopy was performed under local anesthesia and sedation. The pleural space revealed inflammatory changes without obvious nodularity. Twelve biopsies were taken from the parietal pleura, along with diaphragmatic biopsies. The specimens were sent for pathology. Fluid was drained and a chest tube was placed. The patient tolerated the procedure well.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"Right medical thoracoscopy was performed under local anesthesia. Inflammatory changes were noted without nodularity. Eleven biopsies were obtained from the parietal pleura, along with diaphragmatic biopsies. Talc poudrage was performed for pleurodesis. Fluid was evacuated and a chest tube was placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Right medical thoracoscopy was performed. Inflammatory changes were noted without nodularity. Talc poudrage was performed for pleurodesis. All remaining fluid was evacuated, and a chest tube was placed. The lung expanded well.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Right medical thoracoscopy was performed. Multiple malignant-appearing nodules were noted. Ten biopsies were obtained from the parietal pleura, along with diaphragmatic biopsies. Talc poudrage was performed for pleurodesis. Fluid was evacuated and a chest tube was placed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Right pleuroscopy completed. Diaphragmatic mass observed. Twelve tissue samples harvested from parietal pleura; diaphragm also sampled. Talc insufflation executed for symphysis. Fluid drained and catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Right pleuroscopy executed. Inflammatory alterations observed. Talc insufflation executed for symphysis. Effusion drained. Catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"Right pleuroscopy executed. Visual assessment showed inflammatory alterations without nodularity. Twelve tissue samples harvested from the parietal pleura, with further sampling of the diaphragm. Effusion drained. Catheter deployed. No sclerosing agent utilized.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
Right pleuroscopy performed. Inflammatory alterations observed. Eleven tissue samples harvested from parietal pleura; diaphragm also sampled. Talc insufflation executed. Fluid drained and catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Right pleuroscopy performed. Malignant nodules observed. Ten tissue samples harvested from parietal pleura; diaphragm also sampled. Talc insufflation executed. Fluid drained and catheter deployed.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Right pleuroscopy performed. Pleura demonstrated diffuse nodularity. Seven tissue samples harvested from the parietal wall, with additional sampling of the diaphragm. Talc insufflation executed for symphysis. Fluid drained and catheter inserted. Hemostasis secured.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Right-sided tube thoracostomy performed for spontaneous pneumothorax. Standard landmark technique utilized. A 28 Fr tube was placed and secured. Connected to -20cmH2O suction with resolution of pneumothorax on imaging.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
Robert is back with possible recurrence of small cell. Did EBUS in the OR. Sampled 2R 4R 7 and 10R. Station 7 came back positive for small cell on the rapid read. Others looked okay. Admitting him for chemo eval.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"Robotic Bronch
Patient: Patricia Nguyen
Target: RLL superior segment
Steps:
1. Ion nav to target.
2. REBUS confirmed.
3. Needle aspirate (TBNA).
4. Forceps biopsies x6.
5. Brush x2.
ROSE: NSCLC.
Plan: D/C, Onc referral.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"Robotic Bronch RFA
Patient: Kevin White
Target: RLL nodule
Steps:
1. Ion robot registration (CT-to-body).
2. Navigated to RLL.
3. Confirmed with REBUS and Spin (CBCT).
4. RFA catheter in. Burned at 40W for 8 mins.
5. Re-spun. Good margins.
6. Minor bleeding.
Plan: Admit.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
Robotic assisted navigational bronchoscopy performed for peripheral pulmonary nodules. Targets in RUL and RLL localized using digital path planning and radial EBUS confirmation. Transbronchial forceps biopsies obtained from both sites. No complications.,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"Robotic navigational bronchoscopy with RF ablation of RLL metastasis. Patient is a 63-year-old male with oligometastatic colorectal cancer. Ion robotic system used to access RLL lateral basal segment. Radial EBUS confirmed solid lesion, cone-beam CT verified tool-in-lesion. RF ablation catheter advanced; ablation performed at 40 W for 480 seconds. Postablation CBCT showed ablation zone with margin. Small perilesional hemorrhage occurred, hemodynamically stable.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
Robotic navigational bronchoscopy with cryoablation of subpleural RUL lesion. Patient is a 71-year-old male with small peripheral NSCLC. Monarch robotic system used to reach 12 mm RUL apical segment lesion. Radial EBUS confirmed lesion; CBCT demonstrated tip within lesion. 2.4 mm cryoprobe advanced; two freeze-thaw cycles performed. Ice ball seen on CBCT. Mild transient hemoptysis occurred; no pneumothorax. Admitted overnight.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"Robotic-assisted navigational bronchoscopy with radial EBUS and transbronchial biopsies of a right lower lobe nodule. Patient is a 67-year-old female. Ion robotic bronchoscopy platform used. Radial EBUS: Concentric solid lesion pattern obtained. Sampling: Tool-in-lesion confirmed by cone-beam CT. Six transbronchial forceps biopsies, two brushings, and one 21G needle aspiration performed. ROSE suggestive of non-small cell carcinoma. Discharged.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"Ronald Bell, MRN 4830228, a 82-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Academic Health System on 05/22/2024. The indication was peripheral nodule and bilateral hilar adenopathy with a 14.0mm ground-glass lesion in the LUL apicoposterior (B1+2), bronchus sign negative, PET SUV max 17.6. The patient was ASA class 2 with smoking history of 34 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 22-gauge FNB/ProCore needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 2L (14.8mm, 3 passes, ROSE: Atypical cells); station 4L (24.3mm, 2 passes, ROSE: Malignant - squamous cell carcinoma); station 10R (12.9mm, 2 passes, ROSE: Malignant - NSCLC NOS); station 10L (18.8mm, 3 passes, ROSE: Suspicious for malignancy); station 11L (18.7mm, 2 passes, ROSE: Malignant - adenocarcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.5mm. The robotic catheter was advanced to the LUL apicoposterior (B1+2) and radial EBUS probe deployment revealed concentric view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (7 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed adequate lymphocytes, no malignancy.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 114 minutes. Attending physician: Rachel Goldman, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Ruth Cooper, MRN 4172009, a 62-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Presbyterian Hospital on 02/11/2025. The indication was peripheral nodule and bilateral hilar adenopathy with a 21.6mm ground-glass lesion in the RUL anterior (B3), bronchus sign negative. The patient was ASA class 3 with smoking history of 41 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Fujifilm EB-580S bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10L (13.0mm, 3 passes, ROSE: Malignant - NSCLC NOS); station 4L (15.7mm, 2 passes, ROSE: Adequate lymphocytes); station 11L (19.4mm, 2 passes, ROSE: Malignant - small cell carcinoma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.8mm. The robotic catheter was advanced to the RUL anterior (B3) and radial EBUS probe deployment revealed eccentric view of the lesion. Tool-in-lesion was confirmed by cbct. Transbronchial forceps biopsies (8 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed granuloma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 85 minutes. Attending physician: Robert Patel, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Sandra King, MRN 7742855, a 50-year-old female underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Memorial Hospital on 01/14/2025. The indication was right upper lobe mass with ipsilateral mediastinal nodes with a 28.6mm ground-glass lesion in the RLL lateral basal (B9), bronchus sign negative, PET SUV max 8.9. The patient was ASA class 4 with smoking history of 36 pack-years (former). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Olympus BF-UC260F-OL8 bronchoscope with 21-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (17.1mm, 2 passes, ROSE: Atypical cells); station 11R (8.4mm, 2 passes, ROSE: Granuloma); station 11L (22.2mm, 4 passes, ROSE: Malignant - adenocarcinoma); station 2R (21.9mm, 4 passes, ROSE: Atypical cells); station 4L (18.5mm, 4 passes, ROSE: Granuloma). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 2.6mm. The robotic catheter was advanced to the RLL lateral basal (B9) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by augmented fluoroscopy. Transbronchial forceps biopsies (5 specimens), transbronchial needle aspiration (4 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - adenocarcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 92 minutes. Attending physician: Michael Rodriguez, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Service: 31641 (Destruction of tumor).
Method: Microwave Ablation.
Device: Neuwave System.
Support: 31627 (Navigation), 31654 (Radial EBUS).
Narrative: Navigated to RUL nodule. Verified tool-in-lesion. Delivered microwave energy to destroy tumor. Post-procedure check negative for pneumothorax.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"Stephen Torres, MRN 8787443, a 69-year-old male underwent combined endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging and robotic bronchoscopy with peripheral lung biopsy at Northwestern Memorial Hospital on 06/21/2024. The indication was right upper lobe mass with ipsilateral mediastinal nodes with a 29.4mm part-solid lesion in the LLL lateral basal (B9), bronchus sign negative. The patient was ASA class 3 with smoking history of 43 pack-years (current). General anesthesia was induced and the patient was intubated with a 8.0mm endotracheal tube.

Linear EBUS was performed using the Pentax EB-1990i bronchoscope with 22-gauge Standard FNA needle. The following mediastinal and hilar lymph node stations were systematically sampled: station 10R (15.5mm, 3 passes, ROSE: Suspicious for malignancy); station 10L (21.7mm, 2 passes, ROSE: Adequate lymphocytes); station 11R (20.5mm, 3 passes, ROSE: Malignant - NSCLC NOS). Rapid on-site evaluation was available for all stations.

The Ion robotic bronchoscopy system (Intuitive Surgical) was then utilized for navigation to the peripheral target. CT-to-body registration was performed with registration error of 1.8mm. The robotic catheter was advanced to the LLL lateral basal (B9) and radial EBUS probe deployment revealed adjacent view of the lesion. Tool-in-lesion was confirmed by fluoroscopy. Transbronchial forceps biopsies (6 specimens), transbronchial needle aspiration (2 passes), and brushings (2) were obtained. Bronchoalveolar lavage was collected for microbiological studies. ROSE evaluation of the peripheral specimens showed malignant - squamous cell carcinoma.

The procedure was completed without complications. Estimated blood loss was less than 10mL. Post-procedure chest radiograph showed no pneumothorax. The patient was discharged home in stable condition with follow-up scheduled for pathology review. Specimens were sent for cytology, cell block, surgical pathology, and cultures.

Procedure time: 81 minutes. Attending physician: Brian O'Connor, MD.",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"Suspected lung malignancy 25mm nodule in RUL. General anesthesia. Noah Galaxy bronchoscope. Navigated to RB2. TiLT+ sweep revealed 0.8cm divergence. Corrected. rEBUS eccentric. TBNA 21G, Transbronchial forceps biopsy, BAL, and Gold fiducial placement performed. ROSE Malignant cells identified.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
Suspicious nodule 12mm in LLL. General anesthesia. Noah Galaxy bronchoscope. Navigated to LB9. TiLT+ sweep revealed 2.1cm divergence due to atelectasis. Corrected. rEBUS concentric. TBNA 21G and Cytology brushings performed. ROSE Atypical cells. Discharged.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Suspicious nodule with high Brock score. 9mm nodule in RLL. General anesthesia. Galaxy robotic platform. Navigated to RB6. TiLT+ sweep generated updated 3D volume showing 1.7cm divergence. Target updated. rEBUS: Concentric. TBNA (22G), Forceps biopsy, Brush. Gold fiducial marker placed. ROSE: Suspicious for malignancy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Target: 11mm LLL nodule.
System: Galaxy Robot.
Nav: Reg error 3.5mm. TiLT+ showed 1.3cm divergence (atelectasis).
Action: Re-aligned. rEBUS adjacent.
Sampling: TBNA (5 passes), Brush.
ROSE: Granulomatous inflammation.
Comp: None.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Target: 11mm RUL nodule.
Nav: Galaxy. Reg error 3.0mm.
Verify: Fluoroscopy.
Tools: rEBUS (eccentric), TBNA, Forceps.
ROSE: Granuloma.
Result: Benign.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Target: 13mm LLL nodule.
Nav: Galaxy + TiLT (1.9cm div).
Tools: rEBUS (adjacent), TBNA.
ROSE: Suspicious for NSCLC.
Disposition: D/C.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"Target: 22mm RLL nodule.
Tool: Galaxy + TiLT+.
Div: 2.3cm (atelectasis). Corrected.
rEBUS: Adjacent.
Action: TBNA x4, Bx x4, BAL, Fiducial.
ROSE: Suspicious NSCLC.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"Target: 25mm RUL mass.
Nav: Galaxy + TiLT (0.8cm div).
Tools: rEBUS (eccentric), TBNA, Forceps, BAL, Fiducial.
ROSE: Adenocarcinoma.
Plan: SBRT planning.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"Target: 28mm LUL nodule (PET-avid).
Nav: Galaxy electromagnetic. TiLT correction 1.0cm.
Tools: rEBUS (eccentric), 22G TBNA, Cytology Brush, BAL, Fiducial.
ROSE: Suspicious (necrotic/atypical).
Plan: Outpatient discharge.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"Target: 29mm LLL nodule.
System: Galaxy + TiLT.
Correction: 1.4cm divergence (CT-body drift).
Biopsy: TBNA, Forceps, Brush.
ROSE: Adenocarcinoma.
Disposition: Discharge.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Target: 31mm RLL nodule.
Device: Galaxy, TiLT+.
Nav: 1.8cm divergence (positioning). Corrected.
rEBUS: Concentric.
Intervention: TBNA x6, Bx x5, Brush, Fiducial.
ROSE: Malignant (SqCC).",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"Target: 31mm RML nodule.
Nav: Galaxy (2.1mm accuracy).
Check: Fluoro + rEBUS (Concentric).
Action: TBNA x6, Forceps x4, Brush.
ROSE: Atypical cells.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"Target: 8mm nodule Lingula.
Nav: Galaxy + TiLT (1.1cm div).
Tools: rEBUS (eccentric), TBNA, Brush.
ROSE: SCC.
Plan: Oncology.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Task: Robotic RLL sampling.
Methods: TBNA, forceps, brush, BAL.
Guidance: Galaxy, Fluoro, rEBUS (concentric).
Result: ROSE negative.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"Task: Robotic biopsy LUL.
Detail: Galaxy system used. TiLT+ rectified a 1.5cm divergence. rEBUS confirmed location (eccentric). We aspirated, biopsied, and brushed the lesion. A fiducial was deposited.
Pathology: ROSE showed lymphocytes.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
Teresa is here for ablation of that LUL spot. Used the superdimension and the cone beam to find it. Microwave antenna went in 65 watts for 6 minutes. She coughed up a little blood and then we saw a pneumo on the scan. Had to put in a pigtail catheter 10 french. She is going to the floor for monitoring.,1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"The patient presented for diagnostic bronchoscopy regarding a 22mm RUL lesion. Following induction of general anesthesia, the Noah Galaxy robotic system was deployed. Electromagnetic registration was achieved with 3.6mm accuracy. Upon navigation to the RB3 segment, Augmented Fluoroscopy (TiLT+) identified a significant divergence of 1.4cm necessitating alignment correction. Once confirmed via eccentric rEBUS signal, sampling was performed using a 22G needle and bronchoalveolar lavage. A gold fiducial was implanted for future stereotactic planning. Cytopathology revealed benign cells.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"The patient underwent elective robotic bronchoscopy for a suspicious 14mm nodule in the Right Middle Lobe. The Noah Galaxy platform was utilized. Intra-procedural tomosynthesis (TiLT+) revealed a 2.1cm target divergence attributed to respiratory motion, which was digitally corrected. Following concentric rEBUS confirmation, transbronchial needle aspiration was executed. Rapid on-site evaluation suggested necrosis with atypia.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"The patient underwent evaluation of a 13mm LLL nodule. Galaxy robotic navigation was employed. Intraoperative TiLT imaging revealed a significant 1.9cm divergence due to respiratory motion, which was corrected. Following adjacent rEBUS confirmation, 21G TBNA was performed. Cytology is suspicious for non-small cell lung cancer.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"The patient underwent robotic-assisted bronchoscopy for a 21mm RLL lesion. The Galaxy system provided navigational guidance to the RB7 segment. Fluoroscopic and TiLT overlay confirmed tool-in-lesion status. Diagnostic yield was pursued via 22G TBNA, transbronchial forceps biopsy, and brushing. On-site pathology confirmed adenocarcinoma. A fiducial was placed for treatment planning.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
The patient was brought to the endoscopy suite and placed under general anesthesia. A Noah Galaxy bronchoscope was inserted. Registration was performed with a 3.6mm error. Navigation to the 22mm RUL nodule was assisted by TiLT+ tomosynthesis which corrected a 1.4cm divergence. Radial EBUS showed an eccentric view. Transbronchial needle aspiration and BAL were performed. A gold fiducial was placed. There were no complications.,1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"This was a tricky 12mm nodule in the left lower lobe. When we got down there with the Galaxy scope, the TiLT scan showed the target was actually 2.1cm away from where we expected, probably because the lung collapsed a bit. We adjusted, got a bullseye view on EBUS, and took our samples. The pathologist is worried it might be cancer but needs to see the final stains.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"Under moderate sedation, a right medical thoracoscopy was performed. A mass lesion was noted on the diaphragmatic pleura. Twelve biopsies were obtained from the parietal pleura, and additional samples were taken from the diaphragm. Talc poudrage was performed for pleurodesis. The fluid was evacuated, and a chest tube was placed without complication.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"Under moderate sedation, a right-sided single-port thoracoscopy was performed. The pleural space demonstrated diffuse nodularity. Seven biopsies were obtained from the parietal pleura, with additional samples from the diaphragm. Given the findings, talc poudrage was performed for pleurodesis. All fluid was evacuated and a chest tube was placed. Hemostasis was confirmed.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
Urgent bronchoscopy with radiofrequency ablation. Patient with hemothorax following transthoracic biopsy. General anesthesia. Airway clear of active large airway bleeding. Navigation to RUL posterior segment. RFA probe deployed. Hemostasis protocol (low power) followed by ablation protocol (high power) utilizing Vivant system. Hemostasis achieved. Tumor treated. Chest tube output diminished.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"We began the procedure by inducing general anesthesia and securing the airway. The Galaxy robotic scope was introduced, and we navigated to the Right Upper Lobe. Utilizing the TiLT+ feature, we identified and corrected a divergence of 1.4cm. After confirming the lesion with radial EBUS, we obtained samples via needle aspiration and lavage. Finally, a fiducial marker was placed to assist with future radiation therapy.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"We biopsied a 25mm mass in the right upper lobe using the Galaxy robot. The TiLT system showed we were very close, just 0.8cm off, which we fixed. We took plenty of samples with needles and forceps and washed the area. We left a marker for the radiation doctors. It is adenocarcinoma.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"We navigated to the left lower lobe to biopsy a 29mm nodule. The TiLT scan showed that the target had shifted about 1.4cm from where the computer thought it was, likely due to patient movement, so we updated the target. We took needle and forcep samples. The pathologist in the room confirmed it looks like adenocarcinoma.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"We performed a biopsy on Mr. Kyung-Soo Yoon's small lung nodule today. Using a navigation system like a GPS for the lungs, we found the 9mm spot in the left upper lobe. We confirmed we were in the right place with ultrasound and took several samples using a needle, forceps, and a brush. He handled the sedation well.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"We performed a cryobiopsy on Ms. Adams today to figure out the cause of her lung fibrosis. Under general anesthesia, we navigated to the left lower lobe. We used ultrasound to check the area first, then used a freezing probe to grab three distinct tissue samples, plus one with standard forceps. We used a balloon to stop a little bit of bleeding, and the post-procedure X-ray showed her lungs were still fully inflated.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
We performed a left medical thoracoscopy on Mr. Lee. The pleura showed inflammatory changes. We collected twelve biopsies from the parietal pleura and additional samples from the diaphragm. We evacuated the fluid and placed a chest tube. No pleurodesis was done.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
We performed a left medical thoracoscopy on Ms. Lee. We observed visceral pleural tumor implants. We collected eleven biopsies from the parietal pleura and additional samples from the diaphragm. We then performed talc poudrage for pleurodesis and placed a chest tube.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
We performed a navigational bronchoscopy on Samantha Carter to biopsy a 19mm nodule in the left lower lung. We successfully reached the nodule and confirmed it with ultrasound. We took multiple samples using different tools to ensure we get a diagnosis. There were no complications.,1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"We performed a radiofrequency ablation on Mr. Prosser Vogon today. Using a special navigation system and a 3D X-ray, we guided a heat probe right into the tumor in his right lower lung. We heated the tumor to 90 degrees Celsius in two separate steps to make sure we got the whole thing plus a safety margin. He tolerated it well.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"We performed a right medical thoracoscopy on Mr. Taylor. Upon entering the pleural space, we observed diffuse nodularity throughout. We proceeded to obtain seven biopsies from the parietal pleura and additional samples from the diaphragm. Following the biopsies, we performed talc poudrage for pleurodesis. The fluid was evacuated and a chest tube was inserted.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"We performed a right medical thoracoscopy on Mr. Wilson. We visualized a mass on the diaphragmatic pleura. To ensure accurate staging, we took twelve biopsies from the parietal pleura and additional samples from the diaphragm. Given the appearance, we proceeded with talc poudrage for pleurodesis before placing the chest tube.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
We performed a right medical thoracoscopy on Ms. Moore. The pleura showed inflammatory changes. We collected eleven biopsies from the parietal pleura and additional samples from the diaphragm. We then performed talc poudrage for pleurodesis and placed a chest tube.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
We performed a right medical thoracoscopy on Ms. Smith. The pleura showed multiple malignant-appearing nodules. We collected ten biopsies from the parietal pleura and additional samples from the diaphragm. We then performed talc poudrage for pleurodesis and placed a chest tube.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"We performed a robotic biopsy on Mrs. Lewis's right lower lobe nodule. The Galaxy system helped us navigate, and the TiLT+ feature was essential as it showed the nodule was 1.7cm away from the expected spot due to atelectasis. Once corrected, we got a concentric ultrasound view. We took multiple samples and placed a gold marker for future radiation therapy.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"We performed an EBUS procedure on Mr. Carter to stage his lung cancer. We sampled three different lymph node areas: the high right mediastinum, the subcarinal area, and the right hilar area. Unfortunately, the preliminary results show cancer in the 4R lymph node, but the other two spots looked clear. He recovered well and is going home.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"We performed an emergency procedure on Mr. Carter to remove a peanut he inhaled. It was blocking his right lung. Using a small basket and grippers through the scope, we removed the peanut in several pieces. Once it was all out, we suctioned the airway clean, and his lung re-expanded.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"We placed a chest tube in Mr. Nguyen's right side to treat his collapsed lung. We numbed the area and inserted a large tube between the ribs. A lot of air came out, and his breathing improved. The X-ray showed the lung is back up. He is admitted to the hospital.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
We took Mr. Norris to the OR to fix his lung stent. It had slipped up into his windpipe. We put him to sleep and used a scope to carefully push the stent back down into the left lung airway where it belongs. We used a balloon to widen it so it stays put. He is breathing better now.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"We treated Mr. Richard Taylor's lung cancer today using a microwave ablation catheter. Because of his COPD, surgery wasn't an option. We navigated a small catheter to the tumor in his right upper lobe and confirmed its position with a 3D X-ray spin. We then heated the tumor to 85 degrees Celsius for 5 minutes to kill the cancer cells. The procedure was successful.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"We treated Ms. Murphy's lung nodule using microwave energy today. We guided the catheter to the left upper lobe using the navigation system and confirmed it with a CT scan. The ablation went well, but she developed a small air leak (pneumothorax) afterwards. We placed a small tube in her chest to drain the air, and she is stable and being admitted for observation.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"We used the robotic bronchoscope to biopsy a nodule in Ms. Nguyen's right lower lung. Once the robot guided us there, we used ultrasound to confirm we were in the right spot. We took samples using a needle, small forceps, and a brush. The preliminary results look like lung cancer. She tolerated the procedure well and went home.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"We went after a 28mm spot in the left upper lobe today. Using the Galaxy robot, we got close and used the TiLT spin to fine-tune our position, correcting a 1cm error. We threw the kitchen sink at it—needle biopsies, brushing, and a wash. We also left a gold marker behind just in case he needs radiation later. The preliminary slides look suspicious.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"We went after a small 8mm spot in the Lingula. The Galaxy system got us close, and the TiLT 3D spin helped us close the last 1.1cm gap. We got a signal on the ultrasound and took needle and brush samples. It looks like squamous cell carcinoma unfortunately.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"[Indication]
11mm nodule LLL, prior malignancy.
[Anesthesia]
General.
[Description]
Galaxy robot navigated to LB7+8. TiLT+ used to correct 1.3cm divergence. rEBUS adjacent. TBNA and Brush performed.
[Plan]
Follow-up pathology.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"[Indication]
11mm nodule, RUL.
[Anesthesia]
General.
[Description]
Galaxy Nav. Fluoroscopy. rEBUS eccentric. TBNA and Forceps performed.
[Plan]
Follow up.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"[Indication]
13mm nodule, LLL.
[Anesthesia]
General.
[Description]
Galaxy Nav. TiLT correction 1.9cm. rEBUS adjacent. TBNA performed.
[Plan]
Follow up.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"[Indication]
22mm LUL nodule (4X).
[Anesthesia]
GA.
[Description]
Galaxy nav. TiLT+ corrected 1.5cm divergence. rEBUS eccentric. TBNA, Bx, Brush. Fiducial placed.
[Plan]
Wait for final path.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"[Indication]
22mm RLL nodule.
[Anesthesia]
GA.
[Description]
Galaxy nav. TiLT+ corrected 2.3cm divergence. rEBUS adjacent. TBNA, Bx, BAL, Fiducial.
[Plan]
Oncology.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
"[Indication]
25mm mass, RUL.
[Anesthesia]
General.
[Description]
Galaxy Nav. TiLT correction 0.8cm. rEBUS eccentric. TBNA, Forceps, BAL. Fiducial placed.
[Plan]
Oncology.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"[Indication]
31mm RLL nodule.
[Anesthesia]
GA.
[Description]
Galaxy nav. TiLT+ corrected 1.8cm divergence. rEBUS concentric. TBNA, Bx, Brush, Fiducial.
[Plan]
Oncology.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"[Indication]
8mm nodule, Lingula.
[Anesthesia]
General.
[Description]
Galaxy Nav. TiLT correction 1.1cm. rEBUS eccentric. TBNA and Brush performed.
[Plan]
Oncology consult.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"[Indication]
9mm RLL nodule, high risk.
[Anesthesia]
GA.
[Description]
Galaxy nav to RB6. TiLT+ corrected 1.7cm divergence. rEBUS Concentric. TBNA, Bx, Brush done. Fiducial placed.
[Plan]
Oncology referral pending final path.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
"[Indication]
9mm RLL nodule.
[Anesthesia]
GA.
[Description]
Galaxy nav RB10. Fluoro/rEBUS concentric. TBNA, Bx, Brush, BAL performed.
[Plan]
CXR, discharge.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
"[Indication]
Acute hypoxemic respiratory failure, mucus plugging.
[Anesthesia]
ICU Sedation (Propofol/Fentanyl).
[Description]
Therapeutic aspiration performed. Large mucus plugs removed from R main/RML/RLL. Lavage utilized. Airways cleared.
[Plan]
Continue mechanical ventilation. Monitor secretions.",0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
"[Indication]
Dominant RLL nodule 25mm.
[Anesthesia]
GA.
[Description]
Galaxy nav. TiLT+ corrected 1.5cm error. rEBUS adjacent. TBNA and Brush performed.
[Plan]
Follow-up in 1 week.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"[Indication]
Fibrotic ILD, etiology unclear.
[Anesthesia]
General, 8.5 ETT.
[Description]
LLL basal segment selected. Radial EBUS guidance used. 3 cryobiopsies + 1 forceps biopsy taken. Bronchial blocker used for hemostasis.
[Plan]
Admit overnight. Monitor for pneumothorax.",1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31628,31654",golden_019.json
"[Indication]
Foreign body aspiration, respiratory failure.
[Anesthesia]
General (Propofol/Fentanyl).
[Description]
FB identified (Peanut) R lung. Removal via basket/forceps. Airways patent post-removal.
[Plan]
Wean vent. CXR.",0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
"[Indication]
Idiopathic tracheal stenosis.
[Anesthesia]
General.
[Description]
Stenosis ID'd. CRE Balloon dilation (8-12mm). Patency improved from 40% to 80%.
[Plan]
Discharge. F/U ENT.",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
"[Indication]
LLL Nodule (Adenocarcinoma), Medically Inoperable.
[Anesthesia]
General, ETT.
[Description]
Navigation to LLL lateral basal segment (Veran). Radial EBUS confirmation. Cryoablation performed (3 cycles: 6min/6min/5min). Ice ball confirmed via fluoroscopy and REBUS. No complications.
[Plan]
Admit, Telemetry, post-op CT.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"[Indication]
LLL Nodule.
[Anesthesia]
Moderate Sedation.
[Description]
EMN navigation. Concentric REBUS. Sampling: TBNA, TBBx, Brush.
[Plan]
Follow pathology.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"[Indication]
LUL GGO.
[Anesthesia]
Moderate Sedation.
[Description]
EMN navigation to LUL. Concentric R-EBUS view. TBNA, TBBx, Brush performed.
[Plan]
Pathology pending.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"[Indication]
LUL NSCLC, nonsurgical candidate.
[Anesthesia]
General.
[Description]
Navigated to LUL. Confirmed position. MWA performed (65W). Complicated by pneumothorax. 10Fr pigtail placed.
[Plan]
Admit. Monitor chest tube.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654,32557",golden_019.json
"[Indication]
Left pleural effusion, symptomatic.
[Anesthesia]
Local (Lidocaine).
[Description]
US-guided thoracentesis. 1.3L removed. Samples sent.
[Plan]
Monitor O2. Diuretics.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
"[Indication]
Lung mass, adenopathy.
[Anesthesia]
Moderate Sedation.
[Description]
EBUS 4R/7 (Positive). RUL Biopsy/Brush performed.
[Plan]
Wait for final path.",1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
"[Indication]
Lung nodules RUL/RLL.
[Anesthesia]
General.
[Description]
Robotic Nav to RUL & RLL. REBUS confirmation. Transbronchial biopsies performed x2 lobes.
[Plan]
Discharge. CT f/u.",1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
"[Indication]
Lung-RADS 4B nodule (26mm, Lingula).
[Anesthesia]
General, ETT.
[Description]
Galaxy robotic scope used. Registration error 2.1mm. TiLT+ identified 1.8cm divergence; target updated. rEBUS: Adjacent. Sampling: TBNA (5 passes), Forceps (4 samples), Brush.
[Plan]
Results conference 5-7 days. CXR.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"[Indication]
Lung-RADS 4B, 14mm RML.
[Anesthesia]
General.
[Description]
Galaxy navigation. TiLT+ used to sync target (2.1cm divergence). rEBUS concentric. TBNA performed.
[Plan]
Monitor for pneumothorax (negative on immediate check). Discharge.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
"[Indication]
Lung-RADS 4B, 29mm LLL.
[Anesthesia]
General.
[Description]
Galaxy Nav to LB6. TiLT correction 1.4cm. rEBUS adjacent. TBNA, Forceps, Brush performed.
[Plan]
Pathology follow-up.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"[Indication]
Lung-RADS 4X nodule, 22mm RUL.
[Anesthesia]
General, ETT.
[Description]
Galaxy navigation to RB3. TiLT+ correction of 1.4cm divergence. rEBUS eccentric. TBNA (22G) and BAL performed. Fiducial placed.
[Plan]
Discharge to home. Follow up 1 week.",1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
"[Indication]
Lung-RADS 4X, 21mm RLL.
[Anesthesia]
General.
[Description]
Galaxy Nav to RB7. Verified via TiLT/Fluoro. TBNA, Forceps, Brush, BAL. Fiducial placed.
[Plan]
Oncology referral pending final path.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"[Indication]
Mediastinal adenopathy, ?Sarcoid.
[Anesthesia]
General.
[Description]
EBUS-TBNA Stations 7 & 11R. ROSE: Granulomas.
[Plan]
Discharge. Follow-up ILD clinic.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
"[Indication]
Mediastinal adenopathy.
[Anesthesia]
Moderate Sedation.
[Description]
Systematic EBUS-TBNA. Stations 2R, 4R, 4L, 7, 11R sampled. Malignancy confirmed in 4R/7.
[Plan]
Oncology referral.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_012.json
"[Indication]
Mediastinal staging, RUL mass.
[Anesthesia]
General.
[Description]
EBUS-TBNA of stations 4R, 7, 11R. 3 passes each. ROSE positive at 4R.
[Plan]
Oncology follow-up.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"[Indication]
Oligometastatic colorectal cancer, RLL nodule.
[Anesthesia]
General.
[Description]
Ion Robot navigation to RLL. REBUS/CBCT confirmation. RF Ablation (40W/480s). Margin confirmed.
[Plan]
Admit to telemetry. CT in 3 months.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"[Indication]
PET-avid RML nodule.
[Anesthesia]
GA.
[Description]
Galaxy nav to RB4. Fluoro confirmed. rEBUS concentric. TBNA, Bx, Brush done.
[Plan]
Pathology pending.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"[Indication]
PET-avid nodule, 28mm LUL.
[Anesthesia]
General.
[Description]
Galaxy Nav to LB3. TiLT correction (1.0cm). rEBUS eccentric. TBNA, Brush, BAL performed. Fiducial placed.
[Plan]
Results in 5-7 days.",1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
"[Indication]
Pleural effusion, r/o malignancy.
[Anesthesia]
Moderate Sedation.
[Description]
Thoracoscopy R chest. Parietal pleura biopsies x10. Fluid drained. No drain left.
[Plan]
Admit. Path pending.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
"[Indication]
Post-biopsy hemorrhage, RUL tumor.
[Anesthesia]
General.
[Description]
Emergent navigation to RUL tumor. RFA applied for hemostasis and tumor destruction. Bleeding resolved. Tumor ablated.
[Plan]
ICU, monitor Hgb/Chest tube.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"[Indication]
RLL Adenocarcinoma.
[Anesthesia]
General.
[Description]
Navigation to RLL (RB9). RFA performed (2 cycles, overlapping). Tumor ablated.
[Plan]
Admit 7 East.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"[Indication]
RLL collapse, hypoxemic respiratory failure.
[Anesthesia]
Deep sedation (Propofol/Fentanyl) in ICU.
[Description]
Mucus plugs identified in RLL basal segments. Therapeutic BAL and suction performed. Airways cleared.
[Plan]
Continue mechanical ventilation. Repeat CXR.",1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
"[Indication]
RLL nodule, PET positive.
[Anesthesia]
General.
[Description]
Ion Robot nav to RLL. REBUS concentric view. TBNA, TBBx, Brush performed. ROSE positive for NSCLC.
[Plan]
Discharge. Staging follow-up.",1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_019.json
"[Indication]
RUL Adenocarcinoma, inoperable.
[Anesthesia]
General.
[Description]
EMN to RUL posterior. Confirmed w/ REBUS/CBCT. Microwave ablation (65W, 5min). Tumor necrosed.
[Plan]
Admit, f/u CT.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"[Indication]
RUL Adenocarcinoma.
[Anesthesia]
General.
[Description]
Navigation to RUL anterior segment. Microwave ablation (60W x 6min). Lesion destroyed. No complications.
[Plan]
Observation, CT in 24h.",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
"[Indication]
RUL nodule.
[Anesthesia]
GA.
[Description]
Galaxy nav to RB2. Fluoro/rEBUS confirmed. TBNA, Forceps, Brush done.
[Plan]
Discharge.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
"[Indication]
Right Pneumothorax.
[Anesthesia]
Local + Moderate analgesia.
[Description]
28Fr Chest Tube placed R 5th ICS. Air evacuated. Lung re-expanded.
[Plan]
Admit. Suction.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
"[Indication]
Severe Asthma.
[Anesthesia]
General.
[Description]
Bronchial Thermoplasty RLL & LLL. 92 Activations. 
[Complications]
Transient bronchospasm.
[Plan]
Discharge. Session 3 in 3 weeks.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
"[Indication]
Small NSCLC, severe COPD.
[Anesthesia]
General.
[Description]
Monarch robot to RUL. Cryoablation performed (2 cycles). Ice ball confirmed on imaging. Hemostasis achieved.
[Plan]
Admit. CT f/u 3 months.",1,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"31627,31641,31654",golden_019.json
"[Indication]
Staging LUL adenocarcinoma.
[Anesthesia]
MAC (LMA).
[Description]
EBUS-TBNA stations 4L, 7, 11L. 22G needle used. ROSE negative for malignancy.
[Plan]
Discharge. Oncology f/u.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"[Indication]
Station 7 adenopathy.
[Anesthesia]
Moderate Sedation.
[Description]
Targeted EBUS Station 7. 5 passes. ROSE adequate.
[Plan]
Discharge.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
"[Indication]
Stent migration LMSB.
[Anesthesia]
General.
[Description]
Visualization: Stent proximal. Action: Repositioned distal using forceps. Balloon dilation 10-12mm. Position corrected.
[Plan]
Extubate. Obs.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"[Indication]
Suspected recurrent SCLC.
[Anesthesia]
General.
[Description]
EBUS-TBNA of 4 stations (2R, 4R, 7, 10R). Recurrence confirmed at Station 7 via ROSE.
[Plan]
Admit to Oncology.",1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31653,golden_019.json
"[Indication]
Suspected sarcoidosis, bilateral hilar adenopathy.
[Anesthesia]
Moderate sedation (midazolam/fentanyl).
[Description]
Cobblestoning observed. BAL performed in Right Middle Lobe. Transbronchial biopsies (x6) taken from Right Lower Lobe medial basal segment with fluoroscopy.
[Plan]
Discharge home. Follow up in clinic.",1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
"[Indication]
Suspicious nodule, 12mm LLL.
[Anesthesia]
General.
[Description]
Galaxy Nav. TiLT correction 2.1cm. rEBUS concentric. TBNA and Brush performed.
[Plan]
Await final path.",1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
"[Indication] Biopsy-negative malignancy.
[Anesthesia] Moderate.
[Description] Left thoracoscopy. Inflammatory changes. 12 parietal biopsies. Diaphragmatic biopsies. Fluid drained. Chest tube placed.
[Plan] Path results.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"[Indication] Cytology-negative effusion.
[Anesthesia] Moderate.
[Description] Right thoracoscopy. Findings: Inflammatory changes. Interventions: 12 biopsies parietal pleura, plus diaphragmatic samples. Fluid drained. Chest tube placed.
[Plan] Path review, oncology consult if positive.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
"[Indication] Malignant pleural disease.
[Anesthesia] Moderate.
[Description] Right thoracoscopy. Inflammatory changes. Talc poudrage performed. Fluid evacuated. Chest tube placed.
[Plan] Monitor.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
"[Indication] Persistent effusion.
[Anesthesia] Moderate.
[Description] Left thoracoscopy. Visceral tumor implants. 11 parietal biopsies. Diaphragmatic biopsies. Talc poudrage.
[Plan] Path results.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"[Indication] Persistent effusion.
[Anesthesia] Moderate.
[Description] Right thoracoscopy. Malignant nodules. 10 parietal biopsies. Diaphragmatic biopsies. Talc poudrage.
[Plan] Path results.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"[Indication] Pleural nodularity.
[Anesthesia] Moderate.
[Description] Right diagnostic thoracoscopy. Findings: Thickened parietal pleura with nodules. Interventions: Fluid evacuation. Chest tube placement.
[Plan] Monitor drainage.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
"[Indication] Staging lung cancer.
[Anesthesia] Moderate.
[Description] Right thoracoscopy. Mass on diaphragm. 12 parietal biopsies taken. Diaphragmatic biopsies taken. Talc poudrage performed.
[Plan] Monitor output, await path.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"[Indication] Suspected TB pleuritis.
[Anesthesia] Moderate.
[Description] Right thoracoscopy. Inflammatory changes. 11 parietal biopsies. Diaphragmatic biopsies. Talc poudrage.
[Plan] Path results.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"[Indication] Suspected mesothelioma.
[Anesthesia] Moderate sedation, local.
[Description] Right thoracoscopy performed. Findings: Diffuse pleural nodularity. Actions: 7 biopsies parietal pleura, plus diaphragmatic biopsies. Talc poudrage performed.
[Plan] Admit, chest tube to suction, path pending.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
"[Indication] Suspected mesothelioma.
[Anesthesia] Moderate.
[Description] Left diagnostic thoracoscopy. Findings: Fibrinous adhesions, trapped lung. Interventions: Fluid evacuation. Chest tube placement.
[Plan] Path review.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
ablation for John Miller today. he has that RUL nodule and cant have surgery. used the superD nav system and the emprint microwave probe. got right to the middle of it checked with the spinny CT. cooked it at 65 watts for 5 mins. temp got up to 85. looks fried on the ultrasound. no bleeding.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
amanda has a history of cancer now has 11mm nodule rul. galaxy scope. saw it on fluoro. eccentric ebus. needle and forceps. rose says granuloma so probably not cancer. good news.,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
angela brown rll nodule big one 31mm. galaxy robot. tilt spin showed 1.8cm divergence cause of how she was laying. fixed it. concentric ultrasound. six needle passes five forceps bites and a brush. put a marker in. rose is cancer squamous.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
anil patel fluid on the left lung heart failure. did a tap at the bedside used the ultrasound to find a good spot. drained 1.3 liters of yellow fluid he feels better breathing now. sent fluid to lab no complications.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,32555,golden_046.json
barbara has a small nodule 12mm lll. galaxy robot used. huge shift 2.1cm probably atelectasis tilt fixed it. concentric ebus which is good. needle and brush used. rose says atypical cant rule out cancer. home.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
bedside bronch for mrs lopez shes clogging up again tube in place went down with the scope tons of thick junk on the right side vacuumed it all out used some saline took a while but got it open left side looked fine no masses or anything just pneumonia improving sats afterwards.,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31645,golden_046.json
bronch for Frank Costanza. did ebus first. 4R and 7 both cancer. then went to the RUL saw the tumor there took bites and a brush. systematic check done. no bleeding.,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31625,31652,99231",golden_012.json
bronch for Kathryn Janeway LLL nodule. used the electromagnetic nav. got a good signal. radial ebus concentric. took biopsies needle and brush. fluoro was 5 mins. patient stable.,1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
"bronchoscopy note - 01/01/2024

pt Pamela Thomas mrn 7532901 is a 85yo female here for bronch w EBUS staging and robotic biopsy of a 23.3mm RLL nodule that was solid on CT, bronchus sign was negative, PET showed SUV 2.8.

under general we did linear EBUS first using the Pentax EB-1990i scope with 21g needle and sampled stations 10R x3, 4R x2, 7 x4, ROSE was there and showed Malignant - squamous cell carcinoma at multiple stations.

then switched to Galaxy robot and navigated to the RLL posterior basal (B10) lesion, registration was 2.4mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with cbct. took 6 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes, no malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Lisa Thompson md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 01/14/2024

pt Samantha Wilson mrn 6632936 is a 65yo male here for bronch w EBUS staging and robotic biopsy of a 15.4mm RML nodule that was ground-glass on CT, bronchus sign was positive, PET showed SUV 4.3.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 21g needle and sampled stations 10R x3, 4L x2, 4R x2, 11L x4, ROSE was there and showed Adequate lymphocytes at multiple stations.

then switched to Monarch robot and navigated to the RML lateral (B4) lesion, registration was 2.5mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Atypical cells.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Brian O'Connor md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 01/18/2025

pt Joshua Chavez mrn 1977516 is a 77yo female here for bronch w EBUS staging and robotic biopsy of a 22.6mm RUL nodule that was solid on CT, bronchus sign was negative, PET showed SUV 9.7.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 22g needle and sampled stations 11R x3, 2L x2, 4R x3, 11L x3, ROSE was there and showed Malignant - adenocarcinoma at multiple stations.

then switched to Galaxy robot and navigated to the RUL apical (B1) lesion, registration was 1.8mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with cbct. took 4 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Suspicious for malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Brian O'Connor md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 02/04/2025

pt Joshua Wright mrn 4946567 is a 55yo female here for bronch w EBUS staging and robotic biopsy of a 19.4mm RUL nodule that was solid on CT, bronchus sign was positive, PET showed SUV 6.7.

under general we did linear EBUS first using the Olympus BF-UC180F scope with 19g needle and sampled stations 10R x2, 2L x2, 11L x3, ROSE was there and showed Malignant - adenocarcinoma at multiple stations.

then switched to Monarch robot and navigated to the RUL anterior (B3) lesion, registration was 1.5mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with augmented fluoroscopy. took 6 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Granuloma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Eric Johnson md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 02/20/2024

pt Benjamin Thompson mrn 3320855 is a 61yo female here for bronch w EBUS staging and robotic biopsy of a 31.2mm LUL nodule that was solid on CT, bronchus sign was positive, PET showed SUV 5.0.

under general we did linear EBUS first using the Olympus BF-UC180F scope with 22g needle and sampled stations 10R x4, 4R x2, 2L x4, 2R x4, 4L x3, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Monarch robot and navigated to the LUL inferior lingula (B5) lesion, registration was 2.2mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with cbct. took 6 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Brian O'Connor md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 03/04/2024

pt Henry Allen mrn 2842565 is a 59yo male here for bronch w EBUS staging and robotic biopsy of a 31.9mm LLL nodule that was ground-glass on CT, bronchus sign was negative, PET showed SUV 13.4.

under general we did linear EBUS first using the Pentax EB-1990i scope with 22g needle and sampled stations 11L x4, 2L x4, 7 x3, 11R x3, 10R x4, ROSE was there and showed Suspicious for malignancy at multiple stations.

then switched to Ion robot and navigated to the LLL anteromedial basal (B7+8) lesion, registration was 3.2mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with fluoroscopy. took 6 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Suspicious for malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Maria Santos md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 03/05/2025

pt Michael Morgan mrn 2889333 is a 81yo female here for bronch w EBUS staging and robotic biopsy of a 23.2mm LLL nodule that was ground-glass on CT, bronchus sign was positive, PET showed SUV 16.0.

under general we did linear EBUS first using the Olympus BF-UC180F scope with 19g needle and sampled stations 11R x4, 2L x2, 4L x4, ROSE was there and showed Suspicious for malignancy at multiple stations.

then switched to Galaxy robot and navigated to the LLL lateral basal (B9) lesion, registration was 2.8mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Suspicious for malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Jennifer Walsh md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 03/26/2024

pt Ryan Wood mrn 3501890 is a 47yo male here for bronch w EBUS staging and robotic biopsy of a 30.4mm RML nodule that was solid on CT, bronchus sign was negative, PET showed SUV 13.0.

under general we did linear EBUS first using the Olympus BF-UC260F-OL8 scope with 22g needle and sampled stations 2R x3, 11R x3, 4R x3, 7 x2, ROSE was there and showed Adequate lymphocytes at multiple stations.

then switched to Monarch robot and navigated to the RML lateral (B4) lesion, registration was 2.6mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 4 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Suspicious for malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Lisa Thompson md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 03/27/2024

pt Eric Scott mrn 3628963 is a 48yo female here for bronch w EBUS staging and robotic biopsy of a 28.6mm RLL nodule that was ground-glass on CT, bronchus sign was negative, PET showed SUV 8.9.

under general we did linear EBUS first using the Olympus BF-UC260F-OL8 scope with 21g needle and sampled stations 10R x2, 11R x2, 11L x4, 2R x4, 4L x4, ROSE was there and showed Atypical cells at multiple stations.

then switched to Ion robot and navigated to the RLL lateral basal (B9) lesion, registration was 2.6mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with augmented fluoroscopy. took 5 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - adenocarcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Michael Rodriguez md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 04/06/2024

pt Anna Cooper mrn 4146357 is a 82yo female here for bronch w EBUS staging and robotic biopsy of a 16.3mm RUL nodule that was part-solid on CT, bronchus sign was positive, PET showed SUV 12.4.

under general we did linear EBUS first using the Olympus BF-UC180F scope with 21g needle and sampled stations 2L x2, 10L x4, 7 x4, ROSE was there and showed Malignant - adenocarcinoma at multiple stations.

then switched to Monarch robot and navigated to the RUL anterior (B3) lesion, registration was 3.0mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with augmented fluoroscopy. took 6 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - adenocarcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Maria Santos md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 04/10/2025

pt Ruth Bell mrn 1818780 is a 62yo male here for bronch w EBUS staging and robotic biopsy of a 27.1mm LLL nodule that was ground-glass on CT, bronchus sign was positive, PET showed SUV 15.4.

under general we did linear EBUS first using the Olympus BF-UC260F-OL8 scope with 19g needle and sampled stations 2L x4, 4R x4, 7 x3, 11R x3, ROSE was there and showed Malignant - squamous cell carcinoma at multiple stations.

then switched to Ion robot and navigated to the LLL posterior basal (B10) lesion, registration was 1.9mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Atypical cells.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

David Kim md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 04/22/2024

pt Larry Watson mrn 5501668 is a 60yo female here for bronch w EBUS staging and robotic biopsy of a 23.3mm RLL nodule that was solid on CT, bronchus sign was negative, no PET done.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 22g needle and sampled stations 2R x4, 10R x3, 2L x2, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Galaxy robot and navigated to the RLL medial basal (B7) lesion, registration was 1.9mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 5 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes, no malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

David Kim md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 05/13/2025

pt David Flores mrn 7641738 is a 59yo female here for bronch w EBUS staging and robotic biopsy of a 34.7mm LUL nodule that was part-solid on CT, bronchus sign was positive, PET showed SUV 12.7.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 21g needle and sampled stations 7 x2, 11R x4, 11L x4, ROSE was there and showed Atypical cells at multiple stations.

then switched to Ion robot and navigated to the LUL superior lingula (B4) lesion, registration was 2.5mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 5 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Suspicious for malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Steven Park md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 05/16/2025

pt Joyce Powell mrn 5318366 is a 80yo female here for bronch w EBUS staging and robotic biopsy of a 20.2mm LUL nodule that was solid on CT, bronchus sign was positive, PET showed SUV 16.9.

under general we did linear EBUS first using the Pentax EB-1990i scope with 21g needle and sampled stations 4L x2, 7 x3, 10R x4, ROSE was there and showed Adequate lymphocytes, no malignancy at multiple stations.

then switched to Galaxy robot and navigated to the LUL inferior lingula (B5) lesion, registration was 2.3mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - small cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Rachel Goldman md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 05/25/2025

pt Kelly Lewis mrn 1384245 is a 57yo female here for bronch w EBUS staging and robotic biopsy of a 16.3mm RLL nodule that was ground-glass on CT, bronchus sign was positive, PET showed SUV 6.9.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 22g needle and sampled stations 11L x4, 4L x3, 10L x2, ROSE was there and showed Granuloma at multiple stations.

then switched to Galaxy robot and navigated to the RLL superior (B6) lesion, registration was 3.4mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 6 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Andrew Nakamura md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 06/29/2024

pt Heather Hall mrn 5444444 is a 78yo male here for bronch w EBUS staging and robotic biopsy of a 31.5mm RML nodule that was part-solid on CT, bronchus sign was positive, PET showed SUV 7.9.

under general we did linear EBUS first using the Pentax EB-1990i scope with 22g needle and sampled stations 4R x2, 4L x4, 10R x2, 2L x2, ROSE was there and showed Malignant - squamous cell carcinoma at multiple stations.

then switched to Monarch robot and navigated to the RML medial (B5) lesion, registration was 3.2mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with augmented fluoroscopy. took 5 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Lisa Thompson md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 07/13/2024

pt Victoria Jackson mrn 2031984 is a 53yo male here for bronch w EBUS staging and robotic biopsy of a 27.1mm RLL nodule that was solid on CT, bronchus sign was negative, PET showed SUV 6.1.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 22g needle and sampled stations 4L x3, 2R x3, 2L x2, ROSE was there and showed Suspicious for malignancy at multiple stations.

then switched to Ion robot and navigated to the RLL superior (B6) lesion, registration was 1.8mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with augmented fluoroscopy. took 5 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Amanda Foster md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 07/23/2025

pt Brian Foster mrn 2582051 is a 46yo male here for bronch w EBUS staging and robotic biopsy of a 30.2mm LUL nodule that was ground-glass on CT, bronchus sign was positive, no PET done.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 22g needle and sampled stations 4R x4, 2R x4, 2L x2, 10L x3, ROSE was there and showed Atypical cells at multiple stations.

then switched to Monarch robot and navigated to the LUL inferior lingula (B5) lesion, registration was 2.2mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with cbct. took 8 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - small cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Sarah Chen md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 08/13/2024

pt Stephanie Rodriguez mrn 1225416 is a 67yo male here for bronch w EBUS staging and robotic biopsy of a 29.4mm LLL nodule that was part-solid on CT, bronchus sign was negative, no PET done.

under general we did linear EBUS first using the Pentax EB-1990i scope with 22g needle and sampled stations 10R x3, 10L x2, 11R x3, ROSE was there and showed Suspicious for malignancy at multiple stations.

then switched to Ion robot and navigated to the LLL lateral basal (B9) lesion, registration was 1.8mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with fluoroscopy. took 6 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Brian O'Connor md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 08/20/2024

pt Betty Chavez mrn 2150564 is a 58yo male here for bronch w EBUS staging and robotic biopsy of a 30.9mm RUL nodule that was ground-glass on CT, bronchus sign was negative, no PET done.

under general we did linear EBUS first using the Pentax EB-1990i scope with 22g needle and sampled stations 4L x2, 10R x4, 4R x4, 7 x2, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Monarch robot and navigated to the RUL anterior (B3) lesion, registration was 2.0mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with fluoroscopy. took 6 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Granuloma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Steven Park md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 08/20/2024

pt Gary Russell mrn 6554649 is a 54yo female here for bronch w EBUS staging and robotic biopsy of a 19.5mm RLL nodule that was solid on CT, bronchus sign was positive, PET showed SUV 5.4.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 19g needle and sampled stations 10R x3, 7 x3, 2R x2, 4R x3, ROSE was there and showed Malignant - adenocarcinoma at multiple stations.

then switched to Ion robot and navigated to the RLL posterior basal (B10) lesion, registration was 3.2mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with fluoroscopy. took 7 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - NSCLC NOS.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Eric Johnson md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 09/19/2025

pt Kathleen Rogers mrn 8900444 is a 85yo male here for bronch w EBUS staging and robotic biopsy of a 14.0mm LUL nodule that was ground-glass on CT, bronchus sign was negative, PET showed SUV 17.6.

under general we did linear EBUS first using the Pentax EB-1990i scope with 22g needle and sampled stations 2L x3, 4L x2, 10R x2, 10L x3, 11L x2, ROSE was there and showed Atypical cells at multiple stations.

then switched to Ion robot and navigated to the LUL apicoposterior (B1+2) lesion, registration was 1.5mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with fluoroscopy. took 7 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes, no malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Rachel Goldman md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 09/23/2025

pt Jack Smith mrn 6516561 is a 65yo female here for bronch w EBUS staging and robotic biopsy of a 27.5mm RLL nodule that was ground-glass on CT, bronchus sign was negative, PET showed SUV 16.3.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 22g needle and sampled stations 11R x2, 4R x4, 11L x3, ROSE was there and showed Malignant - small cell carcinoma at multiple stations.

then switched to Galaxy robot and navigated to the RLL superior (B6) lesion, registration was 2.8mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with cbct. took 4 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes, no malignancy.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Steven Park md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 09/28/2024

pt Amanda Young mrn 2344928 is a 56yo male here for bronch w EBUS staging and robotic biopsy of a 20.0mm RML nodule that was solid on CT, bronchus sign was negative, PET showed SUV 6.5.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 22g needle and sampled stations 2L x4, 4R x3, 11R x3, 11L x2, ROSE was there and showed Malignant - small cell carcinoma at multiple stations.

then switched to Ion robot and navigated to the RML medial (B5) lesion, registration was 2.5mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with augmented fluoroscopy. took 7 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - NSCLC NOS.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

David Kim md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 10/20/2025

pt Rachel Ross mrn 9187833 is a 43yo male here for bronch w EBUS staging and robotic biopsy of a 24.3mm LUL nodule that was solid on CT, bronchus sign was negative, PET showed SUV 12.7.

under general we did linear EBUS first using the Pentax EB-1990i scope with 21g needle and sampled stations 4L x2, 10L x2, 11L x3, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Ion robot and navigated to the LUL superior lingula (B4) lesion, registration was 1.5mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with augmented fluoroscopy. took 4 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Robert Patel md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 11/01/2025

pt Jennifer Evans mrn 4914277 is a 64yo male here for bronch w EBUS staging and robotic biopsy of a 25.0mm LUL nodule that was solid on CT, bronchus sign was positive, PET showed SUV 9.6.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 21g needle and sampled stations 7 x4, 11L x2, 10R x4, 4L x3, ROSE was there and showed Granuloma at multiple stations.

then switched to Monarch robot and navigated to the LUL anterior (B3) lesion, registration was 1.6mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with fluoroscopy. took 4 forceps bx, 3 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - squamous cell carcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Andrew Nakamura md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 11/20/2024

pt Brian Cruz mrn 3387971 is a 61yo female here for bronch w EBUS staging and robotic biopsy of a 16.9mm RML nodule that was solid on CT, bronchus sign was positive, PET showed SUV 16.9.

under general we did linear EBUS first using the Olympus BF-UC190F scope with 21g needle and sampled stations 10R x3, 4L x2, 4R x3, ROSE was there and showed Adequate lymphocytes, no malignancy at multiple stations.

then switched to Monarch robot and navigated to the RML lateral (B4) lesion, registration was 2.5mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with augmented fluoroscopy. took 8 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Adequate lymphocytes.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

David Kim md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 11/24/2025

pt Linda Johnson mrn 6352799 is a 57yo female here for bronch w EBUS staging and robotic biopsy of a 14.5mm RUL nodule that was ground-glass on CT, bronchus sign was positive, no PET done.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 19g needle and sampled stations 11L x4, 7 x2, 2L x3, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Monarch robot and navigated to the RUL anterior (B3) lesion, registration was 3.2mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Atypical cells.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Brian O'Connor md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 11/30/2024

pt Kenneth Coleman mrn 9119205 is a 80yo female here for bronch w EBUS staging and robotic biopsy of a 29.8mm LUL nodule that was ground-glass on CT, bronchus sign was negative, PET showed SUV 13.7.

under general we did linear EBUS first using the Pentax EB-1990i scope with 21g needle and sampled stations 10R x4, 10L x3, 2L x3, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Ion robot and navigated to the LUL anterior (B3) lesion, registration was 1.8mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with cbct. took 8 forceps bx, 2 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Malignant - adenocarcinoma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Katherine Lee md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
"bronchoscopy note - 12/16/2024

pt Robert Rivera mrn 1007314 is a 62yo female here for bronch w EBUS staging and robotic biopsy of a 21.6mm RUL nodule that was ground-glass on CT, bronchus sign was negative, no PET done.

under general we did linear EBUS first using the Fujifilm EB-580S scope with 22g needle and sampled stations 10L x3, 4L x2, 11L x2, ROSE was there and showed Malignant - NSCLC NOS at multiple stations.

then switched to Ion robot and navigated to the RUL anterior (B3) lesion, registration was 1.8mm which is fine, got radial EBUS showing eccentric view and did tool in lesion confirmation with cbct. took 8 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures.

ROSE from the nodule was Granuloma.

no bleeding no ptx   patient did well

specimens to path for cyto, surgical path, cell block, flow, molecular if needed

d/c home after recovery with standard precautions, f/u 1-2wks for path

Robert Patel md
ip attending",1,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31653,31654",golden_074.json
carol here for lll nodule 13mm. galaxy scope. breathing moved the target 1.9cm tilt fixed it. adjacent ebus view. just did needles. rose thinks nsclc.,1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
charles rodriguez rll nodule. galaxy robot. huge divergence on tilt 2.3cm atelectasis. fixed it. adjacent ultrasound. needle biopsy forceps and a wash. put a fiducial in. rose thinks its non small cell cancer.,1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_057.json
cryo ablation procedure for Lucia Morales today for that LLL cancer shes not a surgery candidate. used general anesthesia intubated. used the veran system to get out there took a while cause of the angle. radial ebus confirmed it solid mass. stuck the cryo probe in froze it three times just to be sure cause its big. saw the ice ball on fluoro looks good. no bleeding really pulled everything out woke her up sent to pacu.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
danielle morgan back for her second thermoplasty session doing the lower lobes today. went smoothly did about 90 burns total in the right and left lower lobes. she got a little tight during the case gave some nebs and steroids she opened up. going home today.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,31661,golden_046.json
diag bronch for charlene king she has hilar adenopathy so we looked for sarcoid. sedation was midaz and fent. airways looked bumpy cobblestone pattern. did a wash in the rml and then took biopsies from the rll medial basal segment using the forceps. no bleeding really. xray showed no lung collapse she went home after.,1,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31628",golden_019.json
diagnostic bronch for Jun-Ho Jung small GGO in the LUL. used the nav system got right to it. radial ebus showed we were in the middle. took a bunch of samples needle biopsy brush. patient did fine no pneumothorax.,1,0,0,0,0,1,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31629,31654",golden_012.json
diagnostic scope on the right side saw some thickened pleura and nodules didn't do biopsies just drained the fluid and put the tube in lung came up fine no air leak sending to floor,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
did a right thoracoscopy on mr taylor saw a lot of nodules on the pleura took about 7 biopsies from the wall and some from the diaphragm sent for path then we did talc poudrage to stop the fluid chest tube is in place no air leak patient fine,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
did the right thoracoscopy on mr wilson saw a mass on the diaphragm took 12 biopsies from the wall and some from the diaphragm too decided to do the talc poudrage while we were in there drained the fluid chest tube is in looks good,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
done by Dr Foster for Kenji Sato. RUL cancer. used the superD to get there and radial ebus to see it. put the microwave needle in. burned it for 6 mins at 60 watts. looks like we got it all based on the scan after. patient woke up fine no pneumo.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
elizabeth lewis here for rll nodule biopsy and marker placement. galaxy robot used. pretty big divergence on the tilt spin 1.7cm so good thing we checked. fixed it. concentric view on ultrasound. did 7 needle passes 4 bites and a brush. put a gold marker in for radiation. rose looks suspicious for cancer.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
emergency bronch for Edward Gibson he was bleeding from that IR biopsy yesterday chest tube putting out blood. we went in intubated him. used the nav system to find the hole in the tumor. stuck the RFA probe in there. cooked it at low power to stop the bleed then high power to kill the cancer. worked great bleeding stopped chest tube looks clear now. sending back to ICU.,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31641,golden_012.json
evelyn sanders fluid on the right lung looks like cancer. did the thoracoscopy looked inside nodules all over the wall. took a bunch of biopsies like 10 of them. drained the fluid out. didn't leave a chest tube just stitched it up. waiting on path.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32604,golden_046.json
hannah keller has that tracheal stenosis again hard to breathe. put her to sleep dilated it with the balloon 8 10 then 12 millimeters. opened up nice looks like 80 percent open now little bit of bleeding but stopped. sending her home.,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31630,golden_046.json
icu bronch for mr rogers he had a collapsed lung on the xray. tube size 8. went down there and saw a lot of thick mucus blocking the right lower lobe. washed it out with saline and sucked it all up. sat dropped a bit to 84 but came back up. lung should be open now kept him on the vent.,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31624,golden_019.json
jacob carter choked on a peanut ems intubated him. right lung down. went in with the scope giant peanut mess in the right main. used the basket and grabbers took a while to get it all out in pieces. cleaned it up nicely lung is up now on xray.,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31635,golden_046.json
james has a pet avid nodule lul. we did the galaxy bronch today. registration ok. tilt showed the nodule was 1cm off from the ct so we fixed that. did needles brushes and a wash. also dropped a seed for radiation. rose guy said it looks weird necrotic. no issues.,1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
jason has a tiny 8mm nodule in the lingula. used galaxy. tilt showed 1.1cm off. fixed it. saw it on ebus. needles and brushes. rose says squamous cell carcinoma. tough case but got it.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
kathleen here for the rll nodule 21mm. galaxy scope. reg was super good 2.7mm. fluoroscopy and tilt confirmed we were right on it. did needles forceps brush and wash. put a gold seed in. rose says its cancer adenocarcinoma. told the family we are waiting for finals.,1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31626,31627,31629,31654",golden_086.json
left side diagnostic scope saw a lot of adhesions and trapped lung didn't biopsy just drained the fluid and put the tube in lung expanded okay no air leak,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,32601,golden_076.json
left thoracoscopy for william inflammation seen no nodules took 12 biopsies from the wall and some from diaphragm drained fluid chest tube in no talc,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
left thoracoscopy on kathleen saw tumor implants took 11 biopsies from parietal pleura and some from diaphragm did talc poudrage drained the fluid put the chest tube in,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
linda reyes for ebus checking for sarcoid. lymph nodes looked big at 7 and 11r. poked them with the needle got good samples rose said granulomas. didn't see anything else weird. patient woke up fine going home.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_046.json
linda white 11mm nodule lll. galaxy robot used. registration was a bit loose 3.5mm. did the tilt scan and found the nodule moved 1.3cm probably atelectasis. adjusted and got it with rebus adjacent view. tbna needle and brush used. rose said granulomas so hopefully benign. patient did fine no bleeding.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
michael taylor rul nodule. galaxy robot used. registration 3.2mm. checked with fluoro looks ok. rebus adjacent. did needle and forceps and brush. rose showed granulomas. patient fine.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
patient jessica flores here for lung nodule biopsy used the galaxy robot today under general anesthesia tube was fine. navigated to the lingula lb4 registered ok. did the tilt spin and saw the nodule was way off like 1.8cm so we fixed that on the screen. confirmed with rebus then did tbna forceps and brush rose came back squamous cell so we stopped. patient woke up ok sending to recovery thanks.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
pt is here for lung rads 4x nodule rul. we used the galaxy robot scope registered ok 3.6mm. went to the right upper lobe had to use the tilt spin because the target was off by like 1.4cm. once lined up we saw it on ebus eccentric view. did some needle passes 22g and washed it out. put a marker in too. rose said benign stuff. no bleeding really. done.,1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
rebecca white here for rll nodule biopsy. galaxy robot. navigated down to rb9. tilt showed we were 1.5cm off cause she was breathing deep. adjusted. adjacent view on ultrasound. five passes with the needle and a brush. rose said no cancer seen.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
right side thoracoscopy done for effusion looked mostly inflammatory didn't see nodules but we took a lot of biopsies anyway 12 from the parietal pleura and some from diaphragm just to be sure drained the fluid put the chest tube in no talc used today,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,32609,golden_076.json
right thoracoscopy for elizabeth saw nodules looked malignant took 10 biopsies from the wall plus some from diaphragm did the talc poudrage too drained it all chest tube in place,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
right thoracoscopy for karen she had inflammation no nodules took 11 biopsies from the wall plus some from diaphragm did the talc poudrage too drained it all chest tube in place no leaks,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,"32609,32650",golden_076.json
right thoracoscopy on matthew inflammation seen no nodules did talc poudrage drained the fluid put the chest tube in,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,32650,golden_076.json
ronald green rml nodule 31mm. used the galaxy robot. registration was good 2.1mm. verified with fluoro and concentric rebus. did needle forceps and brush. rose was atypical cells could be cancer. patient discharged ok.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_057.json
samuel norris his stent moved up into the trachea causing coughing. went in with the scope grabbed the edge of the stent and pushed it back down into the left main where it belongs. dilated it with a balloon so it sticks better. looks fine now no tumor growth just migration.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31638,golden_046.json
"sandra came in for the rml nodule. galaxy scope used. reg was 3.9mm. got to the rml and did the tilt spin thing, huge shift 2.1cm from breathing i guess. fixed it and saw concentric view on ebus. stuck it with the 21g needle 7 times. rose showed necrotic junk and maybe cancer. shes fine going home.",1,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31629,31654",golden_086.json
sandra has a big nodule 29mm in the lll. used galaxy. tilt showed we were 1.4cm off so glad we checked. fixed it. did needles forceps and brushing. rose says adeno. patient did fine.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31627,31629,31654",golden_086.json
shirley walker 82 year old female lul nodule. used the galaxy system. tilt scan showed we were off by 1.5cm cause of breathing motion. fixed it. eccentric view on the radar. took a bunch of samples needle and forceps and brush. put a marker in just in case. rose says benign lymphocytes.,1,0,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31626,31627,31629,31654",golden_057.json
stephen has a mass 25mm rul. galaxy used. tilt showed small shift 0.8cm. good samples needle and forceps and wash. dropped a seed. rose confirmed adeno.,1,1,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31624,31626,31627,31629,31654",golden_086.json
susan gonzalez rll nodule 9mm. galaxy robot. fluoroscopy check good. concentric rebus. did needle forceps brush and a wash bal. rose said no cancer seen.,1,1,0,1,0,0,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31623,31624,31627,31629,31654",golden_057.json
targeted EBUS for Jo March. only needed station 7 oncology said dont bother with the rest. it was huge 31mm. stuck it 5 times. rose said it was good. done.,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,31652,golden_012.json
teresa johnson two spots on the lung right side. used the robot to get out there. found the top one with the ultrasound took some bites. then went to the bottom one found that too took more bites. everything went smooth no bleeding patient went home.,1,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"31627,31628,31632,31654",golden_046.json
thomas nguyen young guy spontaneous pneumo right side. pigtail didn't work so put in a real chest tube. 28 french right side 5th intercostal. big rush of air lung came up nicely on the xray. hooked to suction admitting him.,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,32551,golden_046.json
